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Abstract 
 
Pain is an essential tool for survival, but equally important is the ability to overcome pain in life 
threatening events, allowing us to react. Stress-induced analgesia exemplifies this concept as a 
strong acute stressor activates the hypothalamic-pituitary-adrenal glands (HPA) axis and leads to 
the release of adrenaline, dampening pain processing and resulting in transient analgesia. This 
initial response is followed by the release of corticosteroids in order to re-establish physiological 
homeostasis. On the other hand, the effects of chronic stress upon pain perception are not 
consensual as both inhibition (analgesia) and facilitation (hyperalgesia) of nociception has been 
reported in different contexts. Additionally, several studies showed that patients suffering from 
chronic pain display altered HPA axis function, suggesting an intricate relationship between the 
stress and pain modulatory systems.  
To assess the effect of chronic stress upon nociception, a chronic unpredictable stress (CUS) 
paradigm was used in order to warranty a strong and sustained corticosteroid release throughout 
the experimental period. The specific contribution of each corticosteroid receptor towards spinal 
nociception was also evaluated by mimicking CUS through prolonged administration of 
corticosterone [mineralocorticoid- (MR) and glucocorticoid-receptor (GR) agonist] and 
dexamethasone (GR agonist alone), while the influence of CUS upon the supraspinal pain control 
system was assessed by behavioural and electrophysiological approaches. The tract-tracing 
anatomical identification of the pain modulatory areas targeted by the paraventricular nucleus of 
the hypothalamus (PVN), the coordinator of the stress response, set the basis for the 
electrophysiological evaluation of a direct role for the PVN upon descending antinociception in a 
normal and chronic pain (arthritis) scenario. In parallel, the role in pain modulation of the 
dorsomedial nucleus of the hypothalamus (DMH), a contributor to stress-induced hyperalgesia, 
was also evaluated in normal and arthritic rats using the same behavioural and 
electrophysiological approaches. 
Our results show that the unpredictability of stressor application is essential for a strong HPA axis 
activation and subsequent behavioural analgesia. The spinal antinociceptive effect of sustained 
corticosteroid levels appears to be mediated by GR receptor activation, through the decreased 
expression of nociceptive neurotransmitters and enhanced availability of GABAB2 receptors. At 
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the supraspinal level, CUS decreased both the number and the spontaneous and noxious-evoked 
activity of rostral ventromedial medulla (RVM) pronociceptive ON-cells, thus indicating a role for 
the RVM in chronic stress-induced analgesia. The anatomical analysis of the PVN brain 
connections confirmed that this nucleus is part of an intricate bi-directional neuronal network that 
comprises several supraspinal areas involved in pain modulation, amongst which are the RVM 
and caudal ventromedial medulla (CVLM). The pharmacological manipulation of the PVN 
demonstrated that it has an antinociceptive role, mediated by descending serotonergic and 
noradrenergic pathways (but not opioidergic). The serotonergic PVN-mediated effects were 
depressed following the development of arthritis, which suggests that plastic changes in the pain 
control system should contribute to chronic nociceptive pain. Additionally, we demonstrated that 
the PVN has a tonic and phasic descending antinociceptive effect upon nociceptive modulation, 
which is partly mediated through the RVM and CVLM. Interestingly, hyperalgesia induced by 
stress shares at least a common denominator with antinociceptive descending modulatory 
pathways, as RVM nociceptive cells are also modulated by the DMH. The manipulation of the 
DMH demonstrated its facilitatory nociceptive effect in normal animals. However, the DMH is not 
involved in the pain-induced hyperalgesia occurring during chronic nociceptive pain, as its 
nociceptive facilitatory drive is absent in arthritic animals. Finally, the descending drive from the 
PVN, but not the DMH, is maintained in the presence of arthritis, which points to a stronger 
involvement of the HPA axis in chronic inflammatory disorders.  
In conclusion, analgesia induced by CUS is the reflex of profound changes in the neurochemistry 
of the spinal dorsal horn and descending pain modulatory pathways. In chronic inflammation, the 
HPA axis enhanced activity could contribute to the comorbidities associated with pain due to the 
detrimental effects of corticosteroid hypersecretion that occur during its activation. Future studies 
should evaluate the role of limbic (emotional and cognitive) areas, like the amygdala, upon CUS 
and the PVN, and the potential alterations in these areas triggered by the development of chronic 
inflammatory pain. This will elucidate on the mechanisms of emotional alterations associated 
with chronic stress and chronic pain.  
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Resumo 
 
A capacidade de percepcionar estímulos dolorosos é uma ferramenta essencial para a 
sobrevivência de um indíviduo, apenas ultrapassada pela capacidade de conseguir inibir a dor 
em situações de risco nas quais é necessário reagir para sobreviver. A analgesia induzida pelo 
stress é um exemplo deste mecanismo uma vez que numa situação stressante aguda, capaz de 
activar o eixo hipotálamo-hipófise-suprarrenais (HPA), a imediata secreção de adrenalina interfere 
com a transmissão nociceptiva e resulta numa analgesia intensa mas temporária. 
Posteriormente e como resultado da activação do eixo HPA, ocorre a libertação de 
corticosteróides cuja função é re-estabelecer a homeostasia fisiológica. Por outro lado, o efeito do 
stress crónico na percepção dolorosa não é consensual uma vez que, dependendo do contexto 
experimental, foi já descrita tanto uma diminuição da dor (analgesia) como o seu incremento 
(hiperalgesia). Para além disto, diversos estudos clínicos demonstram que pacientes com dor 
crónica sofrem de disfunção do eixo HPA, o que realça a existência de uma interacção 
importante e complexa entre os mecanismos que modulam a resposta à dor e ao stress. 
Na avaliação do efeito do stress crónico sobre a nocicepção usou-se um paradigma de stress 
crónico imprevisível (CUS) por forma a garantir uma secrecção sustentada de corticosteróides ao 
longo de todo o período experimental. A contribuição específica de cada um dos receptores de 
corticosteróides na modulação espinhal da nocicepção foi avaliada através da administração 
prolongada de corticosterona [agonista dos receptores mineralocorticóides (MR) e 
glucocorticóides (GR)] e de dexametasona (agonista específico de receptores GR), que 
mimetizaram fisiologicamente os efeitos do CUS. A influência do CUS sobre o sistema 
supraspinhal de controlo da dor foi avaliada em termos comportamentais e pela caracterização 
electrofisiológica da actividade neuronal destas áreas.  
A posterior identificação, através de traçadores anatómicos retrógrados e anterogrados, de áreas 
moduladoras da dor que recebem projecções por parte do núcleo paraventricular do hipotálamo 
(PVN), a área coordenadora da resposta fisiológica ao stress, serviu de base para a avaliação 
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electrofisiológica do envolvimento directo deste núcleo na modulação descendente da dor em 
animais normais ou com dor crónica (artrítica). Em paralelo, procedeu-se à avaliação 
comportamental e electrofisiológica do papel do núcleo dorsomedial do hipotálamo (DMH) na 
modulação da dor, já que este núcleo parece mediar a hiperalgesia induzida pelo stress.  
Os nossos resultados demonstram que a aleatoriedade na aplicação prolongada do stress é um 
factor determinante na sustentação da activação do eixo HPA e na subsequente analgesia. O 
efeito antinociceptivo do stress crónico ao nível da medula espinhal parece ser mediado pela 
activação de receptores GR, os quais diminuem a expressão de neurotransmissores nociceptivos 
e aumentam a disponibilidade dos receptores GABAB2 no corno dorsal da medula espinhal. A 
nível supraspinhal, o CUS induziu uma diminuição do número, uma diminuição da actividade 
espontânea e uma diminuição da resposta a estímulos nóxicos das células pronociceptivas ON 
do bolbo rostroventromedial (RVM), evidenciando a participação desta área na analgesia induzida 
pelo stress crónico.  
A avaliação anatómica das projecções do PVN confirmou que este núcleo faz parte de uma 
extensa rede neuronal que compreende conexões recíprocas com várias áreas encefálicas 
envolvidas na modulação da dor, como sejam o RVM e o bolbo caudoventrolateral (CVLM). 
Adicionalmente, a manipulação farmacológica do PVN demonstrou que esta área exerce uma 
acção antinociceptiva através de vias descendentes serotonérgicas e noradrenérgicas (mas não 
opioidérgicas). O efeito antinociceptivo serotonérgico do PVN está deprimido após o 
desenvolvimento de artrite, o que sugere a ocorrência de alterações plásticas no sistema de 
controlo da dor que deverão contribuir para a dor crónica nociceptive. A acção antinociceptiva 
tónica e fásica do PVN sobre a transmissão nociceptiva espinhal, é parcialmente mediada pelo 
RVM e CVLM. Curiosamente, a hiperalgesia induzida pelo DMH partilha parcialmente as vias 
anatómicas com o sistema antinociceptivo descendente da dor, uma vez que as células do RVM 
também são moduladas pelo DMH. A manipulação do DMH confirmou o seu papel 
pronociceptivo em animais normais. No entanto, o DMH não participa na hiperalgesia induzida 
pela dor crónica pois a acção facilitatora deste núcleo desaparece nos animais artríticos. Mais 
ainda, a acção moduladora do PVN (mas não do DMH) é mantida na presença de artrite, o que 
sugere um maior envolvimento do eixo HPA nas doenças inflamatórias crónicas.  
Em conclusão, a analgesia induzida pelo CUS é o espelho de alterações profundas na 
neuroquímica da medula espinhal e das vias descendentes intervenientes no sistema endógeno 
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supraspinhal de controlo da dor. Em patologias inflamatórias crónicas, o aumento da actividade 
do eixo HPA poderá contribuir para as comorbidades associadas à dor como consequência dos 
efeitos deletérios da hipersecreção prolongada de corticosteróides que daí resultam. Estudos 
futuros poderão avaliar o papel das áreas do sistema límbico (emocional-cognitivo), como a 
amigdala, sobre o CUS e o PVN e as alterações plásticas nestas mesmas áreas resultantes do 
desenvolvimento de dor crónica inflamatória. Os dados resultantes contribuirão para elucidar os 
mecanismos das alterações emocionais associados ao stress crónico e à dor crónica.  
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 1. INTRODUCTION 
1.1. Pain as a defence mechanism 
Pain is an aversive experience that results in learned avoidance behaviours, which protect the 
organism to potentially threatening noxious events. Its perception results from the processing of 
the emotional and sensitive components usually evoked by a painful stimulus and classically 
attributed to the activation of the medial and lateral pathways (respectively) of the spinothalamic 
tract (Hodge and Apkarian, 1990). The International Association for the Study of Pain (IASP) 
defined pain as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Apkarian, 2008). It is a 
broadspectrum definition that seeks to encircle all the dimensions of a subjective experience like 
pain and of special importance since pain was not considered a disease until the fourth quarter 
of the last century. The subjectivity of pain results from the fact that, when faced with the same 
stimulus, each individual perceives pain differently and the amount of tissue damage might not 
be directly proportional to pain intensity (Ossipov, 2009). Additionally, pain may chronify and 
remain for long periods, even though no pathological cause is associated with it or when the 
original lesion is already healed, as a result of the deregulation of pain mechanisms (Apkarian, 
2008).  
The most common type of pain is acute or protective pain. Acute pain reflects the encoding of a 
noxious stimulus from the periphery to the central nervous system by specific fibres, the 
nociceptors (Basbaum and Jessell, 2000). Acute pain is a short-lived sensation ranging from 
seconds to minutes in duration and, most importantly, it ceases at the same time, or soon after, 
the noxious stimulus does (Melzack 1999; Millan, 1999). The myriad of afferent sensory modality 
inputs is the result of interplay between the myelinisation degree of transmitting fibres, the type 
of peripheral receptors and the neurotransmitters expressed by each fibre and spinal cord 
targets. Of the three fibre types (Aβ, Aδ and C-fibres) of primary afferent neurones involved in the 
transmission of sensory information, only Aδ and C-fibres are involved in acute nociceptive 
transmission (D’Mello and Dickensen, 2008). However, it has been recently argued that the 
overall exclusion of Aβ-fibres from nociceptive processing is mainly the consequence of 
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experimental limitations (Djouhri and Lawson, 2004). Additionally, Aβ-fibres may be involved in 
pain arising during chronic pain syndromes (Lekan et al., 1996). 
1.1.1. Nociceptors 
Aδ- and C-fibres, responsible for fast and slow nociceptive transmission (respectively) (Meyer et 
al., 2008), contribute differently to the development and maintenance of pain (Pertovaara, 1998; 
Fuchs et al., 2000, Magerl et al., 2001). Besides the velocity of transmission, these fibres can be 
further subdivided into groups according to the type of noxious stimulation to which they respond 
(mechanical, thermal or chemical stimulation) (Lewin and Moshourab, 2004), with a fibre 
responding to more than one modality being denominated as polymodal (Magerl et al., 2001). 
Large and some small myelinated fibres terminate in the dermis ensheathed by Schwann cells, 
forming encapsulated endings that are involved in innocuous perception (Meisnner, Merkel and 
Vater-Pacini corpuscles), whereas Aδ and C-fibres terminate as free-nerve endings in the dermis 
and the epidermis (Willis, 2007).  
Non-myelinated C-fibres can be divided in peptidergic and nonpeptidergic fibres according to its 
neurotransmitter expression (Snider and McMahon, 1998). Peptidergic C-nociceptors express 
both calcitonin gene-related peptide (CGRP) and substance P (SP) and project to lamina I and 
outer lamina II (IIo) of the spinal cord dorsal horn, whereas non-peptidergic C-fibres project only 
to inner lamina II (IIi) (Coutaux et al., 2005). The third group of nociceptors comprise the thinly-
myelinated Aδ-neurones, with fibres terminating in lamina I; a set of Aδ-fibres terminate also in 
lamina V upon spinal nociceptive neurones receiving convergent input from Aδ- (nociceptive) and 
Aβ- (innocuous) fibres (multireceptive neurones; see below) (Basbaum et al., 2009). Aδ-
nociceptors contain CGRP and SP and their membrane express receptors for nerve growth factor 
(NGF) (McCarthy and Lawson, 1989; Coutaux et al., 2005). On the other hand, non-peptidergic 
C-nociceptors express the ATP-gated ion channel P2X3 and express c-Ret neurotrophin receptors 
that respond to glial-derived neurotrophic factor (GDNF) (Snider and McMahon, 1998; Hunt and 
Mantyh, 2001; Zylka et al., 2005; Zylka, 2005) whereas peptidergic C-neurones express TrkA 
neurotrophin receptor targets of NGF (Coutaux et al., 2005; Basbaum et al., 2009). A part of the 
nociceptors containing CGRP also expresses somatostatin (SOM) (Sakamoto et al. 1999). It is 
worth noting that while spinal CGRP originates exclusively from primary afferents (Chung et al., 
4
1988), SP is also present in some spinal neurons and in axons descending from the brainstem 
(Todd and Spike, 1993; Ribeiro-da-Silva and Hokfelt, 2000).  
1.1.2. Spinal Cord and Ascending Pathways 
Intense stimulation (noxious) of peripheral receptors is transduced by membrane receptors in an 
electrical signal that is conveyed by C- and Aδ-fibres and result in the release of 
neurotransmitters in the dorsal horn of the spinal cord (Millan, 1999). Inputs from peripheral 
nociceptive are distributed at different lamina levels of the dorsal horn, and although most 
nociceptors synapse in laminae I and II, some projection neurones in laminae IV-V are also 
targeted (Sugiura et al. 1986). Central branches of primary afferent axons terminating in the 
spinal dorsal cord are orderly distributed based on the degree of myelinisation, sensory modality 
and location of the receptive field (Todd, 2002). As shown above, while C-fibres mainly synapse 
in lamina I and II neurones (Sugiura et al., 1986), Aδ-afferents project to laminae II and V (Light 
& Perl, 1979; Craig et al., 1988) and large-diameter Aβ-fibres terminate on deep laminae III to V 
(Brown et al., 1981). The transmission to and from the spinal cord to supraspinal centres is not a 
linear process, as the arriving nociceptive signal may be transmitted supraspinally ipsi- or 
contralaterally, and it may undergo either local modular processing by spinal interneurones (Lu 
and Perl, 2005) or supraspinal descending modulation (Ren and Dubner, 2002) (see below).  
The spinal targets of peripheral sensory fibres are nociceptive-specific (NS), wide-dynamic-range 
(WDR) and non-nociceptive neurones (NNS) (Han et al., 1998). NS or high-threshold neurones, 
which respond merely to noxious stimulation, include projecting neurones and interneurones and 
are found mainly in lamina I, while WDR (multireceptive cells), which respond both to noxious 
and non-noxious stimulation and are found predominantly in the deep dorsal horn (Menetrey et 
al., 1977). Low-threshold NNS cells respond exclusively to non-noxious stimulation (Willis and 
Coggeshall 1991). Nociceptive spinofugal neurones send their axons through ascending spinal 
tracts and convey information on the discriminative and emotional aspects of pain to supraspinal 
centres for processing the multidimensional pain experience (Braz et al., 2005; Lima, 2009; 
Polgár et al., 2010) (Figure 1).  
One of the most important ascending pathways is the spinothalamic tract (STT). This pathway 
comprises a lateral part that projects principally to the ventral posterolateral and ventral 
posteromedial nuclei of the thalamus (VPL and VPM) and conveys information related to the 
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sensory-discriminative aspects of pain, and a medial part projecting to the medial thalamus and 
related to the autonomic and emotional aspects of pain (Albe-Fessard et al., 1985; Lima, 2009). 
The VPL is mostly targeted by WDR neurones originating from spinal laminae I and V and relays 
nociceptive information to the somatosensory cortices S1 and S2 (Shi and Apkarian, 1995; Price 
2002). The medial pathway projects to the medial thalamus and, through a spinofugal pathway 
relaying in the parabrachial nuclei (PB), the bed nucleus of the stria terminalis (BNST) (Bester et 
al., 2000), the amygdala (AMY), hypothalamus, nucleus cuneiformis, the periaqueductal gray 
matter (PAG) (Hylden et al., 1989) 
and the anterior cingulated cortex 
(ACC) (Bernard and Besson, 
1990; Bernard and Bandler, 
1998). Other spinoreticular 
projections included in the medial 
pain system are those spinal 
connections with the medullary 
dorsal reticular nucleus (DRt) 
(Almeida et al., 1993; 1995) and 
the caudal ventrolateral medulla 
(CVLM) (Lima and Coimbra, 
1991). 
 
 
Figure 1 – Schematic representation 
of the neuronal networks involved in 
nociceptive processing (Bingel and 
Tracey, 2008). 
 
1.1.3. Supaspinal pain processing 
Human brain imaging studies helped to identify the multiple forebrain regions activated during 
acute painful stimulation (Apkarian, 1995). The main brain regions that are activated during an 
acute painful experience include the primary and secondary somatosensory cortex, the anterior 
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cingulated and prefrontal cortices and the thalamus (Tracey, 2007). Other regions as the basal 
ganglia, cerebellum, AMY and the hippocampus can also be activated depending on the 
experimental designs (Tracey and Bushnell, 2009). Recently, the insular cortex and prefrontal 
cortex (PFC) have been associated to the discrimination of pain intensity (Oshiro et al., 2009) 
while the posterior parietal cortex and right dorsolateral PFC are more involved in spatial 
discrimination of pain (Oshiro et al., 2009). The ACC is also important for the processing of pain 
unpleasantness and learned avoidance behaviours (Craig et al. 1996; Apkarian and Shi 1998; 
Malin et al., 2007). Human imaging studies have demonstrated the activation of the ACC after 
noxious (Casey, 1999), but not innocuous, stimulation (Hutchinson et al., 1999). ACC 
glutamatergic projections have been shown to participate in pain facilitation through direct 
projections to the DRt (Lima and Almeida, 2002; Zhang et al., 2005).  
The AMY receives nociceptive information from lamina I and IIo neurones (Jasmin et al. 1997) 
via the spino-PB-amygdaloid pathway. Information received by the lateral and basolateral 
amygdaloid nuclei (Bernard and Besson 1990; Bernard et al. 1996) and relayed to the central 
nucleus of the amygdala (CeA), an area involved in the affective and autonomic responses to 
pain (Bernard et al., 1996; Neugebauer and Li, 2003; Ansah et al., 2009). The AMY is involved 
in analgesia by opioids, an effect mediated by PAG (Pavlovic and Bodnar 1998) and the rostral 
ventromedial medulla (RVM) (Helmstetter et al., 1998; McGaraughty et al., 2004). Moreover, 
synaptic plasticity in the AMY has been shown following the development of arthritis (Neugebauer 
et al., 2003), whereas structural alterations and plasticity of both nociceptive AMY neurones 
(Gonçalves et al., 2008) and their descending modulatory action upon RVM cells (Ansah et al., 
2009) were demonstrated in neuropathic pain.  
Another target of the spino-PB-amygdaloid pathway is the hypothalamus (Bernard et al., 1993; 
Bester et al., 1997) (Figure 1), an important structure in the regulation of neuroendocrine and 
autonomic functions, strongly involved in homeostasis during nociception (Saadé and Jabbur, 
2008). A number of nuclei within the hypothalamus have already been associated with pain 
processing: the ventromedial hypothalamus is implicated in innate affective reaction to pain 
(Borszcz, 2006), particularly in fear-induced antinociception (Freitas et al., 2009); the anterior 
hypothalamic area differentially modulates C- and A-nociceptive inputs to the spinal dorsal horn 
(Simpson et al., 2008); the lateral hypothalamic area (Holstege, 2004) projects to the RVM and 
produces analgesia when activated (Holden and Pizzi, 2008); in the suprachiasmatic nucleus, 
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the oxytocin expression decreased after noxious stimulation (Yang et al., 2008a); the supraoptic 
nucleus is an antinociceptive nucleus (Yang et al., 2008b) that projects to the brainstem, namely 
to the PAG, RVM and locus coeruleus (LC) (Sawchenko and Swanson, 1982); the arcuate 
nucleus is related to antinociception as it is implicated in the release of endogenous opioids (Sun 
and Yu, 2005) and has serotonergic and noradrenergic projections to the PAG, RVM, LC, PB, and 
nucleus tractus solitarius (NTS) (Sim and Joseph, 1991); finally, the medial preoptic area (MPO) 
is involved in autonomic and sensory functions through its projections to the PAG and reciprocal 
serotonergic projections to the NRM (Murphy et al., 1999) and has a role in supraspinal action of 
prostaglandins (Heinricher et al., 2004). Most of these areas project densely to other 
hypothalamic nuclei as well as to areas involved in pain descending modulation (Millan, 1999; 
Parry et al., 2002). Two of the main hypothalamic areas implicated in descending pain 
modulation, specifically in stress-induced analgesia (SIA) and stress-induced hyperalgesia (SIH), 
the paraventricular nucleus of the hypothalamus (PVN) and the dorsomedial hypothalamic 
nucleus (DMH), respectively, as discussed below. 
 
1.1.4. Pain descending modulatory systems 
As evidenced above, the modulation of pain is not restricted to a single pathway but a multitude 
of systems, facilitatory and inhibitory, working in parallel. Classically, two areas were initially 
associated with antinociception, the descending pain modulatory PAG-RVM-spinal cord pathway 
(Basbaum and Fields, 1984; Fields et al., 1991) (Figure 1). Later, other areas were also involved 
in the positive and negative signalling of pain by descending pathways targeting the spinal dorsal 
horn (Almeida et al., 2006), amongst these being the DRt (Lima and Almeida, 2002) and the 
CVLM (Tavares and Lima, 2002).  
The PAG comprises distinct functional areas differentially involved in emotional coping and 
strongly interconnected (Jansen et al., 1998). Although being considered for a long time a 
powerful antinociceptive area (Basbaum and Fields, 1984), it has now been shown that PAG 
activation enhances the activity of A-fibres while simultaneously inhibiting C-fibre information 
(Waters and Lumb, 2008), thus being able of both an antinociceptive and pronociceptive 
descending modulatory action. Afferent input to the PAG arrives from forebrain limbic areas as 
well as structures in the brainstem (Shipley et al., 1991). The PAG shares reciprocal connections 
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with the PVN, the MPO, the AMY, the PFC and insular cortex (Herrero et al., 1991; Shipley et al., 
1991). It receives also a strong afferent input from the spinal cord (Behbehani, 1995), but spinal 
projections are sparse (Mouton and Holstege, 1994). Importantly, it targets the RVM (Li et al., 
1990; Hudson and Lumb, 1996) and strongly projects to the CVLM (Cobos et al., 2003) and the 
DRt (Almeida et al., 2002). 
The RVM is considered the output centre of the midline pain-modulation system (PAG-RVM-spinal 
dorsal horn) since it mediates the descending modulatory effects of different forebrain areas (see 
above). The RVM projects to both superficial and deep dorsal horn laminae (Fields et al., 1995). 
It is a nucleus defined by function rather than anatomical limits, encompassing the raphe 
magnus nucleus and adjacent reticular formation. Electrophysiological studies on the RVM 
revealed the existence of three different cell types (Fields and Heinricher, 1985), based on their 
firing pattern upon peripheral noxious stimulation. The ON-cells, neurones that start firing 
immediately before a motor response to noxious stimulation occurs, have been associated with 
the facilitation of pain. In contrast, the OFF-cells, which stop firing immediately before a motor 
response to noxious stimulation occurs, are considered antinociceptive (Neubert et al., 2004). A 
third cell type was identified, the NEUTRAL-cells, although no changes in activity were recorded 
prior or during noxious stimulation. The RVM was the first area where facilitation of nociception 
was observed, and a major area where the duality/balance of pain descending 
facilitation/inhibition has been demonstrated (Heinricher et al., 2009). Afferent input to this area 
arises from several nuclei within the cortex, the AMY, the hypothalamus, the PAG and the PB 
(Herman et al., 1997). Efferent RVM projections follow a topographical organization and end 
mainly in the spinal cord dorsal horn (Mason, 2001) with ON- and OFF-cells projecting to laminae 
I, II and V (Fields et al., 1995), those spinal areas containing the Aδ- and C-fibre central 
terminations and spinal nociceptive neurones (see above).  
The DRt was the first exclusively nociceptive facilitatory nucleus described (Almeida et al., 1996; 
1999). The DRt is part of a reciprocal excitatory loop with the spinal cord that is activated by 
cutaneous and visceral noxious stimulation (Villanueva et al., 1988; Almeida and Lima, 1997; 
Lima and Almeida, 2002; Almeida et al., 2006). Accordingly, Sotgiu and colleagues (2008) 
demonstrated that this nucleus is involved in the maintenance of spinal sensitization in 
neuropathic pain states. It also shares reciprocal projections with other brainstem nuclei as the 
RVM, LC, CVLM, NTS, PAG and with forebrain structures like the AMY and PVN (Almeida et al., 
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2002; Leite-Almeida et al., 2006), all of which are involved in descending pain modulation. In 
addition to its direct pronociceptive role upon homeotopic noxious stimulation, it decreases 
neuronal background activity thus enhancing the relevance of the threatening stimulation 
(Bouhassira et al., 1992). 
The CVLM has been shown to have antinociceptive properties, not only by producing profound 
analgesia after electrical stimulation (Gebhart and Ossipov 1986; Janss and Gebhart 1987), but 
also by tonically inhibiting spinal nociceptive neurones (Mansikka et al., 1996; Tavares et al., 
1997). Tavares and Lima (2002) postulated that the CVLM modulated nociceptive transmission 
through direct and indirect pathways to the spinal dorsal horn. Moreover, it was also proposed 
that the CVLM descending modulation mechanism appears to be specific to the nature of the 
stimuli and the type of cell where it originates from (Tavares and Lima, 2002). It has been 
demonstrated that the CVLM has reciprocal connections with lamina I and II spinal neurones 
(Tavares and Lima 2002) and with the RVM and the NTS (Cravo and Morrison, 1993; Kawano 
and Masuko, 1996; Cobos et al., 2003). Another interesting fact is that the CVLM, as part of the 
ventrolateral medulla (VLM), is strongly involved in the integration of autonomic functions (Ally, 
1998), namely the hypoalgesia resulting from increased blood pressure (Tavares et al., 1997b). 
Additionally, a noradrenergic nociceptive modulation from the CVLM was shown to be mediated 
by an indirect descending action relaying in the noradrenergic A5 group (Tavares et al., 1997a; 
Marques-Lopes et al., 2010). Finally, the CVLM and the NTS are part of a three-way loop that 
includes supraspinal reciprocal connections with the PVN (Krukoff et al., 1994; Kawano and 
Masuko, 1996).  
Overall, nociception arriving at the spinal dorsal horn by peripheral sensitive fibres is conveyed by 
ascending tracts to several interconnected cerebral structures involved in sensorimotor functions 
and emotional processing. Information resulting from these areas is transmitted to brainstem 
structures directly involved in pain modulation through descending projections to the spinal 
dorsal horn. The resulting spinal modulation in normal conditions is translated into a direct 
presynaptic modulation of primary afferents terminals and/or postsynaptic modulation of both 
second order spinofugal projection neurones and spinal interneurones (Fields et al., 1991). In 
pathological conditions, the ability to process and control nociception is compromised, the areas 
involved in the pain circuitry suffer plastic changes leading to the disruption between 
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antinociceptive and pronociceptive actions (Vanegas and Schaible, 2004; Almeida et al., 2006) 
and the resulting pain chronification no longer has a valuable biological function.   
1.2. Chronic pain 
Persistent pain is a debilitating factor for both the physiological and psychological health of 
patients (Bair et al., 2003; Gambassi, 2009) and, contrarily to acute pain, it has no apparent 
survival value. The central nervous system is a dynamic structure and its plasticity constitutes the 
basis for the development of pathological conditions (Apkarian et al., 2009), even though the 
cellular and molecular mechanisms behind it are not completely clear. The common clinical 
signs that accompany the development of chronic pain (Dworkin et al., 2007; Apkarian et al., 
2009) are hyperalgesia, allodynia and spontaneous pain (Baron, 2009; Schaible et al., 2009), 
although differences between neuropathic and nociceptive persistent pain in man have been 
reported. By definition, hyperalgesia is the exacerbation of pain after a painful stimulus, allodynia 
is the sensation of pain after an innocuous stimulus is applied and spontaneous pain refers to 
pain sensation that arises without any sort of stimulation (Neumann et al., 1996). All these 
chronic pain symptoms are a consequence not only of an increased responsiveness from 
nociceptors (Lumpkin and Caterina, 2007) but also of plasticity of both central nociceptive 
neurones and the peripheral Aβ-fibres that normally signal innocuous sensation (Devor, 2006; 
2009). In chronic pain, neuropathic pain is the result of nerve injury or disease, in either the 
peripheral or central nervous system, while nociceptive pain (like in arthritis) is a consequence of 
the prolonged activation of nociceptors due to injury and is usually accompanied by inflammation 
(Basbaum and Jessel, 2000). 
1.2.1. Pain in arthritis 
A major public health problem that decreases life quality with heavy costs on national health 
systems is arthritis, or inflammation of the joints. Arthritis is one of the major causes of disability 
in adults, in the USA it affects more than 21% of the adults (46 million) but it is expected to 
increase to 40% by 2030 (Helmick et al., 2008). The incidence of arthritis is slightly higher in 
women and 66% of the patients are under 65 years old. Within arthritis large spectrum, 
osteoarthritis represents about 60% of the cases with the hands and knees been the most 
affected parts. Rheumatoid arthritis (RA) constitutes 3% of the cases with higher incidence in 
older people (Lawrence et al., 2008). In terms of the economical impact of the disease, one in 
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four general practice consultations in the UK are associated with arthritis. In the USA, direct and 
indirect costs of arthritis sum up to $86.2 billion ($51.1 billion and $35.1 billion, respectively). In 
the UK, estimated costs of treating arthritis are £5.7 billion/year besides being the second most 
common cause for absenteeism (206 million working days), corresponding to production loses of 
£18 billion. 90% of referrals for physiotherapy are arthritis related, costing £1.6 billion in 
community and social services (Helmick et al., 2008).  
In addition to postganglionic sympathetic fibres present in surrounding areas, three types of 
primary fibres innervate the knee joints, Aβ-, Aδ- and C-fibres (Schaible et al., 2009). Aβ-fibres 
are mostly involved in proprioception and are activated by innocuous stimulation, while Aβ and C-
fibres are mainly high threshold fibres that respond to noxious mechanical stimulation 
(nociceptors) (McDougall, 2006; Schaible et al., 2009). In arthritis, inflammation causes the 
release of prostaglandins, histamine, cytokines, bradikinins amongst other inflammatory 
molecules, either by the peripheral termination of primary afferents, tissue cells or immune 
system cells (D’Mello and Dickensen, 2008), from the injured site to the adjacent areas. 
Nociceptors in the primary damage areas and later in the surrounding areas suffer plastic 
changes in response properties due to their permanent activation by inflammatory signals 
(Schaible et al., 1991). In monoarthritis of the knee joint, per example, former high-threshold 
mechanically insensitive fibres become responsive after inflammation and are thought to be at 
the origin of joint pain (Schaible et al., 2009). Inflammation caused increased firing rates of these 
fibres during normal joint movements and even during rest periods as often reported by arthritic 
patients. A large proportion of articular neurones are peptidergic with a majority expressing SP, 
CGRP and SOM (Schaible et al., 2009), with SP and CGRP displaying increased expression 
(Buma et al., 2000) following arthritis. In addition to their role in vasodilatation and vascular 
permeability in neurogenic inflammation, SP is involved in peripheral sensitization of mechanical 
receptors (Heppelmann and Pawlak, 1997) while CGRP is correlated to the hypersensitivity of 
spinal neurones during the development of inflammatory states, as well as in its maintenance 
(Neugebauer et al., 1996). Peripheral sensitization of primary afferents is accompanied by 
central sensitization and is thought to set the basis for the development of chronic pain 
syndromes. Central sensitization, or the excitability enhancement of second-order neurons in the 
spinal cord and brain, is at the origin of the hyperalgesia and allodynia (Schaible et al., 2002) 
that, if prolonged in time, leads to the reorganization of pain modulatory pathways (McDougall, 
2006). fMRI studies on patients suffering from knee osteoarthritis revealed a bilateral 
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enhancement of brain activity in the thalamus, S2, insular, and cingulate cortices and unilateral 
increased activity in the putamen and AMY (Baliki et al., 2008).  
During the development of arthritis, an increase in the net descending nociceptive facilitation is 
initially observed (Urban and Gebhart, 1999), but the continuous peripheral inflammation 
gradually leads to enhancement of spinal descending nociceptive inhibition (Ren and Dubner, 
1996). Pinto and colleagues (2007) demonstrated a time dependent shift in c-fos evoked 
expression between the spinal cord and brainstem modulatory centres during inflammatory pain 
development, attributed to changes in the circuitry mediating this process (Almeida et al., 2006). 
These dynamic time-dependent changes have been associated with the activation/deactivation of 
the inhibitory and the facilitatory descending pain modulatory systems within the RVM and LC 
(Ren and Dubner, 1996; Wei et al., 1999; Ren and Dubner, 2002). Early inflammatory 
descending facilitation was correlated to dorsal horn hyperexcitability resulting from the release of 
excitatory amino acids in the spinal cord (Heinricher et al., 1999). Additionally, Miki and 
colleagues (2002) observed after a few hours of inflammation not only a phenotype shift of RVM 
cells from neutral to ON- and OFF-cells, but also changes in the baseline activity of these cells 
(Ren and Dubner, 2002).  
Comorbidity between arthritis and depression and anxiety has been reported in chronic pain 
patients (McWilliams et al., 2004; 2008). Interestingly, Neugebauer and Li (2003) observed an 
increase in the firing rate of AMY neurones (CeA) after the noxious mechanical stimulation of 
inflamed joints. The AMY is involved in the affective and autonomic responses to pain 
(Neugebauer and Li, 2003) and is able to modulate RVM neuronal activity, inhibiting or 
facilitating nociception (McGaraughty and Heinricher, 2002). In chronic pain, it has been 
demonstrated that this pathway undergoes plastic changes (Ansah et al., 2009), which are 
paralleled by structural changes in the AMY (Gonçalves et al., 2008). Another study, in patients 
suffering from primary hip osteoarthritis, that investigated possible morphologic alterations in 
brain areas involved in pain transmission, reported a gray matter decrease in the anterior 
cingulate cortex (ACC), the right insular cortex and operculum, the dorsolateral prefrontal cortex 
(DLPFC), the AMY and the brainstem (Rodriguez-Raecke et al., 2009). Importantly, these 
changes were partly reverted once pain was effectively treated (Rodriguez-Raecke et al., 2009). 
In summary, inflammatory diseases are a major cause of disability on working adults resulting in 
direct and indirect costs that have a huge economical impact on society. In arthritis, the increase 
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in primary afferent input, due to direct stimulation or indirect sensitization of nociceptive and non-
nociceptive fibres, leads to central sensitization and compromises normal sensorimotor and 
emotional processing. Profound modulatory adjustments, involving both pain facilitation and 
inhibition, are primarily observed in brainstem areas involved in descending nociceptive 
modulation, probably as a result of changes in forebrain areas of the limbic (emotional and 
cognitive) system that modulate pain through the brainstem.   
1.2.2. The HPA axis, glucocorticoids and arthritis  
If we could dissect arthritis in two separate components, inflammation and pain, signalling 
pathways for both would share a common player, the hypothalamus-pituitary-adrenals axis (HPA). 
Inflammation activates the HPA, as part of the endogenous anti-inflammatory pathways and 
noxious signalling, and triggers a cascade of autonomic, endocrine and immune responses 
involved in the defensive behavioural response (Coutinho and Chapman, 2010). In normal 
conditions, HPA activation leads to the release of the corticotrophin-releasing hormone (CRH) and 
vasopressin (AVP) by the PVN into the hypophyseal portal vasculature (Figure 2). The binding of 
CRH to its receptors in the pituitary induces the secretion of adrenocorticotropic hormone 
(ACTH), which promotes the release by the adrenal glands of cortisol in humans or 
corticosterone (CORT) in rodents, potent endogenous anti-inflammatory agents, to the systemic 
circulation. In normal conditions, the HPA is modulated by a negative feedback loop in which 
CORT will inhibit the production of CRH by the PVN and stop its response. In some chronic 
inflammatory diseases, like RA, both humans and animals display deficiencies in HPA axis 
function that results in a decreased production of corticosteroids (Sternberg and Wilder, 1989; 
Wilder, 1996; Morand and Leech, 2001; Cutolo et al., 2002). HPA impairment leads to 
decreased production of CRH and CORT, which in turn have been shown to enhance arthritis 
susceptibility (Sternberg et al., 1989), a positive feedback mechanism thought to contribute to 
the maintenance of intractable pain (Tracey, 2002). Indeed, recent data shows that the 
administration of prednisone, a synthetic corticosteroid, reduces morning stiffness and pain in RA 
patients (Kirwan et al., 2010). 
Later studies in patients with RA also verified that HPA hyporesponsiveness was not restricted to 
the hypothalamus but also to blunt responsiveness of adrenal glands (Dekkers et al., 2001). Also 
as a result of inflammation, a third element can be added to this plot - mood disorders and 
plastic alterations of the frontal-amygdalar circuits behind it (Marques, et al., 2009). Not only is 
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the AMY capable of directly modulate pain, but other areas of the limbic system such as 
hippocampus and medial prefrontal (Herman et al., 2005) are able to mediate the activity of the 
HPA (Lupien et al., 2009). The AMY stimulates hypothalamic CRF release through serotonergic 
and adrenergic receptors in the parvocellular PVN (Feldman and Weidenfeld, 1998), an effect 
that is enhanced by elevated circulating CORT levels (Shepard et al., 2003). Chronic pain states, 
mood disorders and persistent inflammation seem to function as positive feedback mechanisms, 
as they mutually exacerbate each other.  
 
 
 
 
 
 
 
 
 
 
Figure 2 – Schematic 
representation of the stress 
circuitry (Lupien et al., 2009).  
 
In response to inflammation, the production of CRH increased in order to raise circulating levels 
of cortisol (Webster and Sternberg, 2004). The negative feedback mechanism adjusting 
cortisol/corticosterone production is mediated by glucocorticoid binding to its receptors either 
directly in the hypothalamus and pituitary (Webster and Sternberg, 2004) or indirectly through 
nuclei within the hippocampal formation, prefrontal cortex, septum and medial preoptic area 
(Ziegler and Herman, 2002; McEwen, 2007; Cerqueira et al., 2008). Corticosteroids bind, with 
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different affinities (Reul et al., 1987), to two receptors, mineralocorticoid receptors (MR) and 
glucocorticoid receptors (GR) (Reul and De Kloet, 1985). GR expression varies amongst species 
although its distribution is similar. In primates and rodents, GR receptors are expressed mainly in 
the hippocampal CA1 and CA2, dentate gyrus, amygdala, PFC, cerebellum, PVN and cortical 
layers II/III and VI, whereas MR receptors can be found in the hippocampus, AMY, PFC, caudate-
putamen, lateral septum and cortical layers II/III and V (Ahima and Harlan, 1990; Ahima et al., 
1991; Patel et al, 2000). Receptor binding affinity is physiologically important as low CORT 
affinity for GR is considered to constitute the basis for the negative feedback mechanism of 
glucocorticoids, while high MR affinity has been associated to the maintenance of CORT levels 
and HPA homeostasis (Ratka et al., 1989; Pace and Spencer 2005; Sousa et al., 2008). Over 
the last decades, the use of glucocorticoids in the treatment of rheumatoid arthritis as an anti-
inflammatory agent has consistently increased (Buttgereit et al., 2004), although prolonged 
usage causes well-characterized clinical side-effects (Rauchhaus et al., 2009). While 
corticosteroid administration is primarily targeted at controlling inflammation levels, a direct 
inhibitory action on pain perception (antinociceptive) has also been described (Habib et al., 
2010). One hypothesis is that increased circulating levels of cortisol alter the ability to retrieve 
consolidated memories therefore decreasing the emotional component of on-going pain 
(Quervain et al., 2009), as observed in some anxiety disorders. On the other hand, 
glucocorticoids have been shown to directly modulate SP, CGRP and SOM content in dorsal root 
ganglia (Smith et al., 1991). The spinal dorsal horn is also a major site of GR expression 
(Gonzalez et al., 1990; Marlier et al., 1995), which has been shown to be enhanced after 
peripheral nerve injury (Yan et al., 1999).  
1.3. Pain modulation by the hypothalamus 
The perpetuation of pain and inflammation is strongly associated with the HPA and, therefore, to 
hypothalamic function. Both factors can be considered as discrete stressors in which temporal 
prolongation produces mal-adaptive responses that are not present in normal conditions. As with 
acute pain, an acute stress response represents an important protective mechanism for the 
survival of the individual. Under circumstances of great stress or fear, like in life threatening 
events, acute intense stress produces profound analgesia, a phenomenon known as SIA (Ford 
and Finn, 2008; Butler and Finn, 2009). A positive correlation between the analgesia and the 
activation of the ipsilateral ACC and the AMY has been shown (Zhang et al., 2003), an effect that 
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is mediated by connections with the PAG (Helmstetter, 1993; Floyd et al., 2000; Zhang et al., 
2003) and RVM (Ford and Finn, 2009). Hypothalamic-mediated SIA is thought to be processed 
either by direct projections to the spinal cord (Robinson et al., 2002; Rojas-Piloni et al., 2007) or 
indirectly through efferent projections to the PAG and the RVM (Cechetto and Saper, 1988), 
which would in turn inhibit nociceptive transmission at the spinal cord (Butler and Finn, 2009). 
Lesion as well as stimulation studies of several hypothalamic nuclei have shown that each 
subnuclei differently mediates SIA (Butler and Finn, 2009) and several neurotransmitters 
expressed in the hypothalamus have also being associated with SIA, amongst which are 
vasopressin (Wideman et al., 1996), oxytocin (Robinson et al., 2002), neurotensin (Seta et al., 
2001) and orexin (Watanabe et al., 2005). Concerning the PVN, its lesion did not alter the 
analgesic response of animals to restraint stress (Fuchs and Melzack, 1996), but the involvement 
of corticosteroids in SIA was demonstrated by Filaretov and colleagues (1996) when the 
administration of DEX in the PVN reduced SIA. However, the role of CORT and CRF in SIA is still 
a matter of discussion as both factors are not only able to promote opioid release but also have 
anti-inflammatory actions known to alter nociception (Ford and Finn, 2008).  
Not all forms of acute stress decrease nociception, as anxiety has been proven to increase 
sensitivity to pain (Rhudy and Meagher, 2001), an event also known as stress-induced 
hyperalgesia (SIH) (Imbe et al., 2006). Unlike fear, anxiety arises from uncertain expectation 
associated with negative anticipation of an uncontrollable event (Ford and Finn, 2008). In 
humans, decreasing anxiety levels of chronic pain patients reduces several components of pain, 
such as the intensity and unpleasantness of a stimulus (Rhudy and Meagher, 2001). Albeit the 
numerous animal and human studies, the mechanisms involved in SIH are still not clear and 
several pathways at both the supraspinal and the spinal cord levels have been proposed. Animal 
models of SIH involve the repeated exposure of animals to inescapable non-noxious stressful 
events like serial defeat stress (Marcinkiewcz et al., 2009), cold environments (Satoh et al., 
1992), periods of restraint (Silva-Torres et al., 2003) or forced swimming (Bradesi et al., 2005), 
followed by an acute measure of thermal, chemical and/or mechanical nociception. Although 
mainly associated with analgesia, a pronociceptive role has been attributed to the PAG under 
stressful conditions, which involves cholecystokinin (CCK) (Lovick, 2008) and its antagonist 
action upon opioid analgesia (Tortorici et al., 2003). Alternatively, Quintero and colleagues 
(2000) proposed that SIH after repeated stress was the result of a decrease in central serotonin 
activity. Also important is the activation of the HPA, as the release of glucocorticoids and 
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catecholamines modify signalling pathways in nociceptors, which enhance hyperalgesia evoked 
by inflammatory molecules like prostaglandins and bradykinin (Khasar et al., 2005; Khasar et al., 
2008). Concerning the spinal cord, repeated swimming increased basal c-fos expression of 
lumbar laminae I, II, V, and VI (Quintero et al., 2003) and cold stress enhanced spinal SP and 
CGRP. A role for the HPA axis in SIH is thus reinforced since SP and CGRP co-localize and are 
regulated by glucocorticoid receptors in the spinal cord (DeLeo et al., 1994). Moreover, Suarez-
Killian and colleagues (1995) observed that stress decreased GABAA receptor activation in the 
spinal cord, a place where presynaptic inhibition classically occurs. The decrease in GABA 
receptor expression could then increase the PVN descending oxytocinergic pathway mediated by 
spinal GABAergic interneurones upon WDR nociceptive neurones (Rojas-Piloni et al., 2007), thus 
enhancing spinal nociceptive transmission (desinhibition).  
Stress dependent analgesia or hyperalgesia is strongly mediated by emotions and appear to be 
dependent on prefrontal cortex activity (Neugebauer et al., 2009). Fear and anxiety seem to be at 
the basis of the nociceptive outcome since when faced with an uncontrollable event; anticipation 
will increase pain perception, while unpredictability will originate analgesia.  
 1.3.1. The paraventricular nucleus of the hypothalamus (PVN) 
The PVN plays a pivotal role in the modulation of the HPA axis and is a major integration centre 
of several circuits as body homeostasis (Blair et al., 1996), circadian rhythm (Pickard & Turek, 
1983), food intake (Leibowitz et al., 1990), gastrointestinal and cardiovascular functions (Li et al., 
2006), learning and memory (McEwen, 2004). Although in the human brain a division between 
parvocellular and magnocellular parts cannot be established as different areas overlap (Goudsmit 
et al., 1992), in rats PVN neurones can be divided in five parvocellular (dorsal, lateral, medial 
periventricular and anterior subnuclei) and three magnocellular (anterior, posterior and medial 
magnocellular subnuclei) areas (Goufman, 1991). PVN neurones can also be divided into three 
groups according to their function: (1) neurones that secrete factors involved in neurohypophysis 
function (produce vasopressin and oxytocin); (2) neurones involved in autonomic control, and (3) 
neurones involved in modulating HPA axis activity (Herman et al., 2008). This was confirmed by 
a recent study by Geerling and colleagues (2010). 
 
Forebrain input to the PVN varies slightly between species, in the rat it originates mainly from the 
lateral septal nucleus and the subicular cortex, the circumventricular organs, the subfornical 
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organ, the amygdala (Silverman et al., 1981) and the paraventricular thalamic nucleus (Ferguson 
et al., 1984). Within the hypothalamus, major afferent projections originate from the preoptic, 
suprachiasmatic, ventromedial and arcuate nuclei, the retrochiasmatic and lateral hypothalamic 
areas, and the contralateral PVN (Silverman et al., 1981). Along the rostro-caudal neuraxis the 
density of afferent projections decreases (Larsen et al., 1991), the main caudal areas projecting 
to the PVN being the PB, LC, ventral medulla, A1 catecholamine cell group and NTS (McKellar 
and Loewy, 1981).  
 
Neurones in the PVN project densely to other hypothalamic areas, such as the arcuate, the 
dorsomedial, the ventral premammillary nuclei and the preoptic region (Wittman et al., 2009). 
Forebrain areas targeted by the PVN include the subfornical organ and organum vasculosum 
laminae terminalis (Larsen et al., 1991), the tuber cinereum area, the central amygdaloid 
nucleus, the bed nucleus of the stria terminalis, the lateral septal nucleus, the paraventricular 
thalamic nucleus and median eminence (Carsen et al., 1990; Wittman et al., 2009). More caudal 
targets are the median eminence, the PAG (Larsen et al., 1991), the NTS (van der Kooy et al., 
1984), the DRt (Almeida et al., 2002), the ventrolateral medulla (Pyner and Coote, 1999), 
including the CVLM (Cobos et al., 2003) and the spinal cord (Sawchenko and Swanson, 1982). 
The contribution of the PVN to pain modulation under stress conditions seems obvious (see 
above). However, a direct involved of the PVN in the descending modulation of pain was only 
established when its electric or chemical stimulation induced profound analgesia (Shiraishi et al., 
1995), whereas its lesion decreased nociceptive threshold (Yang et al., 2008c). To the best of 
our knowledge, a systematic evaluation of both the efferent and afferent connections of the PVN 
with areas of the supraspinal pain control system has still not been performed in a single study. 
As the intricate architecture of the PVN is accompanied by a complex neuropeptide secretion 
pattern (McEwen, 2004), numerous studies have been performed in an attempt to discriminate 
neurotransmitters and pathways that mediate this effect.  
 
Vasopressin (AVP) is expressed by both the magnocellular and parvocellular part (Swanson and 
Sawchenko, 1983) and about 40% of the cells in the medial and dorsal parvocellular subdivisions 
project to the spinal cord and several brainstem areas (Hallbeck and Blomqvist, 1999). However, 
Yirmiya and colleagues (1990) verified that direct PVN-AVP projections were not involved in 
nociception and it has since been proposed that PVN-AVP induced analgesia would result from 
multisynaptic projections to the spinal cord that involved relays in the PAG (Yang et al., 2006b), 
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the RVM (Yang et al., 2006c) and the caudate nucleus (Yang et al., 2006a). In addition, AVP-PVN 
projections to the PAG have been shown to terminate upon cells expressing enkephalin, 
endorphin and dynorphin (Yang et al., 2007), the classic mediators of opioid analgesia (Basbaum 
and Fields, 1984).  
 
About 11 to 16% of PVN neurones projecting to the spinal cord and located in the lateral and 
medial parvocellular subdivision (Sawchenko and Swanson, 1982; Hallbeck et al., 2001), 
express oxytocin (OT), a neurotransmitter also involved in spinal nociceptive processing (Condes-
Lara et al., 2006). PVN-OT projections have been proposed to be activated (Condés-Lara et al., 
2008) and to inhibit evoked input from Aδ and C afferents to the superficial spinal cord (Condés-
Lara et al., 2006), through the activation of GABAergic interneurones (Breton et al., 2008) in the 
substantia gelatinosa (spinal lamina II) (Condés-Lara et al., 2009a;2009b). Curiously, an identical 
effect was also observed in deeper spinal laminae, but only in neuropathic animals (Condés-Lara 
et al., 2003; 2005). The firing pattern of superficial and deeper laminae cells differs as wind-up 
of deeper spinal neurones, which does not occur in superficial neurones, could be prevented by 
OT inhibition of the NMDA receptor (Condés-Lara et al., 2003) in healthy subjects. Importantly, 
the electric stimulation of the PVN resulted in the increase of OT levels not only in the spinal cord 
but also in the cerebrospinal fluid (CSF) and plasma (Martinez-Lorenzana et al., 2008), and thus 
the possibility of the involvement of other players cannot be discarded. 
 
PVN neurones expressing GABA are predominantly involved in the modulation of the sympathetic 
outflow (Zhang and Patel, 1998). GABAergic neurones predominate in the dorsal and ventral 
parts of the PVN and surrounding the dorsal cap (Pyner, 2009). PVN GABAergic projections to 
the spinal cord have been proposed to modulate presynaptically the depolarization of incoming 
Aδ and C-fibers (Condes-Lara et al., 2008). In this context, GABAergic interneurones present in 
lamina I and II (Heinke et al., 2004) that colocalize oxytocin receptors (Reiter et al., 1994) would 
inhibit primary afferent input (Rojas-Piloni et al., 2007). 
 
The PVN is a main local of CRF synthesis, and CRF is strongly involved in the mechanisms 
mediating acute as well as chronic pain. The distribution pattern of its receptors (Van Pett et al., 
2000) in association with the CRF effect on the activation of the HPA axis and its pronounced 
effect in clinical pain has lead to its consideration as a possible pain modulator (Lariviere and 
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Melzack, 2000). However, the role of CRH in nociception is not consensual, as early works 
reported both analgesia and hyperalgesia (Bunnett, 2005; Vit et al, 2006) or no effect (Ayesta 
and Nikolarakis, 1989). The mechanisms of CRF analgesia are also not clear (Mousa et al., 
2007) as some studies stated that it is not mediated by opioids, as spinal opioid antagonists did 
not alter pain threshold after intracerebroventricular administration of CRH (Yarushkina, 2008). 
However, CRF in inflamed tissue is required for opioid receptor-specific antinociception (Schafer 
et al., 1996). Inflammatory pain induced an upregulation of CRF receptors, which was 
concomitant with increased levels of enkephalin expression in interneurones in spinal lamina II 
(Mousa et al., 2007). Additionally, CRF inhibits nociceptive behavior when injected in the AMY 
(Cui et al., 2004), it activates noradrenergic pathways in the LC (Lejeune and Millan, 2003) and 
it stimulates OT release by the PVN (Robinson et al., 2002). On the other hand, Hummel and 
colleagues (2010) recently revealed a higher degree of complexity on the role of CRF in 
nociception, as CRF1 receptors are implicated in hyperalgesia.  
 
A role for epinephrine in PVN-induced analgesia has recently been proposed (Pertovaara, 2006). 
Palkovits and colleagues (1999) observed an increase in the release of cathecolamines in PVN 
during sustained pain stimulation, and the activation of α2-adrenoreceptors (α2-ADR) decreases 
GABAergic inhibition of PVN spinal-projecting neurones (Li et al., 2005). Interestingly, α2-ADR 
expression is significantly increased in arthritis (Brandt and Livingston, 1990) and is thought to 
be involved in the inhibition of hypersensitivity (Mansikka et al., 2004).  
 
1.3.2. The dorsomedial nucleus of the hypothalamus (DMH) 
The DMH mediates sympathetic regulation of cardiovascular activity in emotional stress. Either its 
activation or desinhibition mimetizes changes in arterial pressure, heart rate (Hunt et al., 2010) 
as well as neuroendocrine and behavioural changes that are observed after acute emotional 
stress (Dimicco et al., 2002). It is also involved in food consumption (Renner et al., 2010), 
thermoregulation (DiMicco and Zaretsky, 2007), regulation of ACTH levels (Bailey and Dimicco, 
2001) as well as CORT (Bernardis and Bellinger, 1987) and cathecolamine (Wible et al., 1988) 
secretion and in the regulation of circadian cycles (Bellinger et al., 1976). It has been proposed 
that the DMH shares functions with the PVN in the coordination of the physiological, behavioural, 
and neuroendocrine responses evoked by stress and emotion (DiMicco et al., 2002).  
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In an extensive anatomical study, Thompson and Swanson (1998) observed that most DMH 
inputs also arise from within the hypothalamus (preoptic, arcuate, anterior hypothalamic, 
suprachiasmatic, posterior periventricular and dorsal tuberomammillary nuclei and the 
parvocellular PVN), whereas afferents from other forebrain areas include the thalamus, the 
ventral subiculum, infralimbic PFC, lateral septal nucleus and BNST. Brainstem afferent areas 
include the PAG, PB, and ventrolateral medulla. Concerning DMH efferents, the most densely 
hypothalamic areas innervated by the DMH are the PVN, the periventricular zone, the preoptic, 
suprachiasmatic and parastrial nuclei and the retrochiasmatic area. Descending projections 
target primarily the PAG, the pontine reticular formation, the NTS (Thompson et al., 1996) and 
the RVM (Nogueira et al., 2000); contrary to what is observed for the PVN, almost no efferents 
are observed in the spinal cord.   
 
The application of a series of stressors, like footshock, restraint, swimming and immune 
stimulation, resulted in increased c-fos expression in the DMH is observed after (Elmquist et al., 
1996). At least some aspects of the circuits underlying stress appear to be regulated by 
GABAergic inhibition in both the DMH and PVN and the extensive interconnections between each 
other (Thompson and Swanson, 1998; Singru et al., 2005). The blockade of GABAA receptors or 
the excitation of DMH neurones projecting to the PVN-projecting neurones activates CRF- and 
AVP-releasing neurons and, consequently, the HPA axis (Keim and Shekhar, 1996). On the other 
hand, it has been shown that DMH desinhibition causes thermal hyperalgesia through the 
activation of ON-cells in the RVM (Martensen et al., 2009). Moreover, this study also 
demonstrated a link between behavioural SIH and DMH disinhibition, as a consistent increase of 
RVM ON- and a decrease of RVM OFF-cell firing rate was observed.   
 
1.4. Aims 
The hypothalamus stands as a privilege brain area in the integration of the physiological and 
psychological responses to stress. However, it is a neurochemical mosaic and part of an intricate 
and extensive positive and negative feedback neuronal network involved in many vital functions. 
Although it is involved in nociception, some aspects appear to be more pronounced in the 
presence of several pathologies. Additionally, chronic stress can induce antinociception or 
pronociception and the role of the hypothalamus in these processes is not fully understood. 
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The experimental design in this work focused on the specific components of the stress response 
that contribute to the modulation of pain. More specifically, we aimed at: 
1. Analysing the influence of chronic stress upon pain-like behaviour through the use of a 
chronic unpredictable stress (CUS) paradigm (Chapter 2.1.1) and the chronic exogenous 
administration of corticosteroid receptor agonists (Chapter 2.1.2); 
2. Evaluating the effect of CUS upon the activity of nociceptive neurones in a mapor 
supraspinal pain control centre, the RVM (Chapter 2.1.3); 
3. Identifying anatomical supraspinal targets of the PVN as potential sites for stress-induced 
nociceptive modulation (Chapter 2.2.1); 
4. Evaluating the role of the RVM (Chapter 2.3.1) and CVLM (Chapter 2.3.2) as relay 
centres of the descending nociceptive modulatory action of the PVN, in normal and arthritic 
animals; 
5. Assessing whether SIA and SIH share common descending pathways within the pain 
modulating circuitry through the analysis the role of the RVM in the nociceptive modulatory action 
from the DMH, in normal and arthritic animals (Chapter 2.3.3). 
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Abstract
Chronic stress elicits remarkable alterations to the structure and function of several areas of the central nervous system. Nociception is
known to be affected by chronic stress and age, although the observations are contradictory. Herein we report that both young and old rats
submitted to a chronic unpredictable stress paradigm have reduced nociception in the tail-flick nociceptive test. Moreover, stressed animals
show an increase in nociceptive threshold after three successive exposures to noxious stimulation (within a 2 min interval). While the
sustained stress-induced analgesia is usually attributed to the resulting hypercorticalism, the immediate exacerbation of tolerance to pain
displayed by stressed animals is most likely mediated through other mechanisms due to the very rapid antinociceptive effect observed.
q 2004 Elsevier Ireland Ltd. All rights reserved.
Keywords: Rat; Chronic unpredictable stress; Pain tolerance; Tail-flick; Antinociception
Tissue injury and inflammation are associated with
persistent stimulation of nociceptors, which transmit the
nociceptive input from the periphery to second-order
neurons located in the spinal cord dorsal horn [12]. The
transmission of nociceptive messages at the spinal level can
be modulated by the supraspinal pain control system
through endogenous mechanisms mediated by descending
projections to the spinal dorsal horn [8,12]. Recent studies
have shown that these mechanisms involve the descending
facilitation or inhibition of spinal nociceptive transmission
triggered by the activation of supraspinal pronociceptive or
antinociceptive areas [9,12], respectively. Thus, it is
probable that pain may result from the balance between
opposing supraspinal modulatory actions impinging upon
dorsal horn neurons mediating the transmission of nocicep-
tive information to the brain [12].
Nociception can also be modulated by external factors
through alterations in intrinsic pain pathways. Exposure to
acute stress is amongst these factors, as it is known to
produce analgesia [4]. Yet, nociceptive modulation follow-
ing prolonged exposure to stress is still a matter of dispute,
with some studies reporting an increased pain threshold [1]
while others demonstrate hyperalgesia [4]. While the
mechanisms involved in these phenomena remain cryptic,
it is well known that prolonged exposure to stressful stimuli
activates the hypothalamo-pituitary-adrenocortical axis
(HPA), resulting in sustained elevations of corticosterone
(the dominant endogenous glucocorticoid in rodents) [6].
During their lives organisms are challenged with various
stressors and the ability to handle them varies considerably
with age [15]. There is substantial evidence that aging
impacts on neuroendocrine stress responses, and also in
their deleterious consequences upon brain structure and
function [15]. In addition, age differences in the sensitivity
to phasic nociceptive stimulation have also been reported
but show contradictory results: there are studies demon-
strating that acute nociceptive thresholds increase [13],
decrease [2] and do not change [5] with age. Moreover,
inconsistent data are also reported concerning the response
to tonic painful stimulation and pain inhibitory actions [3].
The present study aims to characterize the influence of
chronic stress on nociception with a triple purpose: to
evaluate the effect on (i) pain perception (nociceptive
threshold) and (ii) tolerance to pain (variation of the
nociceptive threshold following a short successive expo-
sition to the same noxious stimulation), and to analyze (iii)
the influence of age on both pain perception and tolerance to
pain. A model of chronic unpredictable stress was chosen in
order to avoid habituation to the stressor and to maintain
robust the stress response throughout the experiment [16].
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All regulations determined by the local veterinarian
committee (in accordance with the European Community
Council Directive 86/609/EEC) concerning the handling of
laboratory animals and the international ethical guidelines
for the study of experimental pain in conscious animals [19]
were followed. Adult male Wistar rats (Charles Rivers,
Barcelona, Spain) were assigned to one of the following
four groups: (i) young non-stressed controls (YNS) (n ¼ 8;
3 months old) and (ii) old non-stressed controls (ONS)
(n ¼ 8; 18 months old) – both groups were maintained
under standard laboratory conditions; (iii) young chronic
stressed animals (YCS) (n ¼ 8; 3 months old) and (iv) old
chronic stressed animals (OCS) (n ¼ 8; 18 months old) –
both groups were submitted during a period of 21 days to a
chronic unpredictable stress paradigm that consisted of
applying one of several stressors (one stressor per day) in a
random order: forced swimming (three times in a 3 min bath
with a 2 min rest between each; water at ^20 8C),
overcrowding (1 h), restraint (30 min) and placement on a
vibrating/rocking platform (1 h). As shown previously [16],
this stress inducing regimen results in chronically elevated
serum corticosterone titers throughout the experimental
period.
Alteration in pain perception was studied using the tail-
flick (TF) test (Model 7360, Ugo Basile, Comerio, Italy),
which is used to assess reflexive nociceptive thresholds.
Rats were tested on day 21 at 11:00 a.m. by being submitted
to three TF tests within a 2 min interval in order to test for
tolerance to pain stimulation. To avoid bias related to the
handling and testing of the rats, a 1 week period prior to the
first nociceptive test was established for the habituation of
the animals to the behavioral test equipment. Animals were
placed daily in the test room for 2 h followed by a 1 min
handling and 1 min training session in the TF apparatus
(without performing the test).
The statistical evaluation of the results was made as
follows: (a) the nociceptive behavior in old/young rats in
stressed/non-stressed groups was analyzed by performing a
two-way ANOVA (considering age and treatment as
independent variables); (b) the variations of TF latencies
trial by trial (from the first to the third trial) were analyzed
by Student’s t-test on young and old groups of animals.
Differences between means were considered statistically
significant when P , 0:05.
Chronic stress induced significant increases in TF
latencies at two levels: (a) between the mean TF latency
of non-stressed and stressed animals; and (b) between the
first and third TF tests of stressed animals. In fact, TF
latency increased significantly between YNS and YCS
animals (Fig. 1) and between ONS and OCS animals [two-
way ANOVA, Fð1Þ ¼ 14; 567, P , 0:001] (Fig. 1). Impor-
tantly, the analysis of TF latencies trial by trial also revealed
a significant increase in the nociceptive threshold from the
first to the third trial in both young and old stressed animals
(t-tests, P ¼ 0:016 and P ¼ 0:027, respectively) but not in
the control groups (t-tests, P ¼ 0:99 and P ¼ 0:93,
respectively) (Fig. 2). The ANOVA analysis failed to reveal
any effect of age on nociceptive threshold [Fð1Þ ¼ 1; 355,
P ¼ 0:24].
Overall, this study shows that chronic unpredictable
stress inhibits pain-like behavior by increasing the nocicep-
tive threshold. Moreover, the strong analgesia observed
from the first to the third noxious stimulation presented in a
very short period of time, in animals never tested before,
illustrates a remarkable tolerance to a painful stimulus
induced by this model of chronic stress. Finally, this
helplessness-like effect of chronic stress on pain tolerance
was demonstrated in both young and old animals.
Individuals exposed to stressful conditions show an
increased nociceptive threshold, known as stress-induced
analgesia, which may involve a different neurochemical
basis related to stress severity [18]. Consistent with these
findings, we have observed that stressed rats (either young
Fig. 1. Effect of chronic unpredictable stress on the nociceptive behavior of
YNS and YCS rats and of ONS and OCS animals. Mean TF latency on day
21 of treatment. Mean ^ SD.
Fig. 2. Mean TF latency on day 21 of the first and third successive TF tests
applied to young (a) and old (b) animals. Mean ^ SD. *P , 0:05.
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or old) show higher TF latencies when compared to
unstressed controls. Although the influence of stress upon
pain perception has been extensively reproduced in several
laboratories using different acute stress paradigms [18], the
same tests in chronic stressed animals produced contra-
dictory results: some studies report decreased pain percep-
tion in chronically stressed subjects [1], while others
demonstrate the opposite effect (hyperalgesia) [4]. This
apparent paradox might, at least partially, result from
differences in the experimental procedures: indeed, whilst
studies reporting stress-induced analgesia presented repeat-
edly the same stressor, others (like the one herein used)
presented multiple stressors in an unpredictable paradigm.
One likely consequence of these two different protocols
(single vs. multiple stressors) is a remarkable difference in
the development of habituation to stress [4,14]; indeed,
repeated exposure to the same aversive stimulus leads to an
attenuated stress response in these subjects [10], while this
response is still robust in those facing unpredictable
paradigms [16].
Besides the maintenance of robust stress responses
during the entire experimental process, chronically stressed
animals displayed increased tolerance to pain, that is, a
decreased nociceptive reaction to painful stimulation.
Indeed, the re-exposure twice to a TF test in the 2 min
after the first exposure produced a remarkable increase in
latency in chronically stressed animals; although age-
related differences in pain responses have been shown
with conflicting results [3], this effect was not dependent on
the age of the subjects, as it was observed both in young and
old animals. Taking into consideration the short period
mediating the three tests (2 min), it becomes evident that the
mechanisms responsible for the phenomena cannot be
directly ascribed to corticosteroid receptor activation
(which involves activation of nuclear receptors). Alterna-
tively, the sustained hypercorticalism is likely to alter other
neurotransmitter systems/levels. Amongst these opioids are
a likely candidate, as was shown in a potentiation of
morphine analgesia (TF and hot-plate tests) in rats given
inescapable shock prior to pain measurements but not in
animals exposed to escapable shocks or restraint stress [17].
These findings confirm that uncontrollable stress enhances
morphine analgesia [7]. Thus, if inescapable shock leads to
opioid release and subsequent analgesia, a similar mechan-
ism might occur in our stressed animals: more specifically,
the first exposure to the TF test may trigger an abnormally
high release of opiates within the CNS in stressed animals,
and the re-exposure to the test in the next 2 min would still
occur under an analgesic state, thereby accounting for the
increased tolerance to painful stimuli. However, exper-
iments involving the administration of opioid antagonists
before the exposure to successive noxious stimulation are
needed in order to test this hypothesis.
Evidence has recently shown that pain perception is the
result of a fine balance between descending antinociceptive
(inhibiting) and pronociceptive (facilitating) actions upon
spinal nociceptive transmission. In fact, manipulations of
different supraspinal pain control centers have revealed the
existence of nuclei that inhibit or increase [9,12] pain
behavior. Disruption of the neurotransmitter balance
regulating the large network of connections between the
different components of the supraspinal pain control system
may lead to changes in pain perception in the model of
chronic unpredictable stress used in this study.
Furthermore, it was proposed that morphological
rearrangements in the brain structures (e.g. hippocampus)
brought on by various types of allostatic load might
influence the cognitive appraisal of the pain response [11].
While previous studies showed a stress-induced structural
reorganization of the hippocampal formation, the present
study confirms that pain threshold is altered in chronically
stressed subjects. These findings suggest that as a con-
sequence of indirect long-term activation of the HPA axis
by stressful stimuli, central mechanisms of pain perception
are likely to be impaired. Ultimately, a more detailed
evaluation of the morphofunctional consequences of
chronic stress and pain in the limbic system might improve
the knowledge of the motivational-affective component of
pain and help in the design of better therapeutic strategies
for the many subjects currently suffering from chronic pain.
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Abstract
Background: While acute effects of stress on pain are well described, those produced by chronic
stress are still a matter of dispute. Previously we demonstrated that chronic unpredictable stress
results in antinociception in the tail-flick test, an effect that is mediated by increased levels of
corticosteroids. In the present study, we evaluated nociception in rats after chronic treatment with
corticosterone (CORT) and dexamethasone (DEX) in order to discriminate the role of each type
of corticosteroid receptors in antinociception.
Results: Both experimental groups exhibited a pronounced antinociceptive effect after three
weeks of treatment when compared to controls (CONT); however, at four weeks the pain
threshold in CORT-treated animals returned to basal levels whereas in DEX-treated rats
antinociception was maintained. In order to assess if these differences are associated with altered
expression of neuropeptides involved in nociceptive transmission we evaluated the density of
substance P (SP), calcitonin gene-related peptide (CGRP), somatostatin (SS) and B2-γ-aminobutiric
acid receptors (GABAB2) expression in the spinal dorsal horn using light density measurements and
stereological techniques. After three weeks of treatment the expression of CGRP in the superficial
dorsal horn was significantly decreased in both CORT and DEX groups, while GABAB2 was
significantly increased; the levels of SP for both experimental groups remained unchanged at this
point. At 4 weeks, CGRP and SP are reduced in DEX-treated animals and GABAB2 unchanged, but
all changes were restored to CONT levels in CORT-treated animals. The expression of SS
remained unaltered throughout the experimental period.
Conclusion: These data indicate that corticosteroids modulate nociception since chronic
corticosteroid treatment alters the expression of neuropeptides involved in nociceptive
transmission at the spinal cord level. As previously observed in some supraspinal areas, the
exclusive GR activation resulted in more profound and sustained behavioural and neurochemical
changes, than the one observed with a mixed ligand of corticosteroid receptors. These results
might be of relevance for the pharmacological management of certain types of chronic pain, in
which corticosteroids are used as adjuvant analgesics.
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Nociception can be modulated at different levels of the
CNS through facilitating (pronociceptive) or inhibiting
(antinociceptive) central actions [1-3]. One of the levels
where nociceptive modulation takes place is in laminae I–
II of the spinal dorsal horn [4], where nociceptors synapse
upon interneurons and projection neurons [5,6]. The
transmission of nociceptive information in the dorsal
horn involves several events, neuropeptides and fibres.
After peripheral noxious stimulation of unmyelinated
nociceptors the release of calcitonin gene-related peptide
(CGRP) [7], substance P (SP) [8] and somatostatin (SS)
[4,9] is increased although it remains largely unchanged
after innocuous stimulation or stimulation of large myeli-
nated fibres [8,9]. Spinal nociceptive neurons that are
excited by CGRP and SP [10,11] receive numerous synap-
tic contacts from primary afferent terminals colocalizing
these neurotransmitters, whereas non-nociceptive neu-
rons lack synaptic input from boutons with both peptides
[12]. Spinal SS [13] and GABA [14] have an inhibitory
effect on nociceptive neurons, being present mainly in
fibres belonging to local inhibitory interneurons [15].
Acute stress induces analgesia but the effects of chronic
stress in nociception are still controversial, with studies
reporting hyperalgesia after prolonged stress [16], while
others observed analgesia [17]. Recently, we demon-
strated that animals submitted to chronic unpredictable
stress display antinociception in the tail-flick test [18];
since the plasmatic levels of corticosteroids were increased
throughout the entire experimental period, we implicated
these hormones in that phenomenon. Corticosteroids can
bind to two types of corticosteroid receptors, mineraloco-
rticoid (MR) and glucocorticoid (GR) receptors. In basal
conditions, MR display greater occupancy than GR; thus,
conditions resulting in elevation of corticosteroids, e.g.
stress, will result mainly in increased activation of GR.
Importantly, the spinal cord is a corticoid-responsive tis-
sue [19] and within the spinal cord the greatest density of
GR and MR occurs in laminae I–II [20]. Of notice, CGRP
and SP (but not SS) coexist with corticosteroid receptors
in neurons of dorsal root ganglia [21] and some studies
demonstrate that an imbalanced corticosteroid milieu
may affect neuropeptide content in the DRG [22,23].
Importantly, corticosteroids are often used as adjuvant
analgesics in the management of several types of pain [24-
26]. Taken together, these findings predict a potential
influence of corticosteroids in the modulation of spinal
nociceptive transmission.
In the premise that a distinctive activation of MR or GR
could be responsible for altered levels of neuropeptides
involved in spinal nociceptive transmission and, conse-
quently, for diverse pain-like effects we evaluated the den-
sity of CGRP, SP, SS and GABAB2 innervation in the spinal
dorsal horn of animals submitted to prolonged adminis-
tration of CORT (activating both MR and GR) and DEX (a
selective ligand of GR). These data were correlated with
pain-like behaviour measured through the tail-flick and
hot-plate tests.
Results
Pain-like Behaviour
Evolution within groups during the experimental period
Analysis of TF and HP latency in CONT revealed no signif-
icant differences between testing sessions throughout the
experimental period (ANOVArm, TF, P = 0.29 and HP, P =
0.60).
Tail-flick test
The chronic subcutaneous administration of CORT and
DEX resulted in a significant decrease in pain-like behav-
iour. Statistical data indicate that both CORT and DEX
induced a significant increase in TF latencies on day 21
(ANOVAow, P = 0.002, pos-hoc Bonferroni, CORT × CONT,
p < 0.05; DEX × CONT, p < 0.01) (Fig. 1A). However, with
the prolongation of the treatment (day 28) only subjects
under DEX treatment maintained the significant increase
in TF thresholds; in contrast in CORT-treated animals
nociceptive behaviour decreased slightly (ANOVAow, P =
0.0003, pos-hoc Bonferroni, CORT × CONT, p > 0.05, DEX
× CONT, p < 0.001 and DEX × CORT, p < 0.001) (Fig. 1B).
Hot-plate test
The prolonged administration of DEX but not CORT
resulted in a significant decrease in nociceptive behaviour.
Statistical data indicates that HP latencies are significantly
increased in DEX-treated animals on day 28 (ANOVAow, P
= 0.02, pos-hoc Bonferroni, DEX × CONT, p < 0.05) (Fig.
1D). Contrary to what was observed for the TF test, no dif-
ferences between groups were observed on day 21,
although a trend towards an antinociceptive effect was
already observed (ANOVAow, P = 0.07) (Fig. 1C).
Neurotransmitter Spinal Innervation
All statistical data presented in this section referring to
immunoreactivity evaluation is based on the study of the
lumbar portion of the spinal cord as no differences in neu-
rotransmitter-IR were found between cervical and lumbar
portions.
Stereology
The stereological analysis of CGRP-, SP-, SS- and GABAB2-
IR in the spinal dorsal horn after prolonged CORT and
DEX treatment is summarized in figure 2. The expression
of CGRP-IR was significantly decreased in both DEX and
CORT-treated animals when compared to CONT on day
21 (ANOVA2 w, p < 0.0001, pos-hoc Bonferroni, CORT ×
CONT, p < 0.01 and DEX × CONT, p < 0.001) (Fig. 2A)
although this effect was sustained only in DEX animals onPage 2 of 11
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CONT, p < 0.05) (Fig. 2E). The level of SP-IR in CORT and
DEX was not significantly different from CONT on day 21
(ANOVA2 w, P = 0.70) (Fig. 2B) but in DEX-treated ani-
mals there was a significant decrease in SP expression on
day 28 (ANOVA2 w, P = 0.033, pos-hoc Bonferroni, DEX ×
CONT, p < 0.05) (Fig. 2F). No changes were observed
between experimental groups in what concerns SS-IR in
the spinal dorsal horn (ANOVA2 w, day 21, P = 0.86 and
day 28, P = 0.88) (Figs. 2C, G). In DEX-treated animals
GABAB2-IR is significantly increased in both 21 and 28
days (ANOVA2 w, p < 0.0001, DEX × CONT, day 21, p <
0.001 and day 28, p < 0.01). A similar increase was
observed in the CORT-group on day 21 (ANOVA2 w, p <
0.0001, CORT × CONT, day 21, p < 0.001 and day 28, p >
0.05) but GABAB2 to returned to basal levels on day 28
(Figs. 2D, H).
Densitometric Measurements
The results obtained through the densitometric analysis of
CGRP, SP, SS and GABAB2-IR were closely related to those
obtained through the stereological quantification both for
day 21 (Pearson analysis, CGRP21 days, r = 0.98 and p <
0.0001; SP21 days, r = 0.98 and p < 0.0001; SS21 days, r = 0.99
and p < 0.0001; GABAB2,21 days, r = 0.97 and p < 0.0001)
(Figs. 3A, B, C, D) and day 28 (Pearson analysis, CGRP28
days, r = 0.94 and p < 0.0001; SP28 days, r = 0.98 and p <
0.0001; SS28 days, r = 0.94 and p < 0.0001; GABAB2,28 days, r
= 0.95 and p < 0.0001) (Figs. 3E, F, G, H).
Nociceptive behaviourFigur  1
Nociceptive behaviour. Tail (A, B) and paw (C, D) withdrawal latency after chronic corticosteroid treatment for 21 (1) and 
28 (2) days with CORT and DEX. Both CORT and DEX groups display higher TF latencies after 21 days of treatment (A, B) 
although this effect is only sustained by DEX group at the end of the experiment (B); note that only DEX induces an increase in 
hind-paw latency and only after 28 days of treatment (D). (*p < 0.05, **p < 0.01 and ***p < 0.001).Page 3 of 11
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Neuropeptide and receptor expression in the spinal dorsal hornFig re 2
Neuropeptide and receptor expression in the spinal dorsal horn. Immunoreactive content in the dorsal horn of the 
spinal cord after 21 and 28 days of chronic corticosteroid treatment. (CGRP(A, E), SP(B, F), SS(C, G) and GABAB2(D, H); *p < 
0.05, **p < 0.01 and ***p < 0.001).
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Pearson correlation between densitometry and stereology quantification methodsFigure 3
Pearson correlation between densitometry and stereology quantification methods. Pearson correlation for valida-
tion of densitometric versus stereologic quantification methods on days 21(A-D) and 28(E-H). (SS(A, E), SP(B, F), CGRP(C, G) 
and GABAB2(D, H)).
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The present study demonstrates that prolonged adminis-
tration of corticosteroids decreases nociception. The anti-
nociceptive effect reflects both a decrease of
pronociceptive neuropeptide expression and an increased
availability of GABA receptors in laminae I–II of the spinal
dorsal horn. After 21 days of treatment the decrease in
pain-like behaviour was correlated with a decrease in
CGRP and an increase in GABAB2 receptors in the spinal
cord of CORT and DEX treated-animals. Interestingly, the
antinociceptive effect in the CORT-group vanished after
four weeks of treatment (which was paralleled by a resto-
ration of CGRP and GABAB2 expression towards control
levels) while it remained unchanged in DEX-treated rats
(which were correlated with a decrease in spinal content
of both CGRP and SP and increased availability of
GABAB2). These findings confirm that corticosteroid
receptors play a crucial role in the mediation of pain trans-
mission at the spinal cord level.
Pain perception involves the transmission of nociceptive
messages from the periphery to the CNS. This transmis-
sion can be modulated by acute [16] and chronic stress
[16,17]. Recently, we showed that chronic unpredictable
stress, which results in a prolonged elevation of plasmatic
glucocorticoid (GC) levels, decreases pain-like behaviour
[18]. Most actions mediated by chronic stress are attrib-
uted to hypercortisolemia, as the increased secretion of
corticosteroids characterizes the sustained phase of the
stress response [27]. Because corticosteroids can bind to
two types of receptors we decided to further explore the
role of each of these corticosteroid receptors on the noci-
ceptive modulation. It is important to note at this point,
that the confounding effect of drug potency has been con-
sidered, as the doses of each corticosteroid were adjusted
accordingly to their glucocorticoid potency. Thus, in this
experimental paradigm CORT treatment differs from DEX
administration basically in terms of MR activation: while
CORT treatment activates these receptors, DEX does not
bind to MR and because it shuts-off the endogenous secre-
tion of corticosteroids, MR remains unoccupied [28].
The results observed after prolonged daily treatment with
corticosteroids demonstrate that these steroids promote
antinociception. GR are likely to mediate this phenome-
non since a similar response was observed in DEX-treated
animals. The TF test evaluates a spinally organized reflex
[29,30] mediated by C-fibres innervating the tail [31,32]
and motoneurons innervating the three sets of back mus-
cles that control tail movements [33-35]. In contrast, the
HP test involves a supraspinally integrated response, and
thus, represents a more complex behavioural response
[36]. Such difference in the neuroanatomical substrates
implicated in both tests might explain why there was only
a trend towards increased HP latencies after 21 days of
CORT and DEX treatments.
It is admissible that the influence of GC upon neuropep-
tidergic innervation results both from direct and indirect
actions. Indirect actions may result from altered availabil-
ity of GABAB2 receptors in CORT and DEX treated animals
on day 21, as GABAB receptors are well known players in
pain modulation [15,37]. Moreover Kangrga and col-
legues [38] described that the antinociceptive effect of
GABAergic transmission in the spinal dorsal horn results
from presynaptic inhibition of the release of excitatory
amino acids and neurotransmitters from the primary
afferents [14,39] which is in accordance with our observa-
tions that CGRP, a pronociceptive neuropeptide, is
decreased in both CORT- and DEX-treated groups. An
alternative indirect action of glucocorticoids might occur
through the modulatory actions of arachidonic pathways
which down-regulate nerve growth factor (NGF); this, in
turn, is known to exert an inhibitory effect in both the
accumulation and release of CGRP mRNA in nociceptors
[40,41]. In parallel, the direct modulation of glucocorti-
coids can be ascribed to the fact that approximately one
third of the afferents that are immunoreactive to SP or
CGRP, also display immunoreactivity to GR [21]. Thus, it
is plausible to assume that GR activation of nuclear
responsive elements alters the expression of such trans-
mitters in spinal dorsal horn afferents. This hypothesis is
further supported by the fact that it was recently shown
that stressors decrease CGRP expression in the frontal cor-
tex, hippocampus, occipital cortex and hypothalamus
[42].
Curiously, the dissimilarity in pain-like behaviour
observed between CORT and DEX groups after 28 days of
treatment, suggests that other mechanisms involving MR
activation are implicated in the modulation of pain. In
fact, the behavioural differences observed between CORT
and DEX treatment at 28 days were paralleled by distinct
patterns in CGRP, SP and GABAB2 expression in the super-
ficial dorsal horn: while in CORT-treated animals the
expression of both CGRP and GABAB2 was restored to con-
trol levels, DEX treatment resulted in a decreased expres-
sion of SP and CGRP and sustained increase in GABAB2.
The explanations for such discrepancy are more complex,
as besides the local effects at the spinal cord level, they
might involve alterations at the supraspinal level. Indeed,
there is a complex feedback system between the neuro-
transmitters herein studied and GC involving supraspinal
processing that is regulated by MR. There is evidence that
the activation of MR is correlated with GABA modulation
[43] in lamina II [44] of the spinal cord, namely in
interneurones [45], and in other supraspinal pain modu-
lating areas such as the rostroventral lateral medulla
(RVM) [46] or the periaductal grey matter (PAG) [47].Page 6 of 11
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tively inhibit the release of SP, but not of CGRP, [15]
which may account at least partly for the differences
observed between the groups. Another alternative, but not
exclusive, mechanism to explain the differential effect of
DEX and CORT upon neuropeptidergic spinal expression
derives from the specific modulatory effects of MR upon
preprotachykinin (PPT), the precursor of SP expression; in
fact, MR activation has been shown to positively regulate
(up to 50%) mRNA PPT expression in the nervous tissues
[48]. The more persistent changes in pain perception
induced by DEX treatment and measured by an increase in
both the TF and HP latency at day 28 might therefore
result from a decrease in SP fibre innervation in the spinal
dorsal horn.
Contrary to CGRP, SP and GABAB2, no effect of GC was
observed on the spinal levels of SS. This differential
change observed between these neuropeptides illustrates
the selectivity of this process, and is likely to be related
with the lack of coexistence of corticosteroid and SS in the
spinal cord [21]. Interestingly, different neurotransmitters
are associated with different roles in pain modulation
[5,49]. In contrast to CGRP/SP, SS is a tonic inhibitor of
peripheral nociceptors [50]. Thus, the data herein
reported suggests that the effects of chronic corticosteroid
treatment on pain perception are associated with changes
in the nociceptive transmitting system (CGRP/SP) but
would not involve specific alterations in the spinal intrin-
sic modulatory system (SS).
In addition to their presence in the spinal dorsal horn,
both glucocorticoid- [51] and mineralocorticoid- [52]
receptors are present also in neurons of a large number of
supraspinal sites along the rostrocaudal extent of the neu-
raxis in the rat. These include several forebrain and brain-
stem components of the supraspinal pain control system,
including areas like the anterior cingulate cortex [53],
amygdala [54], paraventricular hypothalamic nucleus
[55], periaqueductal grey matter [56], locus coeruleus
[57], rostral ventromedial medulla [58], dorsal reticular
nucleus [59] and caudal ventrolateral medulla [60]. Tak-
ing into account data obtained in the present study on the
effect of corticosteroid manipulation upon spinal neuro-
transmitter content, future studies should explore altera-
tions induced at supraspinal levels. Accordingly,
profound structural, physiological and neurochemical
alterations have been observed at different forebrain areas
following chronic manipulation of corticosteroids [30,61-
63].
Conclusion
The present study shows that corticosteroids modulate
nociception by altering the expression of neuropeptides
involved in nociceptive transmission at the spinal cord
level. Moreover, we demonstrate differential modulatory
actions of different ligands of corticosteroid receptors,
which are of relevance for the pharmacological manage-
ment of those conditions involving chronic pain, in
which corticosteroids are recommended as adjuvant anal-
gesics.
Methods
Subjects
Wistar Han rats obtained from Charles Rivers (Barcelona,
UE), weighting between 200–240 g, at the beginning of
the experiment, were housed in groups of three in stand-
ard polycarbonate cages (45.4 × 25.5 × 20 cm). The light
cycle was 12:12 h with lights on at 9:00 am and housing
was maintained at 22°C and 30% relative humidity.
Water and food were available ad libitum. All regulations
determined by the local veterinarian committee (in
accordance to the European Community Council Direc-
tive 86/609/EEC) concerning the handling of laboratory
animals and the international ethical guidelines for the
study of experimental pain in conscious animals were fol-
lowed [64].
Chronic corticosteroid treatment
Corticosterone, dexamethasone and sesame oil were
acquired from Sigma (St Louis, MO, USA). Subjects were
assigned to one of the following three groups (n = 24):
(i) Controls (CONT). Rats were submitted to vehicle
injection (0.5 ml sesame oil) everyday (05:00 pm), during
3 weeks (n = 4) and 4 weeks (n = 4).
(ii) Corticosterone-treated (CORT). Rats were submitted
over a period of 3 weeks (n = 4) and 4 weeks (n = 4) to a
daily subcutaneous injection (05:00 pm) of 40 mg/kg
dose of 4-Pregnene-11β,21 diol-3,20-dione in sesame oil.
(iii) Dexamethasone-treated (DEX). Rats were submitted
over a period of 3 weeks (n = 4) and 4 weeks (n = 4) to a
daily subcutaneous injection (05:00 pm) of 300 μmg/kg
dose of 9α-fluoro-16α-methylpredenisolone in sesame
oil.
Nociceptive testing
Pain-like behaviour was analyzed for each animal using
the tail-flick (TF) and the hot-plate (HP) tests. In the TF
(Ugo Basile, Comerio, Italy) the time spent the start of the
stimulus and the withdrawal of the tail (nociceptive
latency) was recorded, whereas in the HP (Ugo Basile,
Comerio, Italy) as the heating plate was kept at a constant
temperature of 54 ± 0.5°C, it was the latency for hind paw
licking or jumping was recorded.
In order to determine the nociceptive threshold, rats were
tested before corticosteroid administration (day 0) and onPage 7 of 11
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animals were submitted (11:00 am) to 3 TF tests, within a
2 min interval, and 2 HP test, with 45 min interval (Fig.
4). To avoid bias related with the handling and testing of
the rats, a one-week period prior to the first nociceptive
test was established for the habituation of the animals to
the behavioural test equipment and the researcher. Ani-
mals were placed daily in the test room for 2 h followed
by a 10 minute handling and 1 minute training session in
the TF and the HP apparatus (without performing the
test).
Immunocytochemistry
At the end of the experimental period (21 or 28 days), ani-
mals were anesthetized intraperitoneally (sodium pento-
barbital, 0.5 mg/kg) and perfused transcardially with 4%
paraformaldehyde in PBS 0.1 M, pH 7.2. The spinal cord
was removed and placed in 30% sucrose for 24 h. Portions
of the cervical and lumbar spinal cord enlargements were
sampled. Sections, 30 μm thick, were cut on a vibrating
blade microtome (Leica, Germany) and collected in
superfrosted slides. Sections from the same region for all
subjects and treatments were exposed to the same solu-
tions. Sections were permeabilized for 10 min in 0.2% Tri-
ton X-100 in Tris buffer saline (TBS) and microwaved (20
min) while immersed in citrate buffer (0.1 M). Endog-
enous peroxidase activity was blocked with 3% H2O2 in
PBS (10 min) and non-specific staining was blocked with
4% bovine serum albumin (BSA) in PBS (30 min). Alter-
nating sections were incubated overnight at room temper-
ature in rabbit primary antibodies against CGRP (1:3000;
Chemicon, USA) (Fig. 5), SP (1:3000; Chemicon, USA),
SS (1:3000; Chemicon, USA) and GABAB2 (1:1000,
Chemicon, USA) (Fig. 6) in 0.02% Triton X-100 (PBST).
Antigen visualization was carried out using a universal
detection system (BioGenex, San Ramon, CA) and diami-
nobenzidine (DAB; 0.025% and 0.5% H2O2 in Tris-HCl
0.05 M, pH 7.2).
Stereology
The stereological analysis was performed in the dorsal
horn of CGRP-, SP-, SS-and GABAB2-immunoreacted (IR)
spinal cord sections using StereoInvestigator software
(MicroBrightField, Williston/VT, USA). From each set of
serial sections, ten photomicrographs of areas within the
spinal laminae I–II were obtained at a primary magnifica-
tion of × 50 and analyzed at a final magnification of ×
1000. The number of stained fibres per unit of laminae I–
II volume (numerical density) was estimated using the
optical fractionator method [65]. The surface volume
occupied by laminae I–II stained fibres was calculated on
the basis of the surface density of the fibres (surface area
per unit volume, SV) and the volume of laminae I–II. The
SV was estimated, using a 'staggered' cycloid test system in
order to obtain the total number of intersections between
cycloid arcs and stained fibres. Measurements were made
on laminae I–II regions randomly selected by the soft-
ware.
Densitometric Measurements
The densitometric analysis was performed in the dorsal
horn of CGRP, SP, SS and GABAB2-IR spinal cord sections
using a Zeiss light microscope coupled to a PC, using NIH
Time course of testing and sampling sessions throughout the four week experime tal periodF gure 4
Time course of testing and sampling sessions 
throughout the four week experimental period. 
Within a testing session, tail-flick and hot-plate tests were 
performed according to the time course example for day 7.
Photomicrographs of superficial dorsal horn sectionsFigure 5
Photomicrographs of superficial dorsal horn sections. 
Examples of photomicrographs of superficial dorsal horn sec-
tions immunoreacted for CGRP (A) on days 21 (A1–3) and 28 
(A4–6) for CONT (A1,4), DEX (A2,5) and CORT (A3,6).Page 8 of 11
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measurement corresponded to all the area occupied by
laminas I and II of the spinal dorsal horn, bilaterally. Den-
sity levels and distribution of CGRP-, SP-, SS- and
GABAB2-IR were quantified and, for all sections, back-
ground density measurements were subtracted to these
values.
Data analysis
Statistical analysis was performed using GraphPad Prism
version 4.00 for Windows (GraphPad Software, San Diego
California, USA). A two-way ANOVA (ANOVA2 w) was
used to analyze differences between groups at different
time points, while repeated-measures ANOVA (ANO-
VArm) was used to evaluate efficiency of treatment along
different time points within groups; pos-hoc Bonferroni's
test was used to detect significant differences for both
ANOVA analysis. Densitometric and stereological data
was compared using the Pearson correlation analysis. Dif-
ferences were considered statistically significant when p <
0.05. All values are presented as mean ± SD.
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Chronic unpredictable stress alters the activity of nociceptive modulatory neurones 
in the rostral ventromedial medulla. 
 
Pinto-Ribeiro F, Amorim D., Monteiro AM, Sousa, N, Almeida A 
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of 
Minho, Campus de Gualtar, 4710-057 Braga, Portugal 
 
ABSTRACT 
Descending pain modulation is strongly associated with the activity of presumptive pronociceptive 
ON-cells and antinociceptive OFF-cells of the rostral ventromedial medulla (RVM) (1). We have 
previously demonstrated that chronic unpredictable stress (CUS) is antinociceptive as it 
decreases tail-flick latency (2), an effect that was correlated to changes in the neurochemistry of 
the spinal cord (3). In order to evaluate possible plastic changes in supraspinal pain control 
centres caused by CUS, we recorded the spontaneous and noxious-evoked activity of ON- and 
OFF-cells in the RVM. CUS-treated animals displayed increased tail-flick latencies from the third 
week onwards when compared to control (CTRL) animals. A first analysis of the number of active 
neurones in the RVM revealed a significant decrease in the relative number of ON-and OFF-cells 
and an increase in NEUTRAL-cells in the RVM of CUS-treated animals when compared to CTRL. A 
significant decrease in the number of these cells could alter the ability of this area to modulate 
nociception and partly contribute to the analgesic effect of stress. In what concerns the response 
to peripheral stimulation, neurones in the RVM were classified as wide-range-dynamic (WDR – 
responsive to innocuous and noxious stimuli) and nociceptive specific (NS – responsive only to 
noxious stimuli) receptive neurones. Our study focused on the latter as no change in either the 
number of cells or in their spontaneous activity was observed for RVM WDR-responsive ON-, 
NEUTRAL- and OFF-cells. Overall, the activity of RVM NS responsive neurones was impaired by 
CUS as a significant decrease in their spontaneous activity was observed. In what concerns 
noxious-evoked activity, the decreased activity of pronociceptive RVM ON-cells, but not OFF-cells, 
in CUS-treated animals during thermal noxious stimulation, is in accordance with the stress-
induced analgesia observed in behavioural experiments.  
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These results indicate that CUS induces profound plastic changes in the RVM by both altering the 
number of nociceptive-responsive cells in the RVM and their spontaneous and noxious-evoked 
activity. Future studies should evaluate if the antinociceptive effect of CUS is mediated by the 
main effector of the stress-response, the paraventricular nucleus of the hypothalamus, which is 
known to have an antinociceptive role (4). 
1. Heinricher MM, Tavares I, Leith JL, Lumb BM. 2009. Descending control of nociception: 
Specificity, recruitment and plasticity. Brain Res Rev. 60: 214-225 
2. Pinto-Ribeiro et al., 2004 (see Chapter 2.1.1) 
3. Pinto-Ribeiro et al., 2009 (see Chapter 2.1.2) 
4. Pinto-Ribeiro et al., 2008 (see Chapter 2.3.1) 
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Figure 1 – Behavioural and RVM-electrophysiological evaluation of CTRL and CUS-treated rats 
during noxious stimulation. Tail-flick latency of CUS-treated animals increases in comparison to 
CTRL from the third week onwards (A). The number of active RVM ON- and OFF-cells is 
significantly decreased in CUS-treated animals when compared to CTRL, while the opposite 
occurs for NEUTRAL-cells (B) (CHI-test, p<0.0001). In the analysis of the neuronal activity of RVM 
neurones before (BT) and during noxious peripheral stimulation (T) in CTRL and CUS animals, 
neurones were first divided in wide-range dynamic (WDR) (C) and nociceptive-specific (NS) (D) 
receptive neurones. Overall, CUS decreased the activity of NS (ANOVA2W, F(1,102)=100.8, 
p<0.0001) (D) but not WDR neurones (C) (ANOVA2W, F(1,63)=2.303, p=0.13). Additionally, CUS 
decreased the spontaneous activity of ON- (ANOVA2W, F(1,44)=13.15, p<0.01; BT, p<0.001) and 
OFF-cells (ANOVA2W, F(1,18)=8.093, p=0.011) (E-F) as well as the heat noxious-evoked activity of 
ON- (E) (but not of OFF-) (F) cells in the RVM (ANOVA2W, F(1,44)=13.15, p<0.001; T, p<0.001). 
*p<0.05, **p<0.01 and ***p<0.001 
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Abstract 
The paraventricular nucleus of the hypothalamus (PVN) is involved in the neuroendocrine 
response to stress, including the activation of the endogenous pain inhibitory systems in stressful 
conditions, a phenomenon known as stress-induced analgesia (SIA). Despite extensive evidence 
suggesting the involvement of the PVN in SIA, anatomical data on the neuronal connections of 
the PVN with the supraspinal pain control system is scattered. The purpose of this study was to 
make a detailed identification of areas within the brain that are connected to the PVN, with a 
special emphasis on those that might contribute to its role in pain modulation. Projections to and 
from the PVN were identified after the iontophoretic microinjection of retrograde (CTb) and 
anterograde (BDA) anatomical tracers, respectively, in this nucleus.  
Stained nuclei and fibres, respectively, were mainly located ipsilaterally in the telecenphalon, 
diencephalon and mesencephalon. In the forebrain, the bed nucleus of stria terminalis (BDST), 
lateral septal nucleus, several hypothalamic nuclei (the arcuate, dorsomedial, ventromedial 
nuclei, and posterior hypothalamic area) and medial preoptic area were the areas presenting the 
highest number of labelled neurons, followed by periaqueductal gray matter (PAG), deep 
mesencephalic and gigantocellular nuclei in the brainstem. A large number of stained fibres were 
found in the agranular insular cingulated and ventral orbital cortices, amygdala, BDST, caudate-
putamen, dorsomedial hypothalamic nucleus, anterior and posterior hypothalamic areas, 
preoptic nuclei, followed by smaller amounts of fibres in the PAG. 
These anatomical results are discussed in relation to the neuronal networks involving the PVN in 
the regulation of different physiological systems. 
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1. Introduction 
The paraventricular nucleus of the hypothalamus (PVN), located in the medial part of the 
hypothalamus (Paxinos & Watson, 2005) is an heterogeneous area (Swanson and Kuypers, 
1980) that integrates inputs from many systems (Ferguson et al., 2008), including the 
neuroendocrine (Bester et al., 1997), behavioural (Normandin and Murphy, 2008), 
thermoregulatory (Cham et al., 2006) and cardiorespiratory systems (Swanson and Sawchenco, 
1983; Coote, 1987; 1995; Zhong et al., 2008). Additionally, this nucleus mediates the stress 
response through the activation of the HPA axis (Jankord and Herman, 2008), leading to the 
release of corticosteroids by the adrenal glands (McEwen & Sapolsky, 1995). While investigating 
central afferent projections conveying information on acute stress to the PVN, Larsen and 
Mikkelsen (1995) observed that after a intraperitoneal administration of hypertonic saline, 
retrogradely c-fos activated neurones could be visualized in the subfornical organ, the organum 
vasculosum laminae terminalis, the ventrolateral division of the medulla oblongata (A1 and C1), 
the nucleus of the solitary tract (NTS) and the parabrachial nucleus (PBN). In addition, Cullinan 
and colleagues (1996) verified that after an acute stress stimulus PVN-projecting nuclei included 
the parastrial, supramammillary and dorsomedial hypothalamic (DMH) nuclei and the medial 
preoptic, anterior and posterior hypothalamic areas. More recently, studies investigating the 
circuitry of stress integration demonstrated that areas such as the ventral subiculum, the 
prefrontal cortex, the medial amygdala, the lateral septum, the paraventricular thalamus and the 
suprachiasmatic nucleus also project to the PVN (Herman et al., 2002).  
Of special interest is the connection between stress and pain perception, as acute stress or life 
threatening conditions result in profound transient analgesia, known as stress-induced analgesia 
(SIA), in which the PVN has been partly implicated (Truesdell and Bodnar, 1987; Robinson et al., 
2002). From supraspinal pain control centres, the medullary dorsal reticular nucleus (DRt), 
known to participate in pronociceptive descending control of spinal nociceptive transmission 
(Lima and Almeida, 2002; Almeida et al., 2006), was shown to project to the PVN (Leite-Almeida 
et al., 2006). On the other hand, PVN efferent projections terminate in several areas within the 
pain control system, such as the periaqueductal gray matter (PAG), the raphe magnus (RVM), the 
NTS (Holstege, 1987; Hardy, 2001), the DRt (Almeida et al., 2002) and the substantia gelatinosa 
of the spinal cord (Chen & Toney, 2003). Moreover, studies evaluating the pain-activated 
pathways, through c-fos staining (Hunt et al., 1987; Bullit, 1990), also demonstrate that specific 
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sensory afferents ascend bilaterally from the spinal cord and target the PVN (Akaishi et al., 1988; 
Palkovitz et al., 1999) amongst other areas. Finally, Bonaz and colleagues (2000) showed that 
lamina I, V, VII and X nociceptive neurones project directly to the PVN. Finally, PVN neurons 
activated by noxious stimulation were shown to project directly to the spinal dorsal horn (Condés-
Lara et al, 2009). According to the anatomic, endocrine and electrophysiological evidence, the 
PVN was shown to exert an antinociceptive role (Yirmiya et al., 1990) directly upon the spinal 
dorsal horn (Condes-Lara et al., 2007; 2008; Pinto-Ribeiro et al., 2008) and indirectly through 
the regulation of supaspinal pain control areas like the RVM (Pinto-Ribeiro et al., 2008). However, 
the neuronal afferent and efferent pathways that might mediate nociceptive stimuli impinging on 
the PVN and its descending nociceptive modulatory actions, respectively, remain to be fully 
disclosed. Hence, the present study sought to map the detailed supraspinal brain centres 
connected with the PVN, including those that might participate in this process. 
2. Material and methods 
2.1. Animals 
All experiments were performed in male Wistar-Han rats with 280-320g (Charles Rivers, 
Barcelona, Spain) according to the EEC guidelines (Directive 86/609/EEC) and the local 
veterinarian committee for the Handling of Laboratory Animals. Subjects were maintained under 
standard laboratory conditions at the animal facilities of the Life and Health Science School, 
University of Minho. 
2.2 Retrograde-tracing study 
In order to determine the brain nuclei projecting to the different areas of the PVN, 20 adult male 
rats (280–320g) were injected unilaterally with the retrograde tracer Cholera Toxin subunit B 
(CTb; List Biological Laboratories, Campbell, CA). Animals were anaesthetized with 
pentobarbitalsodium (50mg/kg i.p.) and placed in the stereotaxic frame (Stoeling; Chicago, IL) 
where the scalp was exposed through am incision on the midline of the scalp. A small hole, 
caudal to bregma, was drilled to allow the placement of a glass micropipette (20-30 μm 
diameter) into the brain. An injection of 1% CTb was administered iontophoretically into the right 
PVN using a positive DC current of 2.5μA for 5-10min (5s ON/5s OFF) according to the 
stereotaxic parameters of Paxinos & Watson (2005) (-1.72 mm caudal to bregma, +0.2 mm 
lateral to midline; -8.0 mm dorso-ventral).  After completion of the injection the micropipette was 
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left in situ for 10-15 min before being slowly retracted to avoid reflux of the tracer through the 
micropipette tract. One-two weeks later, the animals were reanaesthetized with 35% chloral 
hydrate (1mL/kg body weight) and rapidly perfused transcardially with 100 ml buffered saline 
phosphate (PBS) followed by 4% paraformaldehyde in 0.1 M PBS (pH 7.4). The perfused brains 
were removed from the animals and postfixed with the same fixative for 2h followed by 8% 
sucrose in 0.1 M PBS at 4°C until further treatment. Before sectioning, the contralateral part of 
the brain was marked; coronal sections of the whole brain of each animal were then cut at 50 
μm using a vibratome. One in every three brain sections was immunoreacted for CTb and 
counterstained using the formol-thionin technique (Donovick, 1974) and one in every three 
section was only immunoreacted for CTb. The immunohistochemical procedures used were 
previously described (Almeida & Lima, 1997; Almeida et al., 2000). Briefly, free-floating sections 
of the brain were immersed in a solution containing PBS with 0.3% Triton X-100 (PBST) and 1.5% 
of H2O2 over 15 min in order to inactivate the endogenous peroxidase activity. Sections were 
incubated overnight at room temperature in a goat primary polyclonal antibody against CTb (List 
Biological Laboratories, USA, 1:40.000 dilution in 0.3% PBST). The sections were washed twice 
in PBST, and they were incubated for 1 h in a 1:200 solution of a biotinylated horse anti-goat 
antibody (Vector Laboratories, Burlingame, USA). The sections were washed with PBST and then 
with 0.1M tris-HCl, pH8.2, and incubated for 1 h at room temperature in PBST containing an 
avidin-biotin complex (ABC, 1:200, Vector Laboratories, Burlingame, USA). Peroxidase was 
revealed using 0.0125% 3,3’-diaminobenzidine tetrahydrochloride (DAB; Sigma 
Immunochemicals, St. Louis, USA) and 0.025% H2O2 in the same buffer. The sections were 
washed, dehydrated and placed on SuperFrost Plus glass slides (Menzel-Glaser, Braunschweig, 
Germany) and mounted in Entellan (Merck, Darmstadt, Germany). In order to determine whether 
the injection was restricted to the PVN, a series of injections were performed in control sites. The 
same procedure as above was used to remove, preserve and develop these brains. Furthermore, 
on the remaining set of sections, control experiments for each experiment were done to 
determine whether the primary or the secondary antibodies produced false-positive results. In 
these experiments, sections were stained with all possible combinations of primary and 
secondary antibodies in which a single immunoprobe was omitted. Omission of primary or 
secondary antibodies resulted in the absence of labeling, demonstrating that no false-positive 
results were obtained with these reagents.  
2.3. Anterograde-tracing study 
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Ten rats received iontophoretic injections (as above) of 10% biotinylated dextran-amine (BDA; 
10,000 MW; Vector Laboratories, Burlingame, USA) in the right PVN through glass micropipettes 
(as above). After the completion of the injection period the micropipettes were left in place for 1o-
15 min before being slowing retracted. Two to three weeks later, animals were reanaesthetized 
and perfused as described above. The entire brain was removed and prepared as above. Coronal 
sections of the entire brain were serially cut on a vibratome at 50 μm and the endogenous 
peroxiade activity was blocked as above. Two in every three successive brain sections were 
immunoreacted with ABC (1:200) for 1 h and then BDA was revealed with 0.0125% DAB and 
0.02% H2O2 in Tris-HCl buffer 0.05 M, pH 7.6. Half of these sections were counterstained using 
the formol-Thionin technique and the remaining were left without any counterstaining. Sections 
were then serially placed in SuperFrost Plus slides, dehydrated and mounted in Entellan (Merck, 
Darmstadt, Germany). Some injections were performed around the PVN in order to confirm the 
labeling of injections restricted to the PVN. In a few sections, omission of ABC resulted in 
absence of labeled fibres in the brain. 
2.4. Data analysis 
Cytoarchitectonic diagrams of the injection sites were made using the aid of a camera lucida. 
Retrogradely and anterogradely labeled neurons and fibres, respectively, in brain areas 
connected with the PVN were identified and superimposed on coronal representations of the rat 
brain (Paxinos and Watson, 2005), following the technique of Leite-Almeida and Almeida (2007). 
All sections were observed under a light microscope (Leica), photographed and identified. In all 
animals and sections, neurons and fibres were counted bilaterally along the rostrocaudal axis 
according to the stereotaxic coordinates of the atlas of Paxinos and Watson (2005). In Table 1 is 
discriminated the number of neurones detected along the brain, whereas the presence of fibres 
were taking into account not only the amount of fibres with labeled terminals but also its 
consistency throughout successive serial sections where a given nucleus is present. The 
nomenclature/abbreviations used to designate brain nuclei and fibre tracts, except for a few 
exceptions, are in accordance with those used by Paxinos and Watson (2005). 
3. Results 
3.1. Injection sites 
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Amongst the fifteen CTb injections, three were restricted to the parvocellular part of the PVN, 
three comprised the parvocellular and magnocellular part of the PVN, one was on the 
magnocellular part of the PVN (Fig. 1A), two were located in the parvocellular part of the PVN and 
the periventricular nucleus, one was strictly on the periventricular nucleus. As control injections, 
one was placed dorsally to the parvocellular part of the PVN; one was located laterally to the PVN 
(Fig. 1B); one was ventral to the magnocellular part of the PVN and two showed no traces of 
injection. Ten animals were injected with BDA, two injections were outside the PVN (Fig. 2B) and 
of the remaining eight, five injections were located within the magnocellular PVN (Fig. 2A), two in 
the parvocellular part and one in the periventricular nucleus. The data presented in this study 
represents results from injections that were strictly within the anatomical borders of the PVN.  
3.2. Retrograde labeling 
CTb-labeled neurons were distributed along the rostrocaudal extension of the brain, but mainly in 
the telencephalon and diencephalon. CTb expression, although bilateral, was predominantly 
ipsilateral to the site of the injection. Analysis of CTb-containing neurons showed that they were 
present mainly in the telencephalon area, followed by the diencephalon and then the brainstem. 
A systematic analysis of the location and density of neurones projecting to the PVN is described 
in Table 1. 
3.2.1. Telencephalon 
The most prominent projections from the telencephalon to the PVN were observed from the 
dorsal tenia tecta (DTT) (bilateral), the intermediate part of the lateral septal nucleus (LSI) 
(bilateral) and the ventral lateral septal nucleus (LSV) (ipsilateral) (Fig. 3A-F). An ipsilateral 
projection to the PVN was shown to occur from the anterior and posterior parts of the anterior 
olfactory nucleus (AOM and AOP), the core of the nucleus accumbens (AcbC), the caudate-
putamen (Cpu), the islands of Calleja (ICj and ICjM) and the cingulated (Cg1 and Cg2) cortex. 
Bilateral projections to the PVN occurred from the dorsal endopiriform nucleus (Den), the 
prelimbic (PrL), the infralimbic cortex (IL), the dorsal peduncular cortex (DP), the shell of the 
nucleus accumbens (AcbSh), the adrenaline cells (C1) and the lateral stripe of the striatum 
(LSS). In the amygdala all the projecting neurones were exclusively located ipsilaterally through 
various subnuclei, such as the medial and lateral divisions of the central amygdaloid nucleus 
(CeM and CeL), the posterior and anterior basolateral and basomedial part of the amygdaloid 
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nucleus (BLP and BLA), in the subiculum (VS) (Fig. 4B), the main part of the intercalated 
amygdaloid nucleus (IM and the of the lateral amygdaloid nucleus (LaVL). More ventrally we 
observed a few scattered labelled neurones in the medial and posterior part of the basomedial 
amygdaloid nucleus (BMA and BMP), the posterodorsal and ventral parts of the medial 
amygdaloid nucleus (MePD and MePV), the posteromedial part of the amygdalohippocampal area 
(AHiPM), the amygdalopiriform transition area (APir) the posterolateral and posteromedial cortical 
amygdaloid nucleus (PLCo and PMCo) and the bed nucleus of the accessory olfactory nucleus 
(BAOT). Some neurones were also observed in the ipsilateral side of the substantia innominata 
(SIB). A smaller number of bilaterally labelled neurones were scattered along the lambdoid septal 
zone (Ld), the medial septal nucleus (MS) and the median forebrain bundle (mfbb). On the other 
hand, a massive number of bilaterally labelled neurones were located in the various subnuclei of 
the stria terminalis (BSTMA, BSTL, BSTLV, BSTMV, BSTMPi, BSTMLi) (Fig. 4A). In the anterior 
part of the anterior commissure (aca) a few neurones were labelled bilaterally, whereas from the 
ventral palladium (VP) the projections were exclusively ipsilateral.  
3.2.2. Diencephalon 
In the diencephalon, a large number of neurones were distributed along several hypothalamic 
nuclei (Fig. 3B-F). In the preoptic region, the anterodorsal preoptic nucleus (ADP), the parastrial 
nucleus (PS) and ventrolateral part of the preoptic nucleus (VLPO) were the main PVN-projecting 
nuclei. Projections from the medial preoptic arca (MPA), the medial, central and lateral parts of 
the medial preoptic nucleus (MPOM, MPOC and MPOL), the posterodorsal preoptic nucleus 
(PDP), the ventromedial part of the preoptic nucleus  (VMPO),  the  supraoptic nucleus  (SO),  the  
lateral preoptic area (LPO), the suprachiasmatic nucleus (Sch) and the retrochiasmatic area 
(Rch) were all bilateral. In the anterior region of the hypothalamus the anterior parvicellular and 
medial and the ventral part of the paraventricular hypothalamic nucleus (PAaP, PaMP and PaV), 
the anteroventral periventricular nucleus (AVPe), periventricular hypothalamus nucleus (Pe) and 
the the medial corticohypothalamic tract (mch) presented bilateral staining. Ipsilateral projections 
were observed only from the central part of the anterior and posterior hypothalamic area (AHC 
and AHP) and the striohypothalamic nucleus (StHy). In the tuberal region of the hypothalamus a 
moderate number of retrogradelly ipsilateral labelled neurones were found and only a few were 
located contralaterally. The nuclei projecting to the PVN were the compact part of the 
dorsomedial hypothalamic nucleus (DMC), the dorsal part and compact part of the dorsomedial 
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hypothalamic nucleus (DMV and DMD) the dorsomedial and the ventrolateral part of the 
ventromedial hypothalamic nucleus (VMHDM and VMHVL), the arcuate nucleus (ArcLP, ArcMP, 
ArcD and ArcM) the posterior hypothalamic area (PH), the tuber cinerum (TC) and the medial 
tuberal nucleus (MTu). In the posterior region of the hypothalamus projections were bilateral from 
the mammillary recess of the 3rd ventricule (MRe) and the ventral and dorsal tuberomammillary 
nucleus (VTM and DTM). In the thalamus, many nuclei presented numerous CTb-labelled 
neurones, mainly ipsilaterally, such as the posterior part of paraventricular thalamic nucleus 
(PVP), the medial part of the mediodorsal thalamic nucleus (MDM), the parvicellular part of the 
ventral posterior thalamic nucleus (VPPC) and the ventral reunions thalamic nucleus (VRe), the 
dopaminergic cells (A11), the ventral part of the zona incerta (ZIV) and the periventricular fiber 
system (pv). More laterally, the posterior intralaminar thalamic nucleus (PIL) and the triangular 
part of the posterior thalamic nuclear group (PoT) were strongly labelled. 
3.2.3. Mesencephalon 
In the mesencephalon the most proeminent projections originated from the periaqueductal gray 
matter (PAG), namely the dorsolateral and dorsomedial parts (DLPAG and DMPAG), the posterior 
intralaminar thalamic nucleus (PIL) and from the retrorubral field (RRF) (Fig. 3G,H). Other areas 
presented a small number of scattered labelled neurones, like the central tegmental tract (ctg), 
posterior thalamic nuclear group (PoT) and the commissure of the superior colliculus (csc). A few 
labelled neurones were observed in the nigrostriatal bundle (ns), the rostral linear nucleus of the 
raphe  (RLi), the red nucleus (RPC), the peripeduncular nucleus (PP), the marginal zone of the 
medial geniculate (MZMG), the superior cerebellar peduncule (scp), the pararubral nucleus 
(PaR), the deep mesencephalic nucleus (DPMe), the medial and lateral parts of the medial 
mammillary nucleus (MM and ML) the caudal, dorsolateral, intermediate and rostral subnucleus 
of the interpeduncular nucleus (IPC, IPDL, IPI and IPR), the ventral tegmental arca (VTA) and the 
reticular part of the substancia nigra (SNR). 
3.2.4. Pons and Medulla Oblongata 
Projections originating in the pons and medulla were modest and mostly from the ipsilateral side 
(Fig. 3I-K). The areas with greater projections were the gigantocellular reticular nucleus (Gi), the 
perifacial zone (P7) and the caudal ventrolateral medulla (CVLM) (Fig. 4D). A small number of 
scattered stained neurones were found in reticular nuclei (parvicellular nucleus), intermediate 
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parts of the facial [dorsal intermediate (7L), dorsomedial (7DM) and ventral intermediate (7VI)] 
and prerubral nuclei (Pr). A few labelled neurones were observed in the lateral 
paragigantocellular (LPGiA), the spinal trigeminal (Sp5O), the medullary dorsal reticular nucleus 
(DRt) (Fig. 4C) and the superior salivatory (SuS). 
3.3.  Anterograde labeling 
BDA-stained fibres were distributed along the rostrocaudal extension of the brain, but mainly in 
the telencephalon area, followed by the diencephalon and then the brainstem. BDA expression, 
although bilateral, was predominantly ipsilateral to the site of the injection. A systematic analysis 
of the location and density of areas targeted by the PVN is described in Table 1. 
3.3.1. Telencephalon 
The most prominent PVN projections to the telencephalon included the agranular insular cortex 
(AIV) (Fig. 5C), the ventral palladium (VP) (bilateral), the lateral orbital cortex (Lo), the dorsal 
endopiriform nucleus (DEn), the caudate putamen (CPu) (bilateral) (Fig. 3A-F) and the 
intermediate (bilateral) and posteromedial part of the medial division of the bed nucleus of the 
stria terminalis (STLi and STMPM, respectively). Bilateral fibres were also observed in the core 
and shell of the nucleus accumbens (AcbC and AcbSh, respectively), the olfactory tubercle (Tu1), 
the dorsal part of the substancia innominata (SIB), the septohippocampal nucleus (Shi), the 
secondary Motor Cortex (M2), the lateral entorhinal cortex (LEnt), the nucleus horizontal limb of 
the diagonal band (HDB) and the cingulated cortex (Cg1). Ipsilaterally stained fibres could be 
identified in the ventral orbital cortex (VO), the ventral endopiriform nucleus (VEn), the ventral 
part of claustrum (VCI), the mediomedial area of the secondary visual cortex (V2MM), the 
prelimbic, infralimbic, agranular and dysgranular insular cortices (PrL, IL, AIP and DI, 
respectively) (Fig. 5B), the lateral accumbens shell (LAcbSh), the sublenticular and central 
amygdalar nuclei (EAC and CeE, respectively), the ventral striatum (CB) and the adrenaline cells 
(C1). Scattered ipsilateral fibres were also observed in the mediolateral and lateral areas of the 
secondary visual cortex (V2ML and V2L, respectively), the triangular septal nucleus (TS), the 
temporal association, secondary somatosensory and retrosplenial granular and dysgranular and 
perirhinal cortices (TeA, S2, RSGc, RSD and PRh, respectively), the paracommissural nucleus 
(PaC), the navicular nucleus of the basal forebrain (Nv), the medial septal nucleus (MS), the 
posterodorsal and anteriordorsal medial amygdaloid nuclei (MeAD and MePD, respectively), the 
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ventrolateral part of the lateral amygdaloid nucleus (LaVL), the anterolateral part of the medial 
division of the bed nucleus of the stria terminalis (STMAL), the intermediate endopiriform nucleus 
(IEn), the dorsal peduncular cortex (DP), the dorsal part of the claustrum (DCI), the posterior, 
anterior and ventral parts of the basomedial amygdaloid nucleus (BMP, BMA and BLV, 
respectively), the basal nucleus (B), the posterior part of the anterior olfactory nucleus (AOP), the 
anterior cortical amygdaloid nucleus (ACo), the rostral pole of the nucleus accumbens (AcbR) and 
the anterior amygdaloid area (AA). A few bilateral fibres could be observed in the primary motor 
cortex (M1), the lateral and lambdoid septal zone (LSI and Ld, respectively), the medial part of 
the sublenticular extended amygdala (EAM), the anteromedial part of the medial division of the 
bed nucleus of the stria terminalis (STMAM), the cingulated cortex (Cg2) and the 
amygdalopiriform transition area (APir).  
3.3.2. Diencephalon 
In the diencephalon, strong bilateral efferent output from the PVN targeted mainly the 
hypothalamus followed by a modest but consistent output to thalamic areas (Fig. 3B-F). The 
areas with strongest bilateral stained fibres were the compact and dorsal areas of the 
dorsomedial hypothalamic nucleus (DMC and DMD, respectively), in the dorsal hypothalamic 
area (DA), in the dorsomedial part of the ventromedial hypothalamic nucleus (VMHDM), in 
tuberal region of lateral hypothalamus (TuLH) and in the medial part of the medial preoptic 
nucleus (MPOM), in the juxtaparaventricular lateral hypothalamus (JPLH), in the submedius and 
mediodorsal thalamic nucleus, dorsal part (SubD and MDC, respectively)and the accessory 
neurosecretory nuclei (ANS). Ipsilateral strong staining was also mainly, but not exclusively, found 
in hypothalamic areas such as in the ventral dorsomedial, central ventromedial and lateroanterior 
hypothalamic nuclei (DMV, VMHC and LA, respectively), in the dorsal posterior and anterior 
hypothalamic areas (PHD and AHA, respectively) and the peduncular part of lateral 
hypothalamus (PLH). Other areas with strong ipsilateral staining comprise the ventral and dorsal 
parts of the zona incerta (ZIV and ZID), the parastrial nucleus (PS) and the anteroventral thalamic 
nucleus (AVD). Within the thalamus bilateral but modest projections could be found in the 
posterior paraventricular, the medial and lateral parts of the mediodorsal, intermediodorsal, the 
ventral posteromedial and posterolateral, the paracentral, the interanterodorsal thalamic nucleus, 
the central medial, ventral part of the submedius and in the reunions thalamic nuclei (PVP, MDM, 
MDL, IMD, VMP, VPL, PC, IAD, CM, SubV and Re, respectively), in the perifornical part of lateral 
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hypothalamus (PeFLH), the lateral preoptic area (LPO) and in the A13 dopamine cells. Ipsilateral 
modest projections originated from the ventrolateral part of the laterodorsal and ventral part of 
the anteromedial thalamic nuclei (LDVL and AMV, respectively), the shell of the ventromedial and 
the ventrolateral hypothalamic nuclei (VMHSh and VLH, respectively), the lateral part of the 
medial preoptic, the medial and the lateral part of the habenular, the medial tuberal, the 
perifornical and the septohypothalamic nucleus (MPOL, MHb, LHbL, MTu, PeF and SHy, 
respectively), the nucleus of the stria medullaris (SM) and periventricular fiber system (Pv). 
Scarce but bilateral projections target the reticular, the ventral reuniens and paratenial thalamic 
nuclei (Rt, VRe and PT, respectively), the retrochiasmatic and the medial preoptic areas (RCh and 
MPA) and the anteromedial part of the medial division of the bed nucleus of the stria terminalis. 
A few stained fibres were found in the anteromedial, anterodorsal, anterior paraventricular and 
rhomboid thalamic nuclei (AD, AM, PVA and Rh, respectively), in the ventrolateral, the 
septofimbrial, the arcuate, the central part of the medial preoptic nuclei (VLPo, SFi, ArcM and 
MPOC, respectively), the primary sensory cortex (S1FL) and the ventral area of the secondary 
auditory cortex (AuV).  
3.3.3. Mesencephalon 
In the mesencephalon the most prominent projections are to the periaqueductal gray matter 
(PAG), namely the ventrolateral, dorsolateral and lateral parts (VLPAG, DLPAG and LPAG) (Figure 
5 A) and from the laterodorsal and the pericentral part of the dorsal tegmental nuclei (LDTg and 
DTgP, respectively) and the posterior commissure of the paracommissural nucleus (PaC) (Figure 
3 G,H). Ipsilaterally labeled fibres could be found in the lateral part of the dorsal raphe nucleus 
(DrL) and the dorsomedial periaqueductal gray (DMPAG). A few bilateral labeled fibres were 
observed in the ventral and intermediate parts of the cuneiform nucleus (CnFV and CnFI, 
respectively), in the paramedian and median raphe and pararubral nuclei (PMnR, MnR and PaR, 
respectively), in the pedunculopontine tegmental nucleus (PPtg), the plioglial part of 
periaqueductai gray (PIPAG) and in the intermediate, deep white layer and deep gray layer of the 
superior culliculus (InWh, DpWH and DpG). Scarce ipsilateral fibres were observed in rhadboid 
and peripeduncular nuclei (RBP and PP, respectively), the dorsal tier of the substantia nigra 
(SNCD), the rostral linear nucleus of the raphe (RLi), the triangular part of the posterior thalamic 
nuclear group (PoT), the oral part of the pontine reticular nucleus (PnO), the paranigral nucleus 
of the VTA (PN), the posterior intralaminar thalamic nucleus (PIL), the nucleus of the optic tract 
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(OT), the marginal zone of the medial geniculate (MZMG), the ventral part of the laterodorsal 
tegmental nucleus (LDTgV), the dorsal part of the interpeduncular nucleus (IPDL), the 
intermediate gray layer superior colliculus (InG), the deep mesencephalic nucleus (DpMe), the 
dorsal and the caudal parts of the dorsal raphe nucleus (DrD and DRC) and the commissural 
nucleus of the inferior colliculus (com).  
3.3.4. Pons and Medulla Oblongata 
Considerable bilateral efferent projections from the PVN could only be found in the lateral 
paragigantocellular nucleus (LPGiA) and in the gigantocellular reticular nucleus (Gi) (Figure 3 I-K). 
Ipsilateral stained fibres were located mainly in the raphe pallidus and raphe magnus nuclei (RPa 
and RMg, respectively) and in the intermediate, ventral and medial parts of the medullary 
reticular nucleus (IRtA, MdV and MdM, respectively). Contralateral scarce fibres were also 
detected in the medial lemniscus (ml) and in the alpha part of the gigantocellular reticular 
nucleus (GiA). 
4. Discussion 
 
4.1. Technical considerations 
Histologically, the parvocellular division of the paraventricular nucleus of the hypothalamus can 
be delimitated laterally from the magnocellular division of the PVN, ventrally from the 
periventricular nucleus of the hypothalamus and dorsally from the medial corticohypothalamic 
tract (mch). In this study, we employed the CTb tracer because it produces an intense retrograde 
labelling even when applied through small iontophoretic injections (Ericsson and Blomqvist, 
1988; Almeida et al., 2002).  Four possible sources of uncertainty inherent to the use of tract-
tracing technique were taken into account in the interpretation of the present findings. Firstly, the 
small iontophoretic CTb injections resulted in restricted and perfectly defined injection sites, all 
located within the boundaries of the parvocellular division. Secondly, no leakage of CTb was 
detected after the micropipette track was examined; this was avoided due to the use of 
micropipettes with small diameter tips and to the time allowed for the micropipette to remain in 
the injection place before retraction. Thirdly, the possibility of the CTb being trans-synaptically 
transported was ruled out as it was shown by Almeida et al (1993). Fourthly, the risk that CTb 
may retrogradely label some brain areas because of its uptake by passing fibres, however this 
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possibility was also refuted by others (Lima et al., 1991). Therefore, we concluded that these 
injections resulted exclusively in CTb retrograde labelling of brain neurones with axons 
terminating in the parvocellular division of the PVN. On the other hand, BDA is also a powerful 
anterograde tracer (Novikov, 2001). The specificity of the labeling resulting from BDA has been 
confirmed by injecting slightly different portions of the the DRt (Almeida et al., 1995) or by control 
injections in nuclei just bordering the area of interest (Leite-Almeida et al., 2006) and showing 
that these resulted in completely different patterns of brain projections. However, BDA can be 
incorporated into injured dendrites and fibres at the injection site. The potential labeling of 
passing fibres can be almost abolished by using small diameter micropipette tips during the 
iontophoretic process. This was the case of the present and previous (Leite-Almeida et al., 2006) 
studies since virtually no labeled perikarya were found along the brain of injected animals. 
Finally, the intensity of fibre staining in the mesencephalic, pons and medulla oblongata was 
rather scarce in this study when compared to a recent work (Gueerling et al., 2009). One 
explanation could be the use of different anterograde tracers [BDA vs. PHAL (Phaseolus vulgaris 
leucoagglutinin)], it is however not probable since both tracers are widely used in anatomical 
studies. Alternatively, this fact is probably related a difference in the amount of tracer injected in 
each case, since in our study BDA injections are much smaller than the PHAL injections 
performed by Gueerling and colleagues (2009).   
4.2. Brain connections to the PVN: anatomical considerations 
This is the first work dedicated to the systematic evaluation of the forebrain and mesencephalic 
areas connected to the PVN, through direct anterograde and retrograde tracer iontophoretic 
microinjection to this area, with enphasis on its role in pain modulation. 
4.2.1. Telencephalon 
To the best of our knowledge the projections from the prelimbic cortex, the islands Calleja, the 
caudate-putamen, the cingulated cortex, the bed nucleus of the accessory olfactory nucleus, the 
substantia innominata and the ventral palladium to the PVN were reported here for the first time. 
Several previous studies have mentioned functional relationships between the caudate-putamen, 
the cingulated cortex, the bed nucleus of the accessory olfactory nucleus and the substantia 
innominata however a direct anatomical pathway has never been described (Broad et al., 1993; 
Karimnamazi & Travers, 1998; Bourgeais et al., 2001). Projections from the shell and core of the 
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nucleus accumbens were previously described by several authors (Bertolucci-D'Angio et al., 
1990; Florin et al., 2000; Barrot et al., 2002; Magnusson & Martin, 2002). Perez-Rosado and 
colleagues (2000) referred to projections to several brain nuclei from the caudate-putamen, but 
not specifically to the PVN; the same occurring with the cingulated cortex (Drossman et al., 
2003; Hart et al., 2003; Meller et al., 2003). Bilateral projections were shown from the dorsal 
endopiriform nucleus (Beck & Fibiger, 1995; Florin et al., 2000) and the adrenaline cells 
(Palkovits et al., 1999). Labeled cells were found in the amygdala, primarily in the medial 
nucleus, although the number of projecting neurones was smaller than expected (Kalivas et al., 
1982; Oldfield & Silverman, 1985; Bon et al., 1998; Bourgeais et al., 2001; Michl et al., 2001; 
Alheid, 2003). The amount of labeled neurones in the dorsal tenia tecta (Piekut & Phipps, 1998; 
Weitemier et al., 2001) the intermediate and ventral part of the lateral septal nucleus (McNally & 
Akil, 2002) was considerably higher than what is found in previous works.  In what concerns the 
PVN projections, they terminate mainly in the ipsilateral agranular insular cortex, nucleus 
accumbens, amygdala and caudate-putamen, areas that to the best of our knowledge are 
referred here for the first time. 
4.2.2. Diencephalon 
To the best of our knowledge, the projections from the tuber cinerum and the striohypothalamic 
nucleus were reported here for the first time. Projections originated in other diencephalic nuclei 
have since long been illustrated although the data is often fragmented. As Garris (1979) 
described, labeled neurones were found in the anterior diencephalon scattered along the septal 
zone and nuclei. The stria terminalis is the brain area that presented the largest number of 
projecting cells, which was expected due to its physiological functions, namely in stress and 
homeostasis (Bester et al., 1997; Van de Kar & Blair, 1999; Crown et al., 2000; McNally & Akil, 
2002) and corrobates observations by Dong and colleagues (2001). As Silverman and colleagues 
(1981) observed in the preoptic area and in the hypothalamus, the medial groups have larger 
input than do the lateral areas. Once again it was observed that the PVN receives input from the 
contralateral PVN (Silverman et al., 1981). In the thalamus many nuclei presented intense 
labeled neurones mainly ipsilateral, but none of them showed a consistent number of labeled 
cells. Major projections from the PVN were present in other hypothalamic nuclei, medial preoptic 
nucleus and thalamic nucleus submedius. 
4.2.3. Mesencephalon 
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To the best of our knowledge the projections from the retrorubral field, the nigrostriatal bundle, 
the superior cerebellar peduncule and the pararubral nucleus was reported here for the first time. 
Projections of the central tegmental tract to the PVN have been reported previously (Leibowitz & 
Brown, 1980) as were projections from the commissure of the superior colliculus (Morcuende et 
al., 2002; Tardif & Clarke, 2002), the deep mesencephalic nucleus (Meloni and Davis, 1999; 
Rodriguez et al., 2001; Gonzalez-Hernandez et al., 2002), the medial mammillary nucleus 
(Mihaly et al., 2002; Timofeeva et al., 2003), the tegmental area (Gueerling et al., 2009) and the 
interpeduncular nucleus (Rivest et al., 1995; Salminen et al., 1996; 2000). Concerning PVN 
afferent, the main target of the nucleus is clearly the PAG. 
4.2.4. Pons and Medulla Oblongata 
Both the retrograde and anterograde labeling from the PVN is modest or scarce. Note the 
absence of pain control centres projecting to the PVN, although a small PVN descending 
projection targets RVM regions and the DRt (Almeida et al., 2006). 
4.3. Functional considerations 
Given the wide neuronal network of the PVN, the analysis of possible functional implications of 
these connections was artificially separated by systems and a greater emphasis was attributed to 
connections that may directly contribute to pain and stress modulation. Nonetheless, important 
projections between the PVN and areas involved in the limbic, autonomic and motor system were 
also addressed although to a smaller extent.  
4.3.1. The supraspinal pain modulatory system 
Our results demonstrate that chief supraspinal nuclei involved in the pain modulatory system 
share extense and reciprocal connections with the PVN. The IL, PrL and Cg regions of the 
prefrontal cortex display increased expression of c-Fos after exposure to several forms of stress 
(Ostrander et al., 2003; Morrow et al., 2000; Duncan et al., 1996) reflecting the involvement of 
these areas in the modulation of the endocrine and autonomic response to stress (Herman et al., 
2005; Sullivan, 2004). The PrL has been demonstrated to be activated by fear, playing an 
essential role in the expression of learned fears (Corcoran and Quirk, 2007; Choi et al., 2010). 
The existence of bilateral connections between the PVN and the PrL could partially account for 
the modulatory effect of fear upon pain perception (Holmes and Wellman, 2009). Also interesting 
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is the fact that the PrL regulates the expression of fear memories through projections to the AMY 
(Holmes and Wellman, 2009), an area that modulates the emotional dimension of pain.  On the 
other hand, an excitatory role has been proposed for the IL, it increases stress-induced HPA axis 
activation, resulting in increased levels of plasma ACTH and corticosterone (Radley et al., 2006). 
Curiously, inescapable stress elicits the release of serotonin from the PFC (Grahn et al., 1999; 
Maswood et al., 1998) and a large number of neurones in the IL and PrL areas project to RVM 
(Gabbott et al., 2005). Additionally, the inactivation of the IL and PL results in stress-induced 
learned helplessness (Amat et al., 2005), which contributes maladaptive responses to stress 
(Maier et al., 2006; Maier and Watkins, 2005). The anatomical connections of the PFC with the 
PVN and HPA axis activity and the evidence of serotonergic projections from this area to the RVM 
could contribute, to some extent, to the analgesia induced by chronic unpredictable stress (Pinto-
Ribeiro et al., 2004) and to the role of serotonergic pathways in nociceptive processing by the 
PVN in normal and chronic nociceptive pain conditions (Pinto-Ribeiro et al., 2008). 
Recent studies have suggested that the BNST participates in the physiological manifestation of 
the emotional dimension of pain as part of the extended amygdala (Alheid et al., 1995) and c-Fos 
immunoreactivity increased in the BST in response to noxious mechanical stimulation (Morano et 
al., 2008). Moreover, the BNST areas activated by acute pain in normal animals were different 
from the ones activated by the same stimulus in animals suffering from neuropathic pain 
(Morano et al., 2008). Choi and colleagues (2007) demonstrated that the posterior BNST nuclei 
mainly inhibit the HPA axis while the anteroventral BNST nuclei enhance its activity. The bilateral 
projections shared by the BNST and the PVN further substantiate the existence of a fine tuning of 
this area upon the neuroendocrine and autonomic emotional responses (LeDoux, 2000) to stress 
and pain. 
As the PVN mediates the stress response it is expected that it shares intense reciprocal 
projections with the DMH, an area involved in defensive responses to threatening stressors 
(Fuchs and Siegel, 1984; Dielenberg et al., 2001). Additionally, the DMH is strongly activated 
after swim and immobilization stress (Cullinan et al., 1995) and contributes to anxiolytic states 
(Inglefield et al., 1994), which also result in the activation of the HPA axis. The activation of these 
areas, which appear to counteract each other by inhibiting (Pinto-Ribeiro et al., 2008) or 
facilitating (Pinto-Ribeiro et al., data not published; Martensen et al., 2009) nociception, 
respectively. The activation of these parallel pain modulatory pathways probably depends on 
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specific emotional clues since both areas receive projections from the PFC, the bed nucleus of 
the stria terminalis and the AMY (Geerling et al., 2008; Thompson and Swanson, 1998) and are 
involved in the response to stress. 
The thalamic PVP not only shares bilateral connections with the PVN but is also known to project 
to the PFC (Hurley et al., 1991) while being target by fear and power-dominance motivation areas 
from the hypothalamus (Sewards and Sewards, 2002) and the lateral and dorsolateral PAG 
(Krout and Loewy, 2001), the AMY (Canteras et al., 1995) and the BNST (Numan and Numan, 
1996). In addition, the activation of the PVP can be elicited by fear and stress (Cullinan et al., 
1995; Campeau et al., 1997). Sewards and Sewards (2002) proposed that the power-dominance 
drive is related to the rostral part while fear is connected with the posterior part of the PVP. It 
seems likely that this PVP-PVN might play an important part in the reinforcement of the 
motivational component of pain modulation by stress. 
Reciprocal projections between the PVN and the PAG, an area that plays a crucial role in the 
integration of reactions to threatening or stressful events (Bandler et al., 1991; Cullinan et al., 
1995), were restricted to the lateral, dorsolateral and ventrolateral areas. LPAG and DLPAG 
electric stimulation has been shown to produce a strong affective/defense as well as motor 
response (Bandler, 1982), identical to what is observed after exposure to predators. Also 
important is the fact that DLPAG is activated by audiogenic stress, which in turn activates the 
hypothalamo-pituitary- adrenals (HPA) axis in rats (Campeau et al., 1997).  
Reciprocal projections with the PnO are in line with previous works that proposed this nucleus not 
only has a mediator of hypothalamic stress-induced effects but also has a target for corticosteroid 
negative feedback effects (Li et al., 1998). 
In support of the antinociceptive action mediated directly upon the spinal cord and also with a 
contribution relaying in the RVM (Pinto-Ribeiro et al, 2008; Condés-Lara et al, 2009), the PVN is 
reciprocally connected with brain nuclei shown to be involved in antinociception, like the 
amygdala (Helmstetter and Bellgowan, 1993), basal ganglia (Chudler and Dong, 1995), the PAG 
(Basbaum and Fields, 1984) and deep mesencephalic nucleus (Wang et al, 1992) and projects 
to areas like the DRt (Lima and Almeida, 2002), the NTS and the CVLM (Tavares and Lima, 
2002). 
4.3.2. Other limbic-related connections 
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The PVN also seems to be implicated in the integration of stress response (cingulate cortex; 
Radley et al., 2009), as the prefrontal influences on the HPA output are predominantly inhibitory 
and emanate from the prelimbic and/or dorsal anterior cingulated cortices. The reciprocal 
connections with the bed nucleus of the stria terminalis (BNST) points to an involvement in the 
tonic/unpredictable stress responses (Pêgo et al., 2008). Reciprocal connections with the medial 
septal nucleus imply a possible participation of the PVN in cognitive performance (McKeon-
O'Malley et al., 2003) and avoidance behaviours (Riekkinen, 1994). 
4.3.3. Other autonomic-related connections 
Most of the forebrain and mesencephalic brain nuclei projecting to or receiving projections from 
the PVN belong to the autonomic control system. For that reason the PVN seems to be 
implicated in the immune response (islands Calleja; Engstrom et al., 2003), the Alzheimer's 
disease (striohypothalamic nucleus; Mufson et al., 1999), the generation and entrainment of 
several circadian rhythms (tuber cinerum; Mikkelsen, 1990), temperature, water and salt 
homeostasis (preoptic nucleus and periventricular nucleus; Sellami & de Beaurepaire, 1995; 
Baffi & Palkovits, 2000; Usdin et al., 2000; Spitznagel et al., 2001), the relay of convergent 
inputs from gustatory, baroreceptor, chemoreceptor organs (insular cortex; Hanamori et al., 
1998), blood pressure and cardiovascular function (ventral palladium; Allen & Cechetto, 1993) 
and reproduction (anteroventral periventricular nucleus; Salama et al., 2003; Zup et al., 2003).  
4.3.4. Motor-related connections 
The PVN seems to play a role in motor functions. Motor-related projections originating in the 
forebrain and brainstem regions were observed from the retrorubral field and facial nucleus, 
suggesting an involvement in the control of the orofacial musculature (Von Krosigk & Smith, 
1991). Additionally the PVN projects largely to the basal ganglia and more modestly to the motor 
cortex. 
5. Conclusion 
In conclusion, the present results along with the literature available indicate that the PVN: (1) is 
implicated in a supraspinal network that integrates and / or  information from autonomic, limbic, 
motor and antinociceptive systems; (2) is involved in an antinociceptive pathway, relaying the 
nociceptive information converging from pain-related nuclei in the forebrain, and; (3) is an 
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effector nucleus that triggers response actions in the systems involved in (1) and (2), due to its 
large descending projections to the mesencephalus and spinal cord (Ranson et al., 1998). 
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Figure 1 – Photomicrographs of CTb tracer and of a control injection sites in the paraventricular 
nucleus of the hypothalamus. A – CTb microinjection in the more rostral part of the PVN (RC: -
1.44mm, LM: +0.62mm; DV: -7.9mm). B – Example of a control injection of CTb in an area 
immediately adjacent to the PVN (RC: -1.72mm, LM: +0.8mm; DV: -8.0mm). (RC - rostrocaudal 
coordinate; LM - lateromedial coordinate; DV- dorsoventral coordinate) 
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Figure 2 – Photomicrographs of BDA tracer and of a control injection sites at several coordinates 
of the paraventricular nucleus of the hypothalamus. A – Example of an injection site of BDA (RC: -
1.92mm, LM: +0.6mm; DV: -7.9mm). B – Example of a control injection of BDA outside the 
lateral cap of the PVN (RC: -1.56mm, LM: +0.6mm; DV: -8.0mm). (RC - rostrocaudal coordinate; 
LM - lateromedial coordinate; DV- dorsoventral coordinate) 
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Figure 3 (A-K) – Schematic representation of retrogradely labeled cells (green dots) and 
anterogradelly labeled fibres (black lines) on representative coronal sections of the rat brain atlas. 
A – Represents coronal section at +3.0 mm Bregma; B – Represents coronal at + 0.36 mm 
Bregma line; C – Represents coronal section at -0.48 mm Bregma. D – Represents coronal 
section at -1.80mm Bregma. E - Represents coronal section at -3.24 mm Bregma. F - Represents 
coronal section at -4.56 mm Bregma. G - Represents coronal section at -5.64 mm Bregma. H – 
Represents coronal section at -8.52mm Bregma. I - Represents coronal section at -10.92 mm 
Bregma. J - Represent coronal section at -12.96 mm Bregma. K - Represent coronal section at -
14.28 mm Bregma. For abbreviations see table 1. 
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Figure 4 - Photomicrographs of brain coronal sections with retrogradely labeled neurones. A – 
Labeled neurones present in the bed nucleus of the stria terminalis (STMA) (RC: +0.12 mm 
Bregma). B – Stained neurones in the subiculum (VS) (RC: -5.52 mm Bregma). C – Modest 
staining of the medullary dorsal reticular nucleus (DRt) (RC: -13.92 mm Bregma). D. Stained 
neurones in the caudal ventrolateral medulla (CVLM) (RC: -12.96 mm Bregma). 
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Figure 5 - Photomicrographs of brain coronal sections with anterogradely labeled fibres. A – 
Labeled fibres in the periaqueductal gray matter (PAG) (RC: -8.16 mm Bregma). B – Stained 
fibres in the prefrontal cortex (PrL) (RC: +3.00 mm Bregma). C - Stained fibres in the prefrontal 
cortex (PrL) (RC: +3.24 mm Bregma). D – Detail of labeled fibre corresponding to the area with 
arrows in image A. 
 
122
Table 1 - Density of labeled neurones and fibres from the forebrain to the medulla of the rat after 
injection of retrograde and anterograde anatomical tracers in the paraventricular nucleus of the 
hypothalamus [*DRt corresponds to MdM and VRt to MdV in Paxinos and Watson (2005) atlas]. 
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Available online 28 December 2007We studied the influence of arthritis on descending modulation of nociception from the
hypothalamic paraventricular nucleus (PVN) in the rat. Spinal nociception was assessed by
the heat-evoked limb withdrawal in awake animals while neuronal responses were
recorded in a potential brainstem relay, the rostroventromedial medulla (RVM), under
pentobarbitone anesthesia. Following injection into the PVN, glutamate attenuated and
lidocaine enhanced nociceptive spinal reflex responses in arthritic and control animals. In
controls, PVN-induced antinociception was reversed by spinal administration of a 5-HT1A
receptor or an α2-adrenoceptor antagonist but not by an opioid receptor antagonist. In
arthritic animals, PVN-induced antinociception was not reversed by a 5-HT1A receptor
antagonist, while the roles of α2-adrenoceptors or opioid receptors could not be assessed
due to significant actions of antagonists alone. The spontaneous activity of presumably
pronociceptive ON-cells of the RVM and that of antinociceptive OFF-cells was increased in
arthritis. Lidocaine in the PVN increased ON-cell firing in control animals and decreased
OFF-cell firing in arthritic animals, while glutamate failed to affect activity of RVM cells. The
results indicate that the PVN influences phasic and tonic descending antinociception in
arthritic as well as control conditions, and the RVM may contribute to the relay of this
influence. In arthritis, the neurochemistry of descending antinociception differs at least
partly from that in controls. Arthritis has a dual influence on the PVN-induced drive of relay
cells in the RVM which reduces the arthritis-induced net change in the descending
antinociceptive influence from the PVN.
© 2007 Elsevier B.V. All rights reserved.Keywords:
Arthritic pain
Descending modulation
Hypothalamus
Spinal nociception1. Introduction
The paraventricular nucleus (PVN) of the hypothalamus is
involved in descending modulation of nociception. This is
indicated by the finding that electrical or chemical stimulation
of the PVN has produced spinal antinociception (Condés-Lara
et al., 2006; Miranda-Cardenas et al., 2006; Shiraishi et al., 1995;
Wang et al., 1990a; Yang et al., 2006; Yirmiya et al., 1990). In.
i.fi (A. Pertovaara).
s of the hypothalamus; R
er B.V. All rights reservedline with this, lesions of the PVN facilitated nociception (Yang
et al., 2006) and attenuated stress-induced analgesia (Truesdell
and Bodnar, 1987), although not in all experimental conditions
(Fuchs and Melzack, 1996; Lariviere et al., 1995). Efferent con-
nections to the spinal dorsal horn directly or indirectly through
various relay nuclei in the brainstem, such as the periaque-
ductal gray and the raphe magnus, provide a potential ana-
tomical substrate for the descending antinociceptive actionVM, rostroventromedial medulla; WDR, wide-dynamic range
.
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64 B R A I N R E S E A R C H 1 1 9 7 ( 2 0 0 8 ) 6 3 – 7 5induced by the PVN (Holstege, 1987; Swanson and Sawchenko,
1983).
The role of various descending pathways and the neuro-
chemistry underlying PVN-induced antinociception is only
partly known. Early studies suggested that spinal antinocicep-
tion induced by PVN stimulation is not dependent on opioid
receptors or vasopressin (Shiraishi et al., 1995; Yirmiya et al.,
1990). More recent studies, however, suggest that opioid
receptors have a minor contribution to the PVN-induced anti-
nociception (Yang et al., 2006; Miranda-Cardenas et al., 2006),
while vasopressin (Yang et al., 2006) or oxytocin (Condés-Lara
et al., 2006; Miranda-Cardenas et al., 2006) play a major role in
mediating the descending antinociceptive action from the
PVN. This is in linewith a substantial number of hypothalamo-
spinal cells that are stained with antisera directed against
vasopressin or oxytocin (Cechetto and Saper, 1988; Condés-
Lara et al., 2007; Swanson and Sawchenko, 1983). Recent re-
sults indicate that activation of GABAergic spinal interneurons
by oxytocin may be involved in mediating the PVN-induced
antinociception at the spinal cord level (Rojas-Piloni et al.,
2007). Although the PVN-induced descending antinociception
may be explained by direct hypothalamo-spinal connections,
the potential role of various brainstem nuclei inmediating the
antinociceptive action from the PVN to the spinal cord still
remains to be studied. Concerning potential brainstem relay
nuclei and neurotransmitters mediating their action, it is notFig. 1 – Mean latencies of heat-evoked limb withdrawal respons
(Lido) into the hypothalamic paraventricular nucleus (PVN) of con
was applied to the hind paw that was ipsilateral to the inflamed
lidocaine alone. B) Attempted reversal of glutamate-induced effe
naloxone (+Nx), and the effect of spinal administration of naloxo
effect by spinal administration of anα2-adrenoceptor antagonist,
atipamezole alone (Ati). D) Attempted reversal of glutamate-indu
antagonist, WAY-100635 (+Way), and the effect by spinal admini
S.E.M. (n=5–7). Unless specified otherwise, the asterisks indicate d
or Sal-group). *P<0.05, **P<0.01, ***P<0.005 (within groups: Dunn
134yet known whether the PVN-induced spinal antinociceptive
action involves monoaminergic neurotransmitters, such as
serotonin (5-HT) or norepinephrine, that are known to have an
important role in descending modulation of nociception (Per-
tovaara, 2006; Yaksh, 2006).
Pathophysiological conditionsmayinducesignificantchanges
in the function of descending pain-modulatory pathways lead-
ing to facilitation or attenuationof nociception (Pertovaara and
Almeida, 2006; Vanegas and Schaible, 2004). In experimental
arthritis, for example, the descending inhibition of afferent
barrage from the inflamed joint was enhanced (Schaible et al.,
1991). While it is known that arthritis is associated with
changes in the expressionof neuropeptides in the PVN (Shanks
et al., 1998), it is not known whether the modulation of noci-
ception descending from the PVN is changed in arthritis.
In the present investigation, we studied whether modula-
tion of spinal nociception by the PVN is changed in arthritis.
Also, we studied whether neurons in the rostroventromedial
medulla (RVM), a final common pathway formany descending
pathways (Gebhart, 2004), might have a role in mediating de-
scendingmodulation of nociception from the PVNof control or
arthritic animals. Furthermore, we assessed the roles of spinal
noradrenergic α2, serotoninergic 5-HT1A and opioidergic recep-
tors in mediating the descending modulation of nociception
from the PVNby intrathecalmicroinjections of selective recep-
tor antagonists in control and arthritic animals.es following administration of glutamate (Glu) or lidocaine
trol (Ctrl) or arthritic (Arth) animals. The noxious test stimulus
knee joint in arthritic animals. A) Influence of glutamate or
ct by spinal administration of an opioid receptor antagonist,
ne alone (Nx). C) Attempted reversal of glutamate-induced
atipamezole (+Ati), and the effect by spinal administration of
ced effect by spinal administration of a 5-HT1A receptor
stration ofWAY-100635 alone (Way). The error bars represent
ifferenceswithin groups (reference: the corresponding saline
ett's test; between groups: t-test).
Fig. 2 – Response properties of ON- and OFF-cells of the RVM in control (Ctrl) and arthritic (Arth) animals. A) Spontaneous
discharge rate. B) Response to noxious heating of the hind paw skin (ipsilateral to the inflamed knee joint in arthritic animals).
C) Response to noxious pinch of the tail. D) Response to noxious visceral stimulation (colorectal distension). The error bars
represent S.E.M. (n=14–23 in arthritic groups and n=22–34 in control groups). *P<0.05, **P<0.01, ***P<0.005 (t-test).
Fig. 3 – Mean spontaneous discharge rates of ON- and OFF-cells of the RVM in control (Ctrl) and arthritic (Arth) animals
following microinjection of glutamate or lidocaine into the hypothalamic paraventricular nucleus (PVN). A) Effect of glutamate
on discharge rate of ON-cells (nCtrl=18, nArth=11). B) Effect of glutamate on discharge rate of OFF-cells (nCtrl=9, nArth=6). C) Effect
of lidocaine on discharge rate of ON-cells (nCtrl=8, nArth=8). D) Effect of lidocaine on discharge rate of OFF-cells (nCtrl=4, nArth=5).
The error bars represent S.E.M. The Y-axis shows the time elapsed from the microinjection of glutamate or lidocaine.
Pre = before injection. *P<0.05 (Dunnett's test; Reference: the corresponding pre-injection rate).
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2.1. Behavioral characterization of arthritis
All animals in the arthritic group developed a clear swelling of
the treated knee joint and all of them gave a vocalization
response to aminor extension and flexion of the affected limb
by the experimenter, whereas untreated control animals had
no obvious swelling in the knee joint and they did not vocalize
when the limb was moved.
2.2. Behavioral assessment of spinal antinociception
induced by the PVN
Behaviorally, spinal nociception was assessed by determin-
ing the latency of the limb withdrawal response evoked by
noxious heating of the hind paw. Saline, glutamate (50 nmol)
or lidocaine (4%/0.5 μl) was microinjected into the PVN to
study the phasic and tonic regulation of spinal nociception
in arthritic animals versus controls. Administration of these
compounds in the PVN had a significant effect on the heat-
evoked hind-limb withdrawal latency (F2,26=45.3, P<0.0001):
when compared with saline, glutamate induced a significant
prolongation (antinociception) and lidocaine a decrease (pro-
nociception) of the withdrawal latency (Fig. 1 A). These
modulatory effects by glutamate or lidocaine in the PVN were
not significantly different between arthritic and control
animals (F1,26=0.14).
Naloxone (5.0 μg) was administered intrathecally to study
the potential contribution of spinal opioid receptors to the anti-
nociceptive action induced by glutamate in the PVN. Intrathecal
administration of naloxone did not attenuate the antinocicep-
tive effect induced by glutamate in the PVN of arthritic or con-
trol animals (Fig. 1 B). Intrathecal administration of naloxone
alone had no effect in controls but it increased the withdrawal
latency in arthritic animals.
Atipamezole, an α2-adrenoceptor antagonist (5.0 μg), was
administered intrathecally to study the involvement of spinal
α2-adrenoceptors in the antinociceptive action induced by
administration of glutamate in the PVN. In control animals,
atipamezole reversed the antinociceptive action of glutamate
in the PVN, while atipamezole alone had no significant effect
(Fig. 1 C). In arthritic animals, in contrast, atipamezole did notFig. 4 – Mean changes in spontaneous discharge rates (A) and n
wide-dynamic range (WDR) neurons following injection of glutam
nucleus (PVN) in control (Ctrl) and arthritic (Arth) animals. 100%
bars represent S.E.M. (nSal=5, nGlu=7). *P<0.05, ***P<0.005 (t-test)
136influence the glutamate-induced antinociception, whereas ati-
pamezole alone induced a significant prolongation of thewith-
drawal latency (Fig. 1 C).
To study the role of spinal 5-HT1A receptors in antinocicep-
tion induced by glutamate in the PVN, WAY-100635 (3.0 μg), a
5-HT1A receptor antagonist, was administered intrathecally. In
control but not arthritic animals the antinociceptive action
induced by glutamate in the PVN was reversed by intrathecal
administration of WAY-100635. When administered alone,
WAY-100635 had no significant influence on the limb with-
drawal latency in arthritic or control animals (Fig. 1 D).
2.3. Response characteristics of ON- and OFF-cells of the
RVM
The RVM provides a potential link for mediating the pain-
regulatory effect from the PVN to the spinal dorsal horn. In
this study, we focused on assessing response properties of the
presumably pronociceptive ON-cells and antinociceptive OFF-
cells in the RVM. The number of RVM cells tested quantita-
tively was 37 (23 ON- and 14 OFF-cells) in arthritic animals and
56 (34 ON- and 22 OFF-cells) in controls. The receptive fields of
ON- and OFF-cells were typically wide covering all extremities
and the whole body. The distribution in the number of ON-
and OFF-cells was not significantly different between arthritic
and control animals (Fisher’s exact test).
2.4. Spontaneous discharge rate of RVM cells
The spontaneous discharge rate of ON- and OFF-cells in
the RVM was significantly increased by arthritis (F1,187=32.6,
P<0.0001; Fig. 2 A). The spontaneous discharge rate of OFF-
cells was significantly higher than that of ON-cells (F1,187=17.2,
P<0.0001), and this difference was significantly larger in ar-
thritic animals (F1,187=9.5, P<0.003).
2.5. Peripherally evoked responses of RVM cells
When assessing the peripherally evoked response of ON- and
OFF-cells, thenoxious stimuliwereapplied to thenon-inflamed
areadistal to thearthritic knee joint (heat), the tail (pinch) or the
viscera. The magnitude of the excitatory ON-cell response
evoked by noxious heating of the hind paw skin was not
significantly different between arthritic and control animals,oxious heat-evoked responses (B) of spinal dorsal horn
ate (Glu) or saline (Sal) into the hypothalamic paraventricular
represents the corresponding pre-injection value. The error
.
Fig. 6 – Responses of a spinal dorsal horn WDR neuron to
noxious heat stimulation of the hind paw in an arthritic
animal before PVN injections (A), 30 s after injection of saline
in the PVN (B), and 30 s after injection of glutamate in the
PVN (C). i: neuronal response, ii: heat stimulus that starts
from the baseline temperature of 35 °C and reaches the peak
temperature of 54 °C. Vertical calibration bar for the trace i
represents 50 Hz, and the horizontal one 25 s.
Fig. 5 – Responses of a spinal dorsal horn WDR neuron to
noxious heat stimulation of the hind paw in a control animal
before PVN injections (A), 30 s after injection of saline in the
PVN (B), and 30 s after injection of glutamate in the PVN (C).
i: neuronal response, ii: heat stimulus that starts from the
baseline temperature of 35 °C and reaches the peak
temperature of 54 °C. Vertical calibration bar for i represents
50 Hz and the horizontal one 25 s.
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evoked by noxious heating was reduced in arthritis (Fig. 2 B).
The magnitudes of the ON- and OFF-cell responses evoked by
noxious tail pinchwere reduced in arthritic animals (Fig. 2 C). In
contrast, the magnitudes of colorectal distension-induced
responses of ON- and OFF-cells were slightly but significantly
increased in arthritis (Fig. 2 D).
2.6. Effects of glutamate or lidocaine administration in the
PVN on discharge rates of RVM cells
The spontaneous discharge rate of ON- and OFF-cells of the
RVM was assessed following microinjection of glutamate orlidocaine in the PVN to study arthritis-induced changes in
descending modulation of nociception originating in the PVN
and relaying through the RVM. Glutamate in the PVN had no
significant influence on the discharge rate of ON-cells in
arthritic animals (F2,32=0.5) or controls (F2,53=0.6; Fig. 3 A).
Neither did glutamate in the PVN influence the spontaneous
discharge rate of OFF-cells in arthritic (F2,26=0.5) or control
animals (F2,17=2.1; Fig. 3 B).
Lidocaine in the RVM had no influence on the discharge
rate of ON-cells in arthritic animals (F4,39=1), whereas it in-
creased ON-cell activity in controls (F4,39=3.9, P<0.02; Fig. 3 C).
Following lidocaine administration in the PVN, OFF-cell acti-
vity was decreased in arthritic animals (F4,24=5.0, P<0.01), but
not changed in controls (F4,19=1.2; Fig. 3 C).137
Fig. 9 – A photographic example of a recording site in the
medulla (marked with an asterisk). Gi: gigantocellular
nucleus, GiA: alpha part of Gi, RMg: raphe magnus nucleus,
ml: medial lemniscus.
Fig. 7 – A photographic example of a microinjection site in
the hypothalamus. Pa: paraventricular nucleus, PaV: ventral
part of Pa, PaLM: lateral magnocellular part of Pa, PaDC:
dorsal cap of Pa, PaMP: medial parvocellular part of Pa.
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Effect of glutamate in the PVN on spinal dorsal horn WDR
neurons was determined to exclude the possibility that the
PVN-inducedmodulationof spinal nociceptive reflex responses
was rather due to suppression of spinal motor than sensory
responses.Whilearthritis producedasignificant increase in theFig. 8 – Microinjection sites in the PVN. The anteroposterior
distance from the interaural line is 7.28 mm for section A,
7.20 mm for section B, and 7.09 mm for section C. Each
symbol represents cannula locations in one to four animals.
138baseline spontaneous discharge rate of WDR neurons (P<0.05,
t-test), glutamate in the PVN failed to produce a significant
suppressionof the spontaneous discharge rate ofWDRneurons
(F1,20=2.02; Fig. 4 A), independent of the experimental group
(F1,20=0.73). Heat-evoked responses of spinal dorsal horn WDR
neurons were significantly decreased by glutamate in the PVN
when compared with the effect of saline (F1,20=9.8, P<0.001;
Figs. 4 B, 5 and 6), and this glutamate-induced spinal antino-
ciceptive effectwas not significantly different between arthritic
and control animals (F1,20=0.05).
2.8. Injection and recording sites
Figs. 7 and 8 show microinjection sites in the PVN, and Figs. 9
and 10 show recording sites in the RVM. Based on the esti-
mated spread of the currently used injection volume of 0.5 μl
(Myers, 1966), the injections spread both to the magno- and
parvocellular areas of the PVN and areas immediately adja-
cent to the PVN. The recording sites in the RVM were in the
raphe magnus and the adjacent medial bulboreticular forma-
tion. In the spinal dorsal horn, recording sites were in the deep
spinal dorsal horn as assessed from the depth of recording
sites from the cord surface (400–1000 μm).3. Discussion
3.1. Influence of arthritis on the PVN-induced spinal
antinociception and a potential relay in the RVM
Glutamate in the hypothalamic paraventricular nucleus (PVN)
suppressed and lidocaine in the PVN facilitated noxious heat-
evoked spinal withdrawal responses in arthritic and control
animals. This finding indicates that the PVNhas a role in phasic
and tonic suppression of spinal nociception in arthritic as well
as control conditions. It isnoteworthy that glutamate in thePVN
suppressed not only a spinal withdrawal reflex but also the
response of presumed pain-relay neurons in the spinal dorsal
horn indicating that the PVN induced rather a true antinocicep-
tive action than only a suppression of the motor expression of
nociception.Moreover, thepresent results indicate that arthritis
induces changes in firing rates of presumed pain-modulatory
cells in the rostroventromedial medulla (RVM), a structure that
Fig. 10 – Recording sites marked with electrolytic lesions in the RVM. The anteroposterior distance from the interaural line is
1.92 mm for section A, 2.04 mm for section B, 2.16 mm for section C, 2.40 mm for section D and 2.64 mm for section E. Each
symbol represents recording sites of one to five neurons.
69B R A I N R E S E A R C H 1 1 9 7 ( 2 0 0 8 ) 6 3 – 7 5receives efferent projections from the PVN (Holstege, 1987) and
that is known to be an important relay for descending mo-
dulation of spinal nociception (Gebhart, 2004). Interestingly,
arthritis-induced changes in spontaneous firing rates of prono-
ciceptive ON- and antinociceptive OFF-cells of the RVM were
likely to have opposite effects on spinal antinociception. This is
indicated by the finding that the spontaneous activity of both
pronociceptive ON-cells and antinociceptive OFF-cells was in-
creased in arthritis. The concurrent promotion of descending
pro- and antinociceptive influence from the RVM of arthritic
animals may contribute to the observations that the baseline
nociception of arthritic animals outside of the inflamed region,
as indicated by the withdrawal response to heating of the hind
paw distal to the inflamed joint, was not significantly different
from that in controls. Previous results indicate that during the
first hours, inflammation leads to enhanced descending facil-
itation from the RVM whereas during a later phase the net
descending effect from the RVM is inhibition (Terayama et al.,
2000). This finding suggests that the pronociceptive influence of
arthritis might have been stronger in the present study if the
experiments had been performed within the first few hours,
instead of several days after induction of arthritis. It should also
be noted that the currently used injection volume of 0.5 μl may
have spread to areas adjacent to the target area in the PVN and
therefore, the present results do not allow excluding the pos-
sibility that brain areas adjacent to the PVN contribute to the
present findings.
Glutamate in the PVN failed to influence discharge rates of
RVM cells in arthritic or control animals. This finding suggests
that the RVM may not have a critical role in mediating phasic
antinociception induced by PVN-stimulation. On the other
hand, lidocaine in the PVN increased firing rates of pronoci-
ceptive ON-cells in control animals and decreased firing of
antinociceptive OFF-cells in arthritic animals. This finding
suggests that the PVN in a tonic anddissociative fashiondrives
the RVM and that the drive is changed by arthritis. The net
descending effect of the PVN-induced tonic drive need not,
however, be changed by arthritis, since the PVN-induced tonic
suppression of pronociceptive RVM ON-cells in control ani-
mals may have an equal effect on spinal nociception as the
PVN-induced tonic facilitation of antinociceptive RVM OFF-
cells. In linewith thisproposal, the behavioral results indicatedthat lidocaine in the PVN had an equal spinal pronociceptive
effect in arthritic and control animals. These findings are in
linewith the hypothesis that the RVM is involved inmediating
tonic PVN-induced modulation of spinal nociception.
The magnitudes of pinch- and heat-evoked responses of
RVM cells were decreased in arthritis. It should be noted,
however, that in this study pinch and heat were applied to the
skin area outside of the inflamed joint. Therefore, sustained
nociceptive barrage from the inflamed joint may have atte-
nuated concurrent nociceptive signals evoked by pinch and
heat stimulation of the healthy skin area. In line with this
proposal, this type of a phenomenon that is also called diffuse
noxious inhibitory controls (Le Bars et al., 1979) is known to be
effective in arthritis (Calvino et al., 1987). Although the RVM is
not involved in mediating diffuse noxious inhibitory controls
(Bouhassira et al., 1993), the RVM receives ascending nocicep-
tive signals from the spinal dorsal horn, a structure that is
influenced by diffuse noxious inhibitory controls (Le Bars
et al., 1979). Responses to noxious visceral stimulation, in
contrast, were slightly enhanced in arthritis. Possibly the con-
verging cutaneous receptive fields of spinal neurons mediat-
ing visceral nociception from the colorectal area are large
enough to receive and summate sustained nociceptive signals
from the inflamed joint which might explain enhanced vis-
ceral responses.
Previous studies have shown that a number of pathophy-
siological models such as prolonged noxious thermal stimu-
lation, opioid withdrawal, mustard oil-induced neurogenic
inflammation and spared nerve injury model of neuropathy
produce hypersensitivity that is associated with increased
activity of pronociceptive ON-cells in the RVM (Bederson et al.,
1990; Gonçalves et al., 2007; Kincaid et al., 2006; Morgan and
Fields, 1994; Xu et al., 2007) and that may, in some conditions,
be accompaniedby a decreased activity of antinociceptiveOFF-
cells (Gonçalves et al., 2007). In the present study, arthritis
increased activity of both pro- and antinociceptive RVM cells.
Arthritis failed to produce a significant change in the limb
withdrawal evoked by heating the paw distal to the inflamed
joint; thiswas expectedbasedon thearthritis-induced changes
in discharge properties of RVM cells. Together, the results are
in line with the hypothesis that ON- and OFF-cells of the RVM
have a role in modulation of spinal nociception in various139
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2006), although themagnitude of contribution and the pattern
of firing rate changesmay vary depending on the experimental
condition.
3.2. Spinal neurotransmitter receptors involved in the
PVN-induced antinociception
In control animals, antinociception inducedbyglutamate in the
PVNwas reversed by spinal administration of a 5-HT1A receptor
antagonist and an α2-adrenoceptor antagonist, whereas the
effect of an opioid receptor antagonist on the PVN-induced
antinociception was not significant. This finding indicates that
underphysiological conditions serotoninergic raphe-spinal and
descending noradrenergic pathways acting on spinal 5-HT1A
and α2-adrenoceptors, respectively, are involved in mediating
the PVN-induced spinal antinociceptive action. This is in line
with previous results indicating that the PVN has efferent
connections to various pain-modulatory nuclei in the brain-
stem, including the serotoninergic raphe magnus (Holstege,
1987; Swanson and Sawchenko, 1983) and that electrical or
chemical stimulationof theRVMmay inhibitnociceptiondue to
action on spinal 5-HT1A receptors (el-Yassir and Fleetwood-
Walker, 1990; Wei and Pertovaara, 2006). Efferent connections
from the PVN directly to the noradrenergic locus coeruleus in
the pons (Swanson and Sawchenko, 1983) provide a link for
activation of descending noradrenergic pathways that contri-
bute to thePVN-inducedantinociceptiondue toactiononspinal
α2-adrenoceptors. Additionally, the PVNmight recruit descend-
ing noradrenergic pathways through the RVM (Nuseir et al.,
1999; Sim and Joseph, 1992). In line with earlier findings (Shi-
raishi et al., 1995; Yirmiya et al., 1990), the present results sug-
gest that spinal opioid receptors donot have a critical role in the
PVN-induced antinociception in control animals.
Unlike under control conditions, the contribution of spinal
5-HT1A receptors to the PVN-induced antinociception was not
significant inarthritic animals. Thus, arthritis inducedachange
in the contribution of the serotoninergic system to the PVN-
induced antinociception. While spinal administration of an
α2-adrenoceptor or opioid receptor antagonist alone had no
significant effect on pain-related behavior in control animals,
these compounds produced a significantmodulatory action in
inflamed animals. Paradoxically, the changes produced by an
α2-adrenoceptor or opioid receptor antagonist alone were pro-
longations of the limb withdrawal latency. A plausible expla-
nation for the paradoxically increased withdrawal latency by
the receptor antagonists alone is removal of arthritis-induced
noradrenergic and opioidergic feedback inhibition (Pertovaara,
2006; Yaksh, 2006) and a consequent increase in the sustained
nociceptive barrage fromthe inflamed joint that led to a central
suppression of heat-evoked responses from the cutaneous test
site in thehindpaw; i.e., spinally administeredα2-adrenoceptor
and opioid receptor antagonistsmay have enhanced sustained
jointpainandconsequently, diffusenoxious inhibitory controls
(Calvino et al., 1987) that suppressed concurrent nociception
elsewhere. Due to significant actions by the α2-adrenoceptor
and opioid receptor antagonists alone, the present results do
not allow concluding whether the contribution of spinal nora-
drenergic or opioid receptors to the PVN-induced antinocicep-
tive effect is changed in arthritis.1403.3. Spinal neurotransmitters mediating descending
antinociception from the PVN versus other hypothalamic areas
Interestingly, while the present results indicate that spinal
5-HT1A receptors and α2-adrenoceptors are involved in med-
iating the descending antinociceptive effect from the PVN in
control conditions, earlier results indicate that these mono-
aminergic receptors mediate descending antinociception also
from the lateral hypothalamus (Holden and Naleway, 2001;
Holden et al., 2005). In contrast, while some earlier (Shiraishi
et al., 1995; Yirmiya et al., 1990) and the present results indicate
that spinal opioid receptors have only a minor, if any, role in
the PVN-induced antinociception, the spinal antinociceptive
effect induced by stimulation of the hypothalamic arcuate
nucleus was reversed by spinal administration of an opioid
receptor antagonist (Wang et al., 1990b).
3.4. Conclusions
The PVN has a phasic and tonic descending antinociceptive
influence in arthritic as well as control animals. The RVMmay
contribute to the relay of descending influence from the PVN.
Arthritis induced a dual change in the baseline activity and the
PVN-induced tonic drive of pro- and antinociceptive cells of
the RVM. Due to these dual arthritis-induced changes that
produced opposite actions, the net effect of RVM cells in the
control of baseline nociception or in the relay of tonic inhi-
bitory influence from the PVNmay remain the same, although
the roles of pro- and antinociceptive cells vary between the
arthritic and control conditions. Recent studies indicate that
vasopressin (Yang et al., 2006) or oxytocin (e.g., Condés-Lara
et al., 2006; Miranda-Cardenas et al., 2006) released from hy-
pothalamo-spinal neurons have an important role in the PVN-
induced antinociception. These findings indicate that direct
action by descending axons of hypothalamic neurons in the
spinal dorsal horn may alone be sufficient to induce anti-
nociception. The present results extend these findings by
showing that descending serotoninergic and noradrenergic
pathways acting on spinal 5-HT1A receptors and α2-adreno-
ceptors, respectively, may also contribute to the PVN-induced
inhibition of spinal nociception in control conditions.4. Experimental procedures
4.1. Animals, anesthesia and ethical issues
The experiments were performed in adult male Wistar Han
rats with 250–300 g (Harlan Netherlands, Horst, Netherlands).
The experimental protocol was approved by the Institutional
Ethical Commission and followed the European Community
Council Directive 86/609/EEC for the use of experimental ani-
mals. All efforts were made to minimize animal suffering and
to use only the number of animals necessary to produce reli-
able scientific data.
For the experimental surgery and electrophysiological ses-
sions, anesthesiawas inducedbyadministeringpentobarbitone
(50 mg/kg, i.p.) and the anesthesia was maintained by infusing
pentobarbitone (15–20 mg/kg/h, i.p.) when necessary. The level
of anesthesiawas frequentlymonitored by observing the size of
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noxious pinching. Importantly, the anesthesia level was main-
tained in an identical fashion when studying control and
arthritic animals. Therefore, a potential influence of anesthesia
level, if any, was identical in control and arthritic groups. A
warming blanket was used to maintain the body temperature
within physiological range. At the completion of the experi-
ment, animals received a lethal dose of pentobarbitone.
4.2. Procedures for intrathecal and intracerebral
microinjections
For the insertion of the intrathecal cannula, a thin polyethy-
lene cannula (PE-10, Becton Dickinson & Co., Sparks, MD) was
inserted into the lumbar subarachnoid space as described in
detail elsewhere (Størkson et al., 1996). The intrathecally in-
serted catheter was then fixed through a layer of superficial
muscles, tunneled rostrally and made to appear through the
skin in the occipital region. Upon recovery from anesthesia,
10 μl of 2% lidocaine hydrochloride, followed by 10–15 μl of
saline was given through the catheter – with the help of a
50 μl-Hamilton microsyringe (Hamilton Inc., Reno, NV) – to
verify if it was indeed spinally located. Only rats that devel-
oped reversible symmetrical paralysis of both hind limbs and
tail after the injection of lidocaine were used in the experi-
ments. Intrathecal cannula was inserted at least one week
before actual experiments. Test-drugs were injected intrathe-
cally at a volume of 5 μl using a 50 μl-Hamilton microsyringe,
flushed afterwards with 10–15 μl of saline.
For intracerebral drug administration, the rats were placed
in a stereotaxic frame and a stainless steel guide cannula
(26 gauge; Plastics One, Roanoke, VA) was implanted in the
brain according to the coordinates of the atlas by Paxinos and
Watson (1998). The tip of the guide cannula was positioned
1 mm above the desired injection site in the PVN (AP, 7.2 mm;
LM, 0.2 mm; DV, 7.9 mm to the interaural line). After the guide
cannula was fixed into the skull using a dental screw and
dental cement, a dummy cannula was inserted into the guide
cannula and the top was closed. Animals were allowed to
recover from surgery for one week before testing.
Test-drugswereadministered in thePVN througha33-gauge
injection cannula (Plastics One) inserted into and protruding
1 mm beyond the tip of the guide cannula. The microinjection
was made using a 1.0-μl-Hamilton syringe connected to the
injection cannula by a polyethylene catheter (PE-10). The injec-
tion volume was 0.5 μl and therefore, the spread of the injected
drugs within the brain was at least 1 mm (Myers, 1966). The
efficacy of injection wasmonitored by watching themovement
of a small air bubble through the tubing.The injection lasted30s
and the injection cannulawas left in place for an additional 30 s
to minimize the return of drug solution back to the injection
cannula. Brain injection sites were histologically verified from
post-mortem sections and plotted on standardized sections
derived from the stereotaxic atlas of Paxinos andWatson (1998).
4.3. Induction of arthritis
The induction of arthritis was performed 7–14 days before the
actual experiments as described in detail elsewhere (Ansah
and Pertovaara, 2007). Briefly, 3% kaolin and 3% carrageenan(Sigma, St. Louis, MO, USA) were dissolved in distilled water
and injected into the synovial cavity of the left knee joint at a
volume of 0.1 ml. This model produces mechanical hyper-
algesia with the onset of a few hours and a duration of up to
8 weeks (Radhakrishnan et al., 2003). In each animal, devel-
opment of arthritis was verified 1–2 h prior to each experi-
ment. Only those rats that vocalized every time after five
flexion–extension movements of the knee joint were consid-
ered to have arthritis, and they were included in the arthritis
group. Untreated control animals did not vocalize to any of the
five consecutive flexion–extension movements of the knee
joint.
4.4. Behavioral assessment of nociception
The rats were habituated to the experimental conditions by
allowing them to spend 1–2 h daily in the laboratory during two
to threedaysprecedingany testing. For assessingnociception in
unanesthetized animals, radiant heat-induced latency of paw
withdrawal was determined using radiant heat equipment
(Plantar Test Device Model 7370, Ugo Basile, Comerio, Italy) as
described in detail earlier (Hargreaves et al., 1988). Radiant heat
was applied to theplantar skin of thehind limb ipsilateral to the
inflamed knee joint and the PVN injection. In each drug treat-
ment session, the withdrawal latency was assessed prior to
drug treatment and at various interval following the intracere-
bral and intrathecal injections. At each time point, the mea-
surement was repeated twice at an interval of 1 min and the
mean of these values was used in further calculations. Cut-off
time was 20 s. Since spinal transection does not abolish the
heat-induced limbwithdrawal (e.g., Kauppila et al., 1998), it is a
spinally organized nociceptive reflex, although it is modulated
by brainstem–spinal pathways in intact animals. Therefore, the
heat-induced limbwithdrawal provides amethod for determin-
ing spinalnociceptionand its supraspinalmodulation inbehav-
ing animals and also under anesthesia (e.g., Luukko et al., 1994).
4.5. Recording of neuronal responses in the
rostroventromedial medulla (RVM)
RVM neurons provide a potential relay for descending influ-
ence from the RVM. Therefore, we studied the response pro-
perties of RVM neurons and themodulation of their activity by
the PVN in control and arthritic animals. For electrophysiolo-
gical recordings ofneurons in theRVM, anesthesiawas induced
and continued as described above, and the animal was placed
in a standard stereotaxic frame according to the atlas of
Paxinos and Watson (1998). The skull was exposed and a hole
was drilled for placement of a recording electrode in the RVM.
Thedesired recording site in theRVMwas 1.8–2.3mmposterior
from the ear bar, 0.0–0.5 mm lateral from the midline, and 8.9–
10.7 mm ventral from the dura mater. Single neuron activity
was recorded extracellularly with lacquer-coated tungsten
electrodes (tip impedance 3–10MΩ at 1 kHz) and then amplified
and filtered using standard techniques. Data sampling was
performed with a computer connected to a CED Micro 1401
interface and using Spike 2 software (Cambridge Electronic
Design, Cambridge, U.K.).
Actual recordings of RVM neurons did not start until the
animal was under light anesthesia; i.e., the animals gave a141
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not produce any longer lasting motor activity, nor did the
animals have spontaneous limb movements. RVM neurons
were classified based on their response to noxious heating
(54 °C) of the hind paw with a feedback-controlled Peltier
device (LTS-3 Stimulator, Thermal Devices Inc., Golden Valley,
MN; Wilcox and Giesler, 1984), as described below. For detec-
tion of a heat-evoked limb withdrawal concurrently with the
neuronal response, a piezoceramic movement detector (Sie-
mens Elema Ab., Medicinsk Teknik, Solna, Sweden) of low
weight (<0.5 g) was taped on the skin overlying the hamstring
muscle in the mid thigh level of the stimulated hind limb and
the movement of the limb measured with it as described
earlier (Hämäläinen et al., 1996). For classification of RVM
neurons, the scheme developed earlier (reviewed by Fields
et al., 2006) was adapted. Briefly, neurons giving an excitatory
heat-evoked response that was associated with a hind-limb
withdrawal were considered to be pronociceptive ON-cells,
those giving an inhibitory response that was associated with a
limb withdrawal were considered to be antinociceptive OFF-Fig. 11 – Examples of original recordings of RVM cells.
A) ON-cell in a control animal. B) OFF-cell in an arthritic
animal. In A, i shows the neuronal response, ii the
withdrawal response in the hind limb, and iii the noxious
heat stimulus applied to the hind paw. In B, i shows the
neuronal response, ii the noxious heat stimulus, and iii the
noxious visceral stimulus (colorectal distension). In both
graphs, P–P indicate the duration of the noxious tail pinch.
The vertical calibration bar for neuronal response represents
10 Hz in A and 20 Hz in B. In both graphs, the baseline
temperature of the heat stimulus is 35 °C and the peak
stimulus temperature 54 °C. In B, colorectal distension is
applied at an intensity of 80 mmHg. The horizontal
calibration bar represents 50 s in A and 40 s in B.
142cells (Fig. 11). Neurons showing no or only a negligible (<10%)
change in their discharge rates as a response to noxious sti-
mulation were considered to be NEUTRAL-cells which were
not studied further in this investigation. If a neuron could not
be classified it was not included in the study. Classification of
RVM neurons was not attempted unless the noxious test sti-
mulus induced a hind-limb withdrawal reflex.
Characterization of the response properties of an RVM cell
consisted of the following assessment performed succes-
sively: 1. Spontaneous activity. 2. Response to heating of the
hind paw ipsilateral to the treated knee with a Peltier device
(LTS-3 Stimulator; a heat ramp rising at the rate of 10 °C/s
from the baseline temperature of 35 °C to the peak tempe-
rature of 54 °C and peak duration of 10 s). 3. Response to
pinching of the tail for 5 s by a surgical clamp that produced
painful sensation when applied to the hand of the experi-
menter. 4. Response to colorectal distension (CRD) at a nox-
ious intensity (80 mmHg; Ness et al., 1991) and duration of
10 s. CRD was produced by inflating with air a 7–8 cm flexible
latex balloon inserted transanally into the descending colon
and rectum. The pressure in the balloon was controlled by an
electronic device (Anderson et al., 1987).
When analyzing responses of RVM neurons to peripheral
stimulation, the baseline discharge frequency recorded during
a corresponding period just before the stimulation was sub-
tracted from the discharge frequencies determined during sti-
mulation; i.e., positive values represent excitatory responses
evoked by peripheral stimulation and negative ones inhibitory
responses.
The animals used in recordings had a guide cannula for
drug administrations into the PVN. Electrophysiological expe-
riments were performed one to two weeks after fixation of the
guide cannula to the skull, as described above. After determin-
ing the responses of an RVM neuron to peripheral stimulation,
the phasicmodulation of the discharge rate of RVMneurons by
the PVNwas assessed bymicroinjecting glutamate (50 nmol in
0.5 μl) into the PVN using methods described above. The dis-
charge rate of the RVM cells was followed up to 5min after the
injection of glutamate. Thereafter, tonic control of the RVM by
the PVNwas assessed bymicroinjecting lidocaine (4% in 0.5 μl)
into the PVN and following the discharge rate of RVM neurons
up to 30 min.
4.6. Recording of neuronal responses in the spinal dorsal
horn
To exclude the possibility that the PVN-inducedmodulation of
spinal reflex responses is rather due to action on spinal motor
than sensory neurons, we determined the PVN-induced effect
on responses of wide-dynamic range (WDR) neurons of the
spinal dorsal horn. One to two weeks before the recordings of
spinal dorsal horn neurons, a chronic guide cannula was in-
serted to the PVN as described above. Following induction of
anesthesia with pentobarbitone (50 mg/kg i.p. followed by
15–25 mg/kg/h or more, if required according to continuous
observation of the anesthesia level), a laminectomy was per-
formed at the level of T12–L2 vertebrae. The durawas removed
and the spinal cord was covered with warm mineral oil. Two
spinal clamps, one rostral and one distal to the laminectomy,
were used to stabilize the preparation. Data samplingmethods
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spinal dorsal horn, searchand classificationof spinal unitswas
performed as described in detail elsewhere (Pertovaara et al.,
2001). Only wide-dynamic range (WDR) neurons activated by
innocuous stimulation (brush) and giving a differential re-
sponse to heat stimulation within nociceptive range (46–54 °C)
were studied further. All the WDR neurons included in the
study had their receptive fields in the plantar skin of the hind
paw. The recording depth from the spinal cord surface was
0.4–1.0 mm.
When assessing the PVN-induced modulation of the re-
sponse of a spinal dorsal horn neuron, the noxious test sti-
mulus was a heat ramp applied from a Peltier device (LTS-3
Stimulator). The stimulus started from the baseline tempera-
ture of 35 °C and ascended to the peak temperature of 54 °C at
a rate of 10 °C/s. The duration of the peak temperature was
10 s. The response to heat was determined 5 min prior to and
30 s after the injection of saline or glutamate (50 nmol in 0.5 μl)
into the PVN. The magnitude of the response before the injec-
tion was considered the reference response (100%) for each
neuron. The order of testing glutamate or saline was varied
between the neurons and the interval between testing the
effects of glutamate and saline on the same neuron was at
least 5 min. The interval between testing different neurons in
the same animal was at least 30 min.
4.7. Drugs
The opioid receptor antagonist naloxonehydrochloride and the
5-HT1A receptor antagonist WAY-100635 were purchased from
Sigma (St. Louis,MO,USA),while theα2-adrenoreceptorantago-
nist atipamezole was obtained from Orion Pharma Inc. (Turku,
Finland). The intrathecal doses of naloxone, WAY-100635 and
atipamezole were chosen based on our previous investigations
showing that at the dose range used these receptor antagonists
alone had no significant effects on nociception in control or
neuropathic animals (Pertovaara and Wei, 2003, in press; Wei
and Pertovaara, 2006). It should be noted that unlike many
other α2-adrenoreceptor antagonists, atipamezole does not
bind to 5-HT1A receptors (Pertovaara et al., 2005). Sodium
pentobarbitone, glutamate and physiological saline were
obtained from Orion Pharma Inc. (Espoo, Finland), and the
local anesthetic, lidocaine,was obtained fromAstra (Södertälje,
Sweden).
4.8. Course of the behavioral study
One to two weeks following induction of the arthritis and at
least one week following insertion of the intrathecal catheter
and the guide cannula for PVN injections, the efficacy of PVN-
induced phasic and tonic modulation of spinal nociception
was determined by assessing the effect of glutamate and
lidocaine in the PVN on the heat-evoked spinal withdrawal
reflex in unanesthetized arthritic and control animals. Physio-
logical saline was used for control injections and untreated
animals were used as control animals. In these experiments,
the latency of the withdrawal response was assessed 30 s,
5 min, 15 min and 30 min following the injection. The latency
measured 30 s after glutamate injection and 15 min after
lidocaine injection was used in further calculations, since themaximum effects of the studied compounds are obtained at
these time points. The interval between behavioral assess-
ments of glutamate-, lidocaine- or saline-induced effects was
at least two days and the order of testing different compounds
was varied between the animals.
Assessment of spinal neurotransmitter receptors mediat-
ing the descending antinociceptive influence inducedby gluta-
mate in the PVNwas also assessed one to twoweeks following
induction of arthritis. In these experiments, one of the three
receptor antagonists studied (atipamezole, WAY-100635 or
naloxone)was administered intrathecally immediately follow-
ing the assessment of the pre-drug latency. The effect of the
receptor antagonist alone on the withdrawal latency was
assessed 10 min following its intrathecal administration. At
this time point, all the studied receptor antagonists should
have their maximum effects. Glutamate (50 nmol) was micro-
injected into the PVN about 13 min following the intrathecal
injectionof the receptor antagonist. To assesspossible reversal
of the glutamate-induced antinociception by the spinally ad-
ministered receptor antagonist, the heat-evoked withdrawal
latency was again determined 30 s after injection of glutamate
into the PVN; i.e., the potential reversal of PVN-induced anti-
nociception was determined about 14–15 min following the
intrathecal injection of the receptor antagonist. When testing
different receptor antagonists in the same animal, the interval
between testing sessions was at least two days. The order of
testing different receptor antagonists was varied between the
animals. Each animal participated in 1–3 behavioral testing
sessions. At the end of the experiment, the animalswere given
a lethal dose of pentobarbitone and the brains were removed
for histological verification of the injections sites.
4.9. Course of the electrophysiological study
Electrophysiological recordings of RVM neurons or spinal dorsal
horn neurons were performed under pentobarbitone anesthesia
in different animals one to two weeks following the induction of
arthritis andat least oneweek following the insertionof theguide
cannula for PVN injections. In RVM recordings, the response
properties of the neurons were assessed by determining sponta-
neous activity and response to noxious heating of the skin, tail
pinch andCRD. Then, the change in spontaneous activity of RVM
neurons following successive microinjections of glutamate and
lidocaine at a 15 min interval into the PVN was assessed as
described indetail above. Search for thenextneuron tobe studied
started about 30 min after the testing of the previous one was
completed. At the end of the recording session, electrolytic
lesions weremade in the recording sites, the animals were given
a lethal dose of pentobarbitone and the brains were removed for
histological verification of the recording and injection sites.
In recordings of spinal dorsal hornWDR neurons, the heat-
evoked response was determined before and 30 s after injec-
tion of glutamate or saline into the PVN; i.e., testing was per-
formed at the time point when glutamate has its maximum
effect. The interval between testing the salineandglutamate in
the same neuronswas at least 5min, and the interval between
testing different neurons in the same animal was at least
15 min. At the end of the recording session, the animals were
given a lethal dose of pentobarbitone and the brain removed
for histological verification of the injection site.143
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Two-way analysis of variance (ANOVA) followed by Dunnett's
test (comparisons between three or more groups) or t-test
(comparisons between two groups) were used in statistical
assessment of the data. The differences in the incidence of
various types of RVM neurons were analyzed using Fisher's
exact test. P<0.05 was considered to represent a significant
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Abstract 
In this work the role of the caudal ventrolateral medulla (CVLM) upon pain modulation was 
studied in SHAM and arthritic (ARTH) rats using electrophysiological recordings of neuronal 
activity in the CVLM. As the CVLM participates in the regulation of homeostasis, the effect of the 
activation of the paraventricular nucleus of the hypothalamus (PVN) upon its activity was also 
assessed. The electrophysiological evaluation of CVLM neurones revealed the presence of three 
different types of cells, (+)/(-)/(=) cells, whose response pattern to acute noxious peripheral 
stimulation is similar to the ON-/OFF-/neutral cells of the rostral ventromedial medulla (RVM). 
Arthritis induced an increase in the spontaneous activity of CVLM (+) and (=) cells while it 
decreased (-) cell activity. Significant changes were also observed in (i) the proportion of (+)/(-
)/(=) cells [increase in the total number of (-) cells responsive to cold paralleled by a decrease in 
(=) cells], and in (ii) the noxious-evoked response of both (+)/(-) CVLM neurones to different types 
of stimulation. Additionally, the PVN exerts an inhibitory downstream effect upon the 
pronociceptive CVLM (+) cells during noxious stimulation, but only in ARTH animals.  
These results point to the occurrence of plastic changes in the CVLM and in the PVN-mediated 
descending circuitry due to chronic (arthritic) pain.  
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1. Introduction 
The concept of how pain is perceived and modulated has slowly evolved over the last decades. 
Initially it was thought that the exacerbation of pain was a direct consequence of increased 
signalling of the ascending pathways and analgesia resulted from the activation of the descending 
pathways. At this time, the descending modulatory pain system was mainly associated with the 
periaqueductal gray matter (PAG)-rostral ventromedial medulla (RVM) system (Basbaum and 
Fields, 1984). The electrophysiological examination of RVM neurones revealed the existence of 
three cell classes (Fields and Heinricher, 1985) whose firing pattern “ON-“and “OFF-cells” upon 
peripheral noxious stimulation allowed their association with the facilitation and inhibition of 
nociception, respectively (Fields et al., 1983; Heinricher et al., 2009). These data were essential 
for demonstrating that the descending modulatory pain system alone was a dynamic system 
capable of either inhibiting or facilitating  pain sensation (Ren and Dubner, 2002; Vanegas and 
Schaible, 2004). This concept was further reinforced by more recent studies showing that other 
brainstem areas are also involved in the descending positive and negative facilitation of 
nociceptive transmission, such as the dorsal reticular nucleus (DRt) and caudal ventrolateral 
medulla (CVLM), respectively (Lima and Almeida, 2002; Tavares and Lima, 2002; Heinricher et 
al., 2009). While the DRt is activated mainly by noxious stimulation (Villanueva et al., 1988) and 
facilitates acute, inflammatory (Almeida et al., 1996; 1999) and neuropathic (Sotgiu et al., 2008) 
pain, the CVLM produces profound analgesia after electrical stimulation and glutamate 
administration (Gebhart and Ossipov 1986; Janss and Gebhart 1986), and seems to tonically 
inhibit spinal nociceptive neurones (Tavares et al., 1997).  
It has been proposed that the CVLM modulation of nociceptive transmission is mediated through 
direct and indirect pathways to the spinal cord, mechanisms that appear to be specific to the 
nature of the noxious stimuli and the spinal cell where it originates from (Tavares and Lima, 
2002). Also important is its involvement in indirectly mediating the hypoalgesia due to increased 
blood pressure, through a CVML-A5-spinal cord circuitry (Tavares et al., 1997). In addition, the 
CVLM and the nucleus tractus solitarius are part of a three-way loop that involves supraspinal 
reciprocal projections with the paraventricular nucleus of the hypothalamus (PVN) (Krukoff et al., 
1994; Kawano and Masuko, 1996). The PVN is a major integration centre of several circuits, 
including the stress response through the hypothalamus-pituitary-adrenals axis (Armario, 2006; 
Lightman and Young, 1988) and pain modulation (Pinto-Ribeiro et al., 2008; Delatorre et al., 
2009). In a previous study, we assessed the modulatory effect of the PVN upon RVM cells in 
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normal in arthritic animals (Pinto-Ribeiro et al., 2008) and demonstrated that although the RVM 
may not have a crucial role in mediating phasic antinociception induced by PVN stimulation, this 
nucleus tonically modulates the activity of RVM nociceptive neurones in both control and arthritic 
conditions. However, it is not known if other components of the supraspinal pain system are 
recruited by the PVN in phasic pain control during normal or chronic pain conditions. 
Our purpose in this study was to: (i) characterize the electrophysiological profile of CVLM 
neurones, both at rest and after acute noxious stimulation in normal rats; (ii) analyse eventual 
changes in CVLM neuronal activity after the induction of monoarthritis; (iii) investigate a potential 
role of the PVN as a modulator of CVLM neuronal activity, as an alternative pathway for PVN-
mediated stress-induced analgesia. 
2. Experimental procedures 
2.1. Animals, anaesthesia and ethical issues 
The experiments were performed in adult male Wistar Han rats with 175–250g (Harlan 
Netherlands, Horst, Netherlands). The experimental protocol was approved by the Institutional 
Ethical Commission and followed the European Community Council Directive 86/609/EEC for 
the use of experimental animals. All efforts were made to minimize animal suffering and to use 
only the number of animals necessary to produce reliable scientific data. 
For the experimental surgery and electrophysiological sessions, anaesthesia was induced by 
administering pentobarbitone (50 mg/kg, i.p.) and maintained by infusing pentobarbitone (15–
20 mg/kg/h, i.p.) when necessary. The level of anaesthesia was frequently monitored by 
observing the size of the pupils, the general muscle tone and behavioural responses to noxious 
pinching. Importantly, the anaesthesia level was maintained in an identical fashion when studying 
control and arthritic animals to avoid a potential influence of this factor amongst groups. A 
warming blanket was used to maintain the body temperature within physiological range. At the 
completion of the experiment, animals received a lethal dose of pentobarbitone. 
2.2. Recording of neuronal responses in the caudal ventrolateral medulla (CVLM) 
In order to perform electrophysiological recordings of the activity of CVLM neurones after being 
anaesthetized (as described above), the animals were placed in a standard stereotaxic frame. 
The skull was exposed and a hole was drilled for placement of a recording electrode in the CVLM 
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(4.08 mm posterior to interaural, 2.0–2.2 mm lateral from the midline, and 10.0 mm ventral 
from the dura mater) according to the atlas of Paxinos and Watson (2005) (Fig. 1). Single 
neurone activity was recorded extracellularly with lacquer-coated tungsten electrodes (tip 
impedance 3–10 MΩ at 1 kHz) and then amplified and filtered using standard techniques. Data 
sampling was performed with a computer connected to a CED Micro 1401 interface and using 
Spike 2 software (Cambridge Electronic Design, Cambridge, U.K.). 
Recording of CVLM neurones was started after the animal was under light anaesthesia; i.e., the 
animals gave a brief withdrawal response to noxious pinch, but the pinch did not produce any 
longer lasting motor activity, nor did the animals have spontaneous limb movements. CVLM 
neurones were classified based on their response to noxious heating (54 °C) of the hind paw 
with a feedback-controlled Peltier device (LTS-3 Stimulator, Thermal Devices Inc., Golden Valley, 
MN; Wilcox and Giesler, 1984), as described below. For detection of a heat-evoked limb 
withdrawal concurrently with the neuronal response, a piezoceramic movement detector 
(Siemens Elema Ab., Medicinsk Teknik, Solna, Sweden) of low weight (< 0.5 g) was taped on the 
skin overlying the hamstring muscle in the mid thigh level of the stimulated hind limb and the 
movement of the limb measured with it as described earlier (Hämäläinen et al., 1996). For the 
functional classification of CVLM neurones, the scheme developed earlier for the RVM (Fields et 
al., 1983) was adapted.  
Briefly, neurones displaying an increase in firing rate evoked by heat stimulation of the tail, 
associated with a hind-limb withdrawal, were considered to be positive/excitatory (+) neurones to 
that stimulus, while those decreasing its activity were considered to be negative/inhibitory (-) 
neurones (Fig. 2). Neurons displaying no or only a negligible (< 10%) change in their discharge 
rates as a response to noxious stimulation were considered to be neutral (=) cells, which were 
not studied further in this investigation. If a neuron could not be classified it was excluded from 
the study. Classification of CVLM neurones was not attempted unless the noxious test stimulus 
induced a hind-limb withdrawal reflex. 
Characterization of the response properties of CVLM cells consisted of the following assessments 
performed successively: (i) Spontaneous activity; (ii) Response to heating of the hind paw 
ipsilateral to the arthritic or SHAM knee with a Peltier device (LTS-3 Stimulator; a heat ramp 
rising at the rate of 10 °C/s from the baseline temperature of 35 °C to the peak temperature of 
54 °C and peak duration of 10 s); (iii) Response to pinching of the tail for 5 s by a surgical clamp 
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that produced painful sensation when applied to the hand of the experimenter; (iv) Response to 
colorectal distension (CRD) at a noxious intensity [80 mmHg  (Ness et al., 1991) and duration of 
10 s]. CRD was produced by inflating with air a 7–8 cm flexible latex balloon inserted transanally 
into the descending colon and rectum; the pressure in the balloon was controlled by an electronic 
device (Anderson et al., 1987); (v) Response to cold stimulation of the hind paw ipsilateral to the 
treated knee with a Peltier device (LTS-3 Stimulator; a heat ramp decreasing at the rate of 10 
°C/s from the baseline temperature of 35 °C to the peak temperature of 4 °C and peak 
duration of 10 s). 
When analyzing responses of CVLM neurons to peripheral stimulation, the baseline discharge 
frequency recorded during a corresponding period just before the stimulation was subtracted 
from the discharge frequencies determined during stimulation; i.e., positive values represent 
excitatory responses evoked by peripheral stimulation and negative ones inhibitory responses. 
The animals used in recordings had a guide cannula for drug administration into the PVN (see 
section 2.3). Electrophysiological experiments were performed one to two weeks after fixation of 
the guide cannula to the skull, as described above. After determining the responses of a CVLM 
neurone to peripheral stimulation, the phasic modulation of the discharge rate of CVLM neurones 
by exciting PVN neurones was assessed by microinjecting glutamate (50 nmol in 0.5 μL) into the 
PVN using methods described above. The discharge rate of the CVLM cells was followed up to 5 
min after the injection of glutamate. All results from the drug administration were plotted against 
the values obtained for the same time points after saline (SAL) injection in the PVN. 
2.3. Procedures for intracerebral microinjections 
For intracerebral drug administration, the rats were placed in a stereotaxic frame and a stainless 
steel guide cannula (26 gauge; Plastics One, Roanoke, VA) was implanted in the brain according 
to the coordinates of the atlas by Paxinos and Watson (2005). The tip of the guide cannula was 
positioned 1 mm above the desired injection site in the PVN (AP, 7.2 mm; LM, 0.2 mm; DV, 7.9 
mm to the interaural line) or the CVLM. After the guide cannula was fixed into the skull using a 
dental screw and dental cement, a dummy cannula was inserted into the guide cannula and the 
top was closed. Animals were allowed to recover from surgery for one week before testing. 
Test-drugs were administered in the PVN through a 33-gauge injection cannula (Plastics One, 
Bilaney, Germany) inserted into and protruding 1 mm beyond the tip of the guide cannula. The 
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microinjection was made using a 1.0-μL-Hamilton syringe connected to the injection cannula by a 
polyethylene catheter (PE-10; Plastics One, Bilaney, Germany). The injection volume was 0.5μL 
and therefore, the spread of the injected drugs within the brain was expected to be 1 mm (Myers, 
1966). The efficacy of injection was monitored by watching the movement of a small air bubble 
through the tubing. The injection lasted 20s and the injection cannula was left in place for an 
additional 30s to minimize the return of drug solution back to the injection cannula. Brain 
injection sites were histologically verified from post-mortem sections and plotted on standardized 
sections derived from the stereotaxic atlas of Paxinos and Watson (2005). 
2.4. Induction of arthritis 
The induction of arthritis (ARTH) was performed 7–14 days before the actual experiments, as 
described in detail elsewhere (Ansah and Pertovaara, 2007). Briefly, 3% kaolin and 3% 
carrageenan (Sigma, St. Louis, MO, USA) were dissolved in distilled water and injected into the 
synovial cavity of the left knee joint at a volume of 0.1 mL. This model produces mechanical 
hyperalgesia, which begins just in a few hours after surgery and extends up to 8 weeks 
(Radhakrishnan et al., 2003). In each animal, development of arthritis was verified 1–2 h prior to 
each experiment. Only those rats that vocalized every time after five flexion–extension 
movements of the knee joint were considered to have arthritis, and they were included in the 
arthritis group. An experimental group used as SHAM animals were also injected with 0.1 mL 
saline in the synovial cavity of the left knee joint. SHAM animals did not vocalize to any of the five 
consecutive flexion–extension movements of the knee joint. 
2.5. Drugs 
Sodium pentobarbitone, glutamate and physiological saline were obtained from Orion Pharma 
Inc. (Espoo, Finland). 
2.6. Course of the electrophysiological study 
Electrophysiological recordings of CVLM neurones were performed under pentobarbitone 
anesthesia in different animals one to two weeks following the induction of arthritis and at least 
one week following the insertion of the guide cannula for PVN injections. In CVLM recordings, the 
response properties of the neurons were assessed by determining spontaneous activity and 
response to noxious heating of the skin, tail pinch and CRD. Then, the change in spontaneous 
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activity of CVLM neurones following successive microinjections of glutamate at 30 min interval 
into the PVN was assessed as described in detail above. Search for the next neuron to be studied 
started about 30 min after the testing of the previous one was completed. At the end of the 
recording session, electrolytic lesions were made in the recording sites, the animals were given a 
lethal dose of pentobarbitone and the brains were removed for histological verification of the 
recording and injection sites. 
2.7. Statistics 
The differences in the number of the different types of CVLM neurones between experimental 
groups (SHAM and ARTH) were analyzed using Fisher's exact test (Fig. 3). The differences in 
spontaneous activity between controls and arthritic animals were tested using a student t-test 
comparison (Fig. 4). The statistical assessment of differences in neuronal activity between 
experimental groups during the pharmacological treatments was assessed using two-way analysis 
of variance (ANOVA) followed by Bonferroni post-hoc test (Figs. 5,6). A value of p<0.05 was 
considered to represent a significant difference. 
3. Results 
3.1 Activity of CVLM neurones in control and arthritic animals 
Our first aim was to investigate the response of CVLM cells to a noxious stimulus in basal 
conditions and a total number of 78 neurones were studied (Table 1). The application of a 
noxious heat stimulus to the hindpaw allowed us to identify three types of nociceptive responsive 
CVLM cells (Fig. 3A). A group of cells was excited after noxious peripheral stimulation (NPS) and 
was classified has excitatory (+) cells; the firing rate of a second group of neurones was 
decreased by NPS, which were thus classified as inhibitory (-) cells; finally, we observed no 
change in neuronal activity after NPS in a third group of neurones [(=)-cells]. The application of 
other modalities of cutaneous and visceral noxious stimuli resulted also in a similar change of 
activity pattern from CVLM cells, which presented increase [(+)-cells], decrease [(-)-cells] and no 
changes [(=)-cells] in their firing rates (Figs. 3B,C,D; Table 1). The spontaneous activity of these 
neurones was also consistent with the cell type, with (=) cells displaying the lowest firing rate 
followed by (+) cells and by (-) cells (Fig. 4). In an attempt to further correlate the activity of these 
cells to nociceptive processing, a second group of animals was subjected to arthritis and the 
activity of CVLM was again evaluated after several modalities of NPS. For this part of the study 
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the number of neurones studied was 77 (Table 1). After ARTH induction, the number of (+), (-) 
and (=) CVLM cells responding to noxious stimulation by heat (Chi-test, p=0.38), pinch (Chi-test, 
p=0.60) and colorectal distension (Chi-test, p=0.52) was identical to SHAM (Figs. 3A-C). 
However, an alteration in CVLM cell type ratio was observed between SHAM and ARTH animals 
after stimulation by cold (Chi-test, p=0.04) (Fig. 3D); although no difference was observed for (+) 
cells, the number of (-) neurones responsive to cold increased significantly, which was paralleled 
by a decrease in the (=) type (Fig. 3D).  Additionally, arthritis exerted an overall strong effect upon 
cell activity (ANOVA2w, F2,18=3,9, p<0,022), as the spontaneous activity of CVLM neurones in ARTH 
animals was considerably altered (Fig. 4). We observed a significant increase in the spontaneous 
activity of (+) cells (t(2.732)=0.007) and (=) cells (t(2.173)=0.0329), which was paralleled by a decrease 
in  (-) cells (t(2.9)=0.006) firing rate (Fig. 4). 
 
3.2 Noxious-evoked activity of CVLM neurones in control and arthritic animals 
Interestingly, in ARTH animals, it is not only the spontaneous activity of CVLM neurones but also 
the noxious evoked activity of each cell type that is altered (Fig. 5). After the induction of arthritis, 
the heat-evoked activity was altered independently of the cell type; while the evoked activity of (+) 
cells decreased (nSHAM=9 and nARTH=9), the opposite effect was observed in (-) cells (nSHAM=24 and 
nARTH=24) [ANOVA2W, ARTH, Fint(1,62)=60.39, p<0,0001; Bonferroni, (+) cells – CTRL X ARTH, p<0.05 
and (-) cells – CTRL X ARTH, p<0.001] (Fig. 5A). After noxious mechanical ((+) cells, nSHAM=18 and 
nARTH=18 and (-) cells, nSHAM=19 and nARTH=19) and cold ((+) cells, nSHAM=21 and nARTH=18 and (-) cells, 
nSHAM=19 and nARTH=17) stimulation we observed a significantly increased activity of (+) neurones 
[ANOVA2W, ARTH – mechanical, Fint(1,70)=36.55, p<0,0001; Bonferroni, (+) cells – CTRL X ARTH, 
p<0.001 and ARTH – cold, Fint(1,71)=33.93, p<0,0001; Bonferroni, (+) cells – CTRL X ARTH, 
p<0.001], respectively] but no changes were detected for  (-) cells (Figs. 5B,D). Finally, visceral 
noxious-evoked activity ((+) cells, nSHAM=22 and nARTH=22 and (-) cells, nSHAM=21 and nARTH=18) is 
decreased in both CVLM cell types [ANOVA2W, ARTH, F(1,79)=33.91, p<0,0001; Bonferroni, (+) cells 
– CTRL X ARTH, p<0.01 and (-) cells – CTRL X ARTH, p<0.001] (Fig. 5C).  
3.3 Activation of the PVN always decreases the activity of CVLM (+)-cells 
In the evaluation of the effect of the PVN upon CVLM cells activity a total of 47 cells were studied. 
Pharmacological activation of the PVN with glutamate did not alter the spontaneous activity of 
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CVLM cells in both SHAM [(+) cells - ANOVArm, p=0.21 and (-) cells - ANOVArm, p=0.12] and ARTH 
[(+) cells - ANOVArm, p=0.76 and (-) cells - ANOVArm, p=0.51], although changes in evoked-
responses were observed.  
During noxious heat stimulation (Fig. 6A), the microinjection of glutamate in the PVN altered 
neuronal activity depending on the CVLM cell type (F(1,36)=25.53, p=0.001) but this effect was not 
influenced by the presence of ARTH (F(1,36)=1.724, p=0.2). Neuronal activity was significantly 
decreased in CVLM (+) cells in the ARTH group when compared to basal activity [ANOVA2W, 
p=0.001; Bonferroni, SHAM, p>0.05 and ARTH, p<0.05], and when compared with SHAM 
[ANOVA2W, p=0.001; Bonferroni, SHAM, p<0.01 and ARTH, p>0.05]. Additionally, (-) cell activity 
was increased only in the SHAM group [ANOVA2W, p=0.001; Bonferroni, SHAM, p<0.05 and 
ARTH, p>0.05] (Fig. 6A). 
Interaction between the induction of arthritis and cell-type was detected during noxious 
mechanical-evoked activity in the response of CVLM neurones [ANOVA2W, mechanical-evoked 
response, Fint(1,28)=7.161, p=0.012] (Fig. 6B). Glutamate activation of the PVN significantly 
decreased the activity of CVLM (+) cells in the ARTH group when compared to basal evoked 
responses [(+) cells, ANOVA2W, p=0.03; Bonferroni, (+) cells, p=0.02] and when compared with 
SHAM animals [SHAM, ANOVA2W, p=0.04; Bonferroni, (+) cells, p=0.03]. Additionally, (-) cell 
activity was increased only in ARTH animals [ANOVA2W, p=0.03; Bonferroni, (-) cells, p=0.004] 
(Fig. 6B). 
Interaction between the induction of arthritis and cell-type was also detected after visceral 
stimulation [ANOVA2W, CRD-evoked response, Fint(1,37)=5.38, p=0.026]. Glutamate activation of the 
PVN exclusively decreased (+) cell activity in ARTH when compared to basal evoked responses 
[ARTH, ANOVA2W, p=0.0002; Bonferroni, (+) cells, p<0.05] and to SHAM animals [GLU, ANOVA2W, 
p=0.026; Bonferroni, (+) cells, p<0.01] (Figure 6C).  
The influence of arthritis was not independent of CVLM cell type [ANOVA2W, cold-evoked response, 
Fint(1,26)=33.25, p<0.0001] in cold-evoked responses after the administration of glutamate in the 
PVN. Again, activation of the PVN decreased (+) cell activity only in ARTH animals [ARTH, 
ANOVA2W, p=0.03; Bonferroni, (+) cells, p=0.014] when compared to basal evoked responses, 
with no difference on (-) cell response for both groups (Fig. 6D). The evoked-responses of the 
CVLM cells was significantly altered, (+) cells decreased while (-) cells increased [GLU, ANOVA2W, 
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p<0.0001; Bonferroni, (+) cells, p<0.001 and (-) cells, p<0.05] in ARTH animals when compared 
to SHAM (Fig. 6D). 
4. Discussion 
In this work we demonstrate for the first time the presence in the CVLM of nociceptive responsive 
neurones that display an activity pattern similar to the pronociceptive ON- [(+) cells] and 
antinociceptive OFF- [(-) cells] neurones that were previously observed in other descending pain 
modulatory areas, such as the RVM (Heinricher et al., 2009) and the PAG (Heinricher et al., 
1987). Additionally, changes in neuronal activity after induction of arthritis indicate that the CVLM 
has different roles in the processing of different types of noxious stimulation. Finally, we propose 
that the PVN, as part of the HPA axis, acts as a compensatory mechanism to the sensitization 
process in arthritic animals at the supraspinal level since its activation systematically decreases 
the activity of CVLM ON-cells and mostly increases the activity of CVLM OFF-cells, but only when 
chronic pain is installed. 
4.1. Technical considerations 
This study presents two major constrains, one related to the ability to verify the exact coordinates 
of each cell recorded and a second associated with the fact that the electrophysiological analysis 
of activity between SHAM and ARTH were performed in two different sets of animals.  The first 
constrain we consider to be unavoidable; the confirmation of the specific coordinates of each 
neurone recorded would imply the use of a single animal per recording which would then 
ethically compromise the study in terms of the number of animals needed. Since more than one 
cell was recorded by session, the exact coordinates (dorsoventral, lateromedial and rostrocaudal) 
of each recording site were carefully registered at the time of its recording and were later plotted 
in relation to the coordinates of the last cell recorded confirmed by the analysis of post-mortem 
slides of the brain.  
As for the second constrain, animals from both the SHAM and the ARTH groups could have been 
implanted with multiple chronic electrodes in the CVLM at the beginning of the experiment. This 
procedure would have allowed the continuous recording of cell activity during not only the 
inflammatory process, but more importantly, during pain chronification. A continuous recording 
would provide detailed data about the time point at which neuronal activity patterns shift, as 
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shown by our study. Alternatively, in order to compensate, the number of cells we recorded in 
SHAM and ARTH was identical and the differences observed were significant. 
4.2. Activity pattern of CVLM neurones 
In the present work we show that CVLM neurones (i) change their firing pattern after noxious 
stimulation, (ii) undergo changes in their firing patterns in chronic pain (arthritis) confirming a 
clear involvement of this area in the modulation of nociception (Gebhart and Ossipov, 1986) and 
(iii) are modulated by the hypothalamus. In 1983, Fields and colleagues associated changes in 
the cell activity of the RVM to the modulation of nociceptive inputs. There is a strong similarity 
between what was observed for the RVM and our results in the CVLM. Neurones within the CVLM 
responded in three different ways after noxious heat stimulation: (i) a first group of cells, with 
medium/low basal activity, was excited during the TF test and started firing just before or at the 
beginning of the tail withdrawal reflex; (ii) a second group, with a steady firing pattern as basal 
activity, decreased its activity just prior or at the start of the tail flick reflex, and; (iii) a third group 
of neurones, with low basal activity, whose firing pattern was not changed after noxious heat 
stimulation (Heinricher et al., 2009). Following the same rationale as for ON-, OFF and NEUTRAL-
cells (Heinricher et al., 2009), it is suggested that the CVLM (+), (-) and (=) cells have a 
presumptive descending pronociceptive, antinociceptive and no effect upon spinal nociceptive 
transmission. A direct involvement of the CVLM in spinal modulation is not surprising, as this 
area not only shares reciprocal projections with lamina I and II nociceptive neurones (Tavares 
and Lima, 2002) but also with the RVM (Colombari et al., 2001) and the NTS (Kawano and 
Masuko, 1996), areas strongly involved in pain modulation at the spinal level (Mtui et al., 1993; 
Fields et al., 1995).  
It was interesting to verify that although the analysis of noxious-evoked activity of CVLM cells was 
performed using a heat stimulus, these same cells responded to other modalities of noxious 
stimulation. According to Schnell and colleagues (2002), classifying cell type using one single 
type of noxious stimulation was insufficient to determine the response pattern to noxious 
stimulation. Although some RVM neurones behaved as neutral cells to noxious heat, their 
response to mechanical noxious stimulation was as a typical ON- or OFF-cell. In our work, we not 
only verified that heat-evoked neutral cells could respond to either or both mechanical, visceral 
and cold stimulation as (+)/(-)/(=), but also that this was true for the majority of the cells studied. 
In fact, in the CVLM only a few cells were responsive to only one type of noxious stimulation or 
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alternatively had a clean (+)/(-)/(=) profile for all stimuli types. The CVLM seems to be 
constituted by a heterogeneous population of nociceptive cell profiles suggesting that this area is 
capable of fine tuning when it comes to the discrimination of nociceptive modalities. Nonetheless, 
the type and number of cells responsive to each type of noxious stimulation does not seem to be 
differently distributed within the CVLM. The highest number of (+) responsive cells were 
associated with heat and mechanical noxious stimulation, whereas most cells were (=) to visceral 
stimulation and were either (=) or (-) following cold stimulation. Taking into account that a 
predominance of (+) cells over other types of cells indicates a facilitatory role, that (+) cells in the 
CVLM are mostly associated with heat and mechanical stimulation and that the CVLM 
participates in the stress response (Bienkowski and Rinaman, 2008), it is possible that these 
CVLM (+) cells nuclei are partly involved in the fight or flight response triggered by external 
factors. In parallel, a comparatively higher number of (-) cells for COLD stimulation also supports 
the development of a response towards survival since intense cold can be debilitating. On the 
other hand, the CVLM does not seem deeply involved in visceral pain, as (=) responsive cells 
predominate following this type of stimulus. 
Finally, it is worth noting that the basal activity of (+) CVLM cells is considerably higher (two to 
three-folds) than what has been described for ON-cells in the RVM (Fields et al., 1983). One 
possible explanation for this discrepancy is the level of anaesthesia, as deeper or lighter 
anaesthesia levels might have altered not only the spontaneous, but also the evoked activity of 
neurones involved in nociception. Another possibility is that since all cells were initially classified 
as (+), (-) or (=) according to their response to heat stimulation and considering that they may 
display different response patterns to the other types of noxious stimulation, it is possible that a 
(+) cell to heat stimulation would have a higher basal firing rate since it could be a (-) cell to 
either/or pinch, visceral or cold stimulation. Accordingly, the basal activity of both ON- and OFF- 
RVM atypical cells, although slightly lower than what was observed in the CVLM, was also higher 
(Schnell et al., 2002) than originally reported (Fields et al., 1983). 
4.3. CVLM neuronal activity in monoarthritis 
Substantial data support a role of the CVLM in descending antinociception (Tavares and Lima, 
2002). Tonic descending inhibition decreased after lesions in the CVLM (Hall et al., 1982; Gall et 
al., 1998) and the electrical or pharmacological stimulation of the CVLM produces a profound 
and long lasting analgesia (Gebhart and Ossipov, 1986). However, it has been stated by several 
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authors that the role of the CVLM under pathological conditions remains unstudied (Lumb, 2002; 
Tavares and Lima, 2002). The induction of monoarthritis resulted in pronounced changes in the 
spontaneous and noxious-evoked activity of CVLM cells as well as in the number of neurones that 
responded to a specific type of stimulation. It is also interesting to note that the arthritis-induced 
activity changes were different between cell types. The spontaneous activity of (+) cells is 
increased in ARTH animals while the opposite effect was observed for (-) cells, which suggests a 
possible pronociceptive role of the CVLM in pathological (arthritic) conditions. In fact, although 
previous studies have reported an antinociceptive role for the CVLM (Tavares and Lima, 2002), 
other studies pointed to a pronociceptive influence of the CVLM/lateral reticular nucleus region 
(Mansikka and Pertovaara, 1996; Marques-Lopes et al., 2010). 
The proportion of cells reactive to cold noxious stimulation is altered in arthritic rats with an 
increase in (-) cells, which is in accordance with a previous study where an increase in the 
number of OFF-cells in the RVM occurred after inflammation (Montagne-Clavel and Oliveras, 
1994). More importantly, there seems to be a shift in the number of cold-responsive cells 
between (=) and (-) neurones. While analysing changes in the brainstem after inflammation, Miki 
and colleagues (2002) reported a similar effect for RVM cells; during continuous 
electrophysiological recordings of RVM neutral cells, these cells changed their response profile to 
ON- and OFF-cells after the induction of inflammation. Neutral cells have for long been discarded 
due to its lack of responsiveness during acute stimulation; however, there is a growing number of 
reports that view these cells as great candidates for the increased allodynic effect of former 
innocuous input (Neumann et al., 1996) that involve mechanical and, specifically in this case, 
cold sensitivity. 
Heat hyperalgesia (during sleep), spontaneous pain (resting time) and especially mechanical 
hyperalgesia (associated to movement) are common complaints in arthritic patients (Schaible et 
al., 2009). Although evoked responses of CVLM neurones vary greatly between the type of 
stimulus applied, this area does not seem involved in heat hyperalgesia since heat stimulation 
induced a decrease in (+) and an increase in (-) activity, suggesting an antinociceptive role. 
Visceral stimulation evokes a similar response in (+) cells, but since (-) activity is also significantly 
decreased it is difficult to evaluate the final net effect of these changes. However, the CVLM 
might facilitate mechanical analgesia since (+) cell activity is significantly increased while (-) cells 
remain unchanged. Most remarkably, noxious-evoked activity after cold stimulation was similar to 
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mechanical, as (+) cells activity was increased and (-) cell activity remained unchanged. There is 
an apparent paradox between an increase in the number of (-) cold-responsive cells, while a 
marked increase in cold-evoked (+) cell activity occurred. It has been suggested that OFF-cells 
activation is prevalent in relation to ON-cell activation since OFF-cells are responsible not only for 
exciting more off-cells, but also for inhibiting on-cells (Fields et al., 1991) but it is difficult to 
estimate this effect without recording several neurones at the same time.  
4.4 Influence of the PVN upon CVLM neuronal activity 
Overall, the activation of the PVN descending inhibitory control during noxious stimulation 
appears to target mainly CVLM (+) cells by consistently depressing their activity.  These results 
are not unexpected since it has already been shown that in pathological conditions (neuropathic 
pain), although the activity of both ON- and OFF-cells is changed, the resulting hypersensitivity 
seems to be strongly associated with increased ON-cell activity (Gonçalves et al., 2007). The 
PVN-mediated decrease in the CVLM (+) cells can be consider a pathway to counteract and 
compensate for the increased sensitivity induced by arthritis. As for CVLM (-) cells, their activity is 
only influenced (increased) by the PVN during noxious cold stimulation reinforcing the idea that 
cold stimuli seem to constitute an intense hyperalgesic input that recruits both types of 
modulatory neurones in the CVLM of arthritic animals.  
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Figure 1 – A photographic example of a recording site in the caudal ventromedial medulla (CVL) (marked 
with an asterisk). (Gi – gigantocellular reticular nucleus, Li – linear nucleus of the medulla, IRt – 
intermediate reticular nucleus, Sp5l – lateral part of the trigeminal nucleus, PCRt – parvicellular reticular 
nucleus).  
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 Figure 2. Examples of original recordings of CVLM cell responses to noxious peripheral stimulation. A) 
Simultaneous recording of two different CVLM neurones, neurone (a) increased its activity after noxious 
heat and mechanical stimulation, but decreased it after noxious cold stimulation of the hindpaw, whereas 
neurone (b) increased its activity after both noxious heat and cold stimulation of the hindpaw, but does not 
respond to noxious mechanical stimulation of the tail. B) Example of CVLM (-) cell, it decreases its activity 
after noxious colorectal distension and after heat and cold stimulation of the hindpaw. C) Simultaneous 
recording of two different CVLM neurones, neurone (a) is neutral to noxious heat stimulation however this 
cell decreases and increases its activity after noxious colorectal distension and cold stimulation of the 
hindpaw (respectively), whereas neurone (b) increased its activity after both noxious heat and cold 
stimulation of the hindpaw, but does not respond to colorectal distension. D) Example of a (+) cell, this 
neurones is responsive to all modalities of noxious stimulation applied, namely heat and cold stimulation 
of the hindpaw and colorectal distension. [a,b – represent different neurones within the same recording; i 
– represents the noxious heat and cold stimulus applied to the hind paw; ii – represents the noxious 
visceral stimulus (colorectal distension); red arrows – indicate an increase in neuronal activity; green 
arrows – indicate a decrease in neuronal activity; gray arrows – indicate no changes in neuronal activity; 
P–P indicates the duration of the noxious tail pinch (mechanical stimulation)]. The vertical calibration bar 
for neuronal response represents 10 Hz in A,B,D and 20 Hz in C. In all the graphs, the baseline 
temperature of the heat stimulus is 35 °C while the superior peak stimulus temperature is at 54°C and 
the inferior peak stimulus temperature at 4°C. In B, C and D colorectal distension was applied with an 
intensity of 80 mmHg. The horizontal calibration bar represents 50 s in D and 40 s in A, B and,C. 
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Figure 3 – Analysis of the firing pattern of CVLM cells in CONT and ARTH animals after noxious 
stimulation. Note that only noxious cold stimulation altered the (+)/(-)/(=) cell ratio of CVLM cell types, 
with a significant increase in the number of (-) cells and the opposite effect on (=) cells. (A – noxious heat 
stimuli to the hindpaw; B – noxious mechanical of the tail; C – noxious visceral stimulation; D – noxious 
cold stimuli to the hindpaw) (*p<0.05) 
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Figure 4 – Spontaneous activity of CVLM neurones in CONT and ARTH animals. Note that after the 
induction of arthritis the activity of CVLM neurones was significantly altered, with an increase in the firing 
rate of (+) and (=) cells being paralleled by a decrease in (-) cell activity. (*p<0.05, **p<0.01). 
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 Figure 5 - Evoked response of CVLM (+) and (-) cells after the application of different modalities of noxious 
stimulation in SHAM and ARTH animals. Note the significant decrease of both (+) and (-) cells after heat 
stimulation, the increase of (+) cells after both mechanical and cold stimulation and the decrease of both 
(+) and (-) cells during visceral stimulation. (A – noxious heat stimulation to hind-paw; B – noxious 
mechanical stimulation of the tail; C – Noxious visceral stimulation; D – noxious cold stimulation of the 
hind-paw) (*p<0.05, **p<0.01, ***p<0.001) 
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Figure 6 – Modulatory effect of PVN pharmacological manipulation upon evoked activity of CVLM (+) and (-
) neurones in SHAM and ARTH animals after several modalities of noxious stimulation. The bars represent 
differences between noxious-evoked activity and baseline spontaneous activity (which is represented as 
the zero line in the x axis), comparisons within groups were performed using t-test analysis. Two-way 
ANOVA analysis was used to compare the overall effects of glutamate microinjection in the PVN between 
experimental groups. Note that the activity of (+) cells in ARTH animals was consistently depressed when 
compared with basal activity and with SHAM. (A – noxious heat stimulation to hind-paw; B – noxious 
mechanical stimulation of the tail; C – Noxious visceral stimulation; D – noxious cold stimulation of the 
hind-paw) (*p<0.05, **p<0.01, ***p<0.001) 
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 Table 1 – Number of nociceptive-responsive CVLM neurones, before and after the induction of ARTH, 
according to their response to heat/pinch/CRD/cold noxious stimulation. (The number of cells found in 
ARTH animals is shown in bold) (C – controls; A – Arthritic; CRD – colorectal distension). 
 
Response to Heat Response to Pinch Response to CRD Response to Cold 
 
 C A  C A  C A  C A 
(+) cells 44 48 (+) cells 21 18 (+) cells 9 12 (+) cells 14 15 
   (-) cells 9 11 (-) cells 11 13 (-) cells 13 23 
   (=) cells 14 19 (=) cells 24 23 (=) cells 17 10 
 
(-) cells 17 19 (+) cells 9 11 (+) cells 6 2 (+) cells 2 2 
   (-) cells 6 4 (-) cells 8 7 (-) cells 13 10 
   (=) cells 2 4 (=) cells 3 10 (=) cells 2 7 
 
(=) cells 17 12 (+) cells 6 2 (+) cells 3 0 (+) cells 4 3 
   (-) cells 0 4 (-) cells 2 3 (-) cells 4 7 
   (=) cells 12 6 (=) cells 12 9 (=) cells 9 2 
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Chapter 2.3.3 
Pinto-Ribeiro F, Monteiro AM, Amorim D, Pertovaara A, Almeida A.  
Descending pronociception from the dorsomedial nucleus of the hypothalamus (DMH) in acute 
pain is mediated by the rostral ventromedial medulla (RVM) but is absent in arthritic animals 
(Manuscript in preparation) 
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Abstract 
The dorsalmedial nucleus of the hypothalamus (DMH) has recently been implicated in stress-
induced hyperalgesia, but the mechanisms underlying forebrain-mediated facilitation of pain are 
still poorly understood. Moreover, due to its involvement in the mediation of the stress response, 
the DMH might play an important role in the hyperalgesia of chronic inflammatory diseases, as 
these pathologies are known to evoke the stress response. The role of the DMH upon pain 
modulation in NAIVE, SHAM and arthritic (ARTH) rats was studied. Intracerebral administration of 
glutamate (vs. saline) in the DMH of NAIVE and SHAM decreased noxious-evoked thresholds in 
both the tail-flick and paw-withdrawal tests, whereas lidocaine block of the DMH activity had an 
opposite effect, increasing nociceptive thresholds. These data confirmed the existence of a 
descending facilitatory drive from the DMH. Surprisingly, glutamate reduction of DMH pain-like 
facilitation was absent in ARTH animals. To further evaluate the mechanisms underlying this 
phenomenon, an electrophysiological analysis of the effect of the DMH upon the activity of pain 
modulatory cells in the RVM was performed in SHAM and ARTH rats undergoing noxious-evoked 
peripheral stimulation. In SHAM animals, DMH-induced hyperalgesia is, at least in part, tonically 
mediated by RVM cells since lidocaince in the DMH inhibited and facilitated the activity of 
presumptive pronociceptive ON-cells and antinociceptive OFF-cells, respectively. Similarly to what 
was observed in noxious-evoked pain-like behavioural tests, DMH descending drive upon RVM 
nociceptive cells was absent in ARTH animals. These data point to a role of DMH nociceptive 
facilitation in acute behaviour defensive responses to noxious stimuli and in the enhancement of 
spontaneous, but not noxious-evoked, responses in chronic (arthritic) pain.  
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1. Introduction 
The dorsomedial nucleus of the hypothalamus (DMH) is implicated in a variety of physiological 
responses including feeding (Chen et al., 2008), thermoregulation (Dimicco and Zaretsky, 2007), 
cardiovascular function (DiMicco et al., 1986), autonomic responses to acute stress (DiMicco et 
al., 2002), anxiety (Shekhar, 1993) and modulation of the stress axis activity (Boudaba et al., 
1997). Activation of GABA receptors in the DMH have been shown to inhibit the autonomic 
aspects of the response to stress and anxiety in both anesthetized (DiMicco and Monroe, 1998) 
and wake behaving animals (Stotz-Potter et al., 1996). Anatomical studies have demonstrated 
that the majority of DMH afferents arise from other nuclei within the hypothalamus, although 
there are a few significant projections from the telencephalon and brainstem (Thompson et al., 
1996). Conversely, DMH efferent projections target not only intrahypothalamic areas, but also the 
thalamus, the telencephalon and the brainstem (Thompson and Swanson, 1998). More recently, 
as part of the network involved in the activation of the stress response, a novel role for the DMH 
in descending pain modulation has been proposed. It has been shown that the DMH contributes 
to stress-induced hyperalgesia through direct and indirect connections to the raphe nuclei 
(Samuels et al., 2004; Sarkar et al., 2007) in the rostral ventromedial medulla (RVM), an area 
implicated in supraspinal pain control (Almeida et al., 2006; Heinricher et al., 2009). 
Additionally, disinhibition of the DMH induced activation of RVM pronociceptive ON-cells and 
suppression of RVM antinociceptive OFF-cell firing, which is in accordance with behavioural 
hyperalgesia (Martenson et al., 2009). 
In terms of pain perception, hyperalgesia or the increased perception of pain after a noxious 
stimulus can be associated either to acute or chronic pain (Millan, 1999). In inflammatory 
diseases, such as arthritis, the initial peripheral sensitization of nociceptors by injury (McMahon 
et al., 2008) cause primary hyperalgesia which, as the area affected enlarges, results in 
secondary hyperalgesia (Basbaum et al., 2009). Additionally, increased peripheral nociceptive 
inputs upon spinal dorsal horn neurons sensitize the ascending tracts causing central 
sensitization (Dubner, 2005; Woolf and Salter, 2006), which if sustained in time alters the 
normal functioning of the brain and its descending modulatory pain pathways (Burgess et al., 
2002). During the process of pain chronification, both facilitatory and inhibitory circuits are 
activated (Herrero and Cervero., 1996; Gozariu et al., 1998) and dynamic temporal changes in 
synaptic activation in the brainstem are observed. Accordingly, the activity of both ON- and OFF-
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cell activity increased in arthritis (Miki et al., 2002), although the net effect of the RVM 
descending modulation has not yet been established.  
Our purpose in this study was to: (i) evaluate the effect of pharmacological manipulation of the 
DMH upon the behavioural responses of rats to noxious peripheral stimulation; (ii) associate the 
behavioural data with possible changes in the electrophysiological activity of RVM nociceptive ON- 
and OFF-neurones; (iii) study the involvement of the DMH in the hyperalgesia observed in 
animals with monoarthritis. 
2. Experimental procedures 
2.1. Animals, anaesthesia and ethical issues 
The experiments were performed in adult male Wistar Han rats with 175–250g (Charles Rivers, 
Barcelona, Spain). The experimental protocol was approved by the Institutional Ethical 
Commission and followed the European Community Council Directive 86/609/EEC for the use of 
experimental animals. All efforts were made to minimize animal suffering and to use only the 
number of animals necessary to produce reliable scientific data. 
For the experimental surgery and electrophysiological sessions, anaesthesia was induced by 
administering pentobarbitone (50 mg/kg, i.p.) and maintained by infusing pentobarbitone (15–
20 mg/kg/h, i.p.) when necessary. The level of anaesthesia was frequently monitored by 
observing the size of the pupils, the general muscle tone and behavioural responses to noxious 
pinching. Importantly, the anaesthesia level was maintained in an identical fashion when studying 
control and arthritic animals to avoid a potential influence of this factor amongst groups. A 
warming blanket was used to maintain the body temperature within physiological range. At the 
completion of the experiment, animals received a lethal dose of pentobarbitone. 
2.2. Recording of neuronal responses in the rostral ventromedial medulla (RVM) 
In order to perform electrophysiological recordings of the activity of RVM neurones after being 
anaesthetized (as described above), the animals were placed in a standard stereotaxic frame. 
The skull was exposed and a hole drilled for placement of a recording electrode in the RVM (5.88 
mm posterior to interaural, 0.4–0.6 mm lateral from the midline, and 8.8 mm ventral from the 
dura mater) according to the atlas of Paxinos and Watson (2005). Single neurone activity was 
recorded extracellularly with lacquer-coated tungsten electrodes (tip impedance 3–10 MΩ at 1 
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kHz) and then amplified and filtered using standard techniques. Data sampling was performed 
with a computer connected to a CED Micro 1401 interface and using Spike 2 software 
(Cambridge Electronic Design, Cambridge, U.K.). 
Recording of RVM neurones was started after the animal was under light anaesthesia; i.e., the 
animals gave a brief withdrawal response to noxious pinch, but the pinch did not produce any 
longer lasting motor activity, nor did the animals have spontaneous limb movements. RVM 
neurones were classified based on their response to noxious heating (54 °C) of the tail with a tail-
flick device (Ugo Basile, Comerio, Italy). The functional classification of RVM neurones followed 
the scheme developed earlier by Fields and colleagues (1983).  
Briefly, neurones displaying an increase in firing rate evoked by heat stimulation of the tail, 
associated with its withdrawal, were considered ON-cells, while those decreasing its activity were 
classified as OFF-cells (Fig. 1). Neurons displaying no or only a negligible (< 10%) change in their 
discharge rates as a response to noxious stimulation were considered NEUTRAL-cells and were 
not studied further in this investigation. If a neuron could not be classified it was excluded from 
the study.  
Characterization of the response properties of RVM cells consisted of the following assessments 
performed successively: (i) Spontaneous activity; (ii) Response to heating of the tail, and (iii) 
Response to pinching of the tail for 5 s by a surgical clamp that produced painful sensation when 
applied to the hand of the experimenter. 
When analyzing responses of RVM neurons to peripheral stimulation, the baseline discharge 
frequency recorded during a corresponding period just before the stimulation was subtracted 
from the discharge frequencies determined during stimulation; i.e., positive values represent 
excitatory responses evoked by peripheral stimulation and negative ones inhibitory responses. 
The animals used in recordings had a guide cannula for drug administration into the DMH (see 
section 2.3) (Fig. 2). Electrophysiological experiments were performed one to two weeks after 
fixation of the guide cannula to the skull, as described below. After determining the responses of 
a RVM neurone to peripheral stimulation, the phasic modulation of the discharge rate of RVM 
neurones by exciting DMH neurones was assessed by microinjecting glutamate (GLU, 50 nmol in 
0.5 μL) into the DMH using methods described above. The discharge rate of the RVM cells was 
followed up to 5 min after the injection of GLU. Thereafter, tonic control of the RVM by the DMH 
187
was assessed by blocking the activity of the nucleus by microinjecting lidocaine (LIDO, 4% in 0.5 
μL) into the DMH and following the discharge rate of RVM neurones up to 30 min. All results 
from the drug administration were plotted against the values obtained for the same time points 
after saline (SAL) injection in the DMH. 
2.3. Procedures for intracerebral microinjections 
For intracerebral drug administration, the rats were placed in a stereotaxic frame and a stainless 
steel guide cannula (26 gauge; Plastics One, Roanoke, VA) was implanted in the brain according 
to the coordinates of the atlas by Paxinos and Watson (1998). The tip of the guide cannula was 
positioned 1 mm above the desired injection site in the DMH (RC, 5.76 mm interaural; LM, 0.4 
mm; DV, 8.5 mm to the interaural line) (Figs. 1). After the guide cannula was fixed into the skull 
using a dental screw and dental cement, a dummy cannula was inserted into the guide cannula 
and the top was closed. Animals were allowed to recover from surgery for one week before 
testing. 
Test-drugs were administered in the DMH through a 33-gauge injection cannula (Plastics One, 
Bilaney, Germany) inserted into and protruding 1 mm beyond the tip of the guide cannula. The 
microinjection was made using a 1.0-μL-Hamilton syringe connected to the injection cannula by a 
polyethylene catheter (PE-10; Plastics One, Bilaney, Germany). The injection volume was 0.5 μL 
and therefore, the spread of the injected drugs within the brain was expected to be 1 mm (Myers, 
1966). The efficacy of injection was monitored by watching the movement of a small air bubble 
through the tubing. The injection lasted 20s and the injection cannula was left in place for an 
additional 30s to minimize the return of drug solution back to the injection cannula. Brain 
injection sites were histologically verified from post-mortem sections and plotted on standardized 
sections derived from the stereotaxic atlas of Paxinos and Watson (2005). 
2.4. Induction of arthritis 
The induction of arthritis (ARTH) was performed 21 days before the actual experiments, as 
described in detail elsewhere (Ansah and Pertovaara, 2007). Briefly, 3% kaolin and 3% 
carrageenan (Sigma, St. Louis, MO, USA) were dissolved in distilled water and injected into the 
synovial cavity of the left knee joint at a volume of 0.1 mL. This model produces mechanical 
hyperalgesia, which begins just in a few hours after surgery and extends up to 8 weeks 
(Radhakrishnan et al., 2003). In each animal, development of arthritis was verified 1–2 h prior to 
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each experiment. Only those rats that vocalized every time after five flexion–extension 
movements of the knee joint were considered to have arthritis, and they were included in the 
arthritis group. An experimental group used as SHAM animals were also injected with 0.1 mL 
saline in the synovial cavity of the left knee joint. SHAM animals did not vocalize to any of the five 
consecutive flexion–extension movements of the knee joint. 
2.5. Behavioural assessment of nociception 
The rats were habituated to the experimental conditions by allowing them to spend 1–2 h daily in 
the laboratory during two to three days preceding any testing. For assessing nociception in 
unanaesthetized animals, radiant heat-induced latency of the tail (Tail-flick test, device model 
37360, Ugo Basile, Comerio, Italy) and hindpaw (Hargreaves test, device model, Ugo Basile, 
Comerio, Italy) was determined using radiant heat equipment. In each drug treatment session, 
the withdrawal latency was assessed prior to drug treatment and at various intervals following the 
intracerebral injections. At each time point, the measurement was repeated twice at an interval of 
1 min and the mean of these values was used in further calculations. Cut-off time was 15s.  
2.6. Drugs 
Solutions for intracerebral drug administration in the DMH were prepared with sterilized saline 
0,9% (Unither, Amiens, France; pH 7,2) except for lidocaine, which was acquired as a solution. 
Each injection volume, 0.5 µL, contained either (1) 50 nmol of glutamate (Merck, Darmstadt, 
Germany) or lidocaine 2 % (B. Braun Medical, Portugal). These doses were chosen according to 
previous studies (Pinto-Ribeiro, 2008). Control injections were performed with saline (SAL) and 
we used them as base of comparison to the drugs, in order to avoid any confounding effect that 
might result from the injection itself. 
2.7. Animal groups 
For the purpose of this study the animals were divided in three groups NAIVE, SHAM and ARTH. 
In the first set of experiments, NAIVE animals were used to test DMH facilitatory action while in a 
second set, SHAM and ARTH animals were used to evaluate its role in a chronic inflammatory 
context. In both experimental sets, all the animals were microinjected with saline (SAL), 
glutamate (GLU) and lidocaine (LIDO) every two days.  
2.8. Course of the behavioural study 
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One to two weeks following induction of the arthritis and at least one week following insertion of 
the guide cannula for DMH injections, the efficacy of DMH-induced phasic and tonic modulation 
of spinal nociception was determined by assessing the effect of glutamate and lidocaine injection 
in the DMH upon the heat-evoked spinal withdrawal reflex in unanesthetized ARTH and NAIVE 
and SHAM animals. Physiological saline was used as a control for the volume of injection (in 
NAIVE, SHAM and ARTH groups) while NAIVE and SHAM animals were used as controls to ARTH 
animals. In these experiments, the latency of the withdrawal response was assessed 30 s, 5 min, 
15 min and 30 min following the injection (Fig. 3). The latency measured 30 s after glutamate 
injection and 15 min after lidocaine injection was used in further calculations, since the 
maximum effects of the studied compounds are obtained at these time points. The interval 
between behavioural assessments of glutamate-, lidocaine- or saline-induced effects was at least 
two days and the order of testing different compounds varied between the animals. 
2.9. Course of the electrophysiological study 
Electrophysiological recordings of RVM neurones were performed under pentobarbitone 
anesthesia in different animals one to two weeks following the induction of arthritis and at least 
one week following the insertion of the guide cannula for DMH injections. In RVM recordings, the 
response properties of the neurons were assessed by determining spontaneous activity and the 
response to noxious heating of the tail and tail pinch. Then, the change in spontaneous activity of 
RVM neurones following successive microinjections of glutamate and lidocaine at a 30 min 
interval into the DMH was assessed as described in detail above (Fig. 3). Search for the next 
neuron to be studied started about 30 min after the testing of the previous one was completed. 
At the end of the recording session, electrolytic lesions were made in the recording sites, the 
animals were given a lethal dose of pentobarbitone and the brains were removed for histological 
verification of the recording and injection sites. 
2.10. Statistics 
The differences in spontaneous activity between controls and arthritic animals were tested using 
a t-test comparison. The ANOVA repeated measures test was used while analysing the 
effectiveness of the administration of a compound in a group of cells throughout time (Fig. 6). 
The statistical assessment of differences in neuronal activity between experimental groups during 
the pharmacological treatments was assessed using two-way analysis of variance (ANOVA) 
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followed by Bonferroni post-hoc test (Figs. 7-9). A value of p<0.05 was considered to represent a 
significant difference. 
 
3. Results 
3.1 The induction of monoarthritis did not alter the behaviour in nociceptive tests. 
In order to assess if monoarthritis, induced in the knee joint of right hind-paw, altered by itself 
baseline withdrawal latencies we compared the PF latencies amongst the left and right side and 
between groups. Baseline PF latencies for NAIVE, SHAM and ARTH animals were identical 
amongst the left and the right paws (Table 1) and between groups [ANOVA1W, F(2,228)=1,114, 
p=0,4132].  
3.2 The behavioural pronociceptive drive from the DMH is lost in monoarthritis 
To investigate a possible phasic role of the DMH in pain modulation in monoarthritis, tail-flick (TF) 
and paw-flick (PF) latencies were assessed after GLU microinjection in this nucleus in NAIVE, 
SHAM and ARTH animals. Overall, DMH activation by GLU microinjection significantly decreased 
TF latency in NAIVE and SHAM animals but not in ARTH animals. Activation of the DMH by GLU 
significantly decreased TF latencies in NAIVE and SHAM animals when compared to SAL in 
NAIVE and SHAM [ANOVA2w, F(1,56)=33,37, p<0.0001; Bonferroni, NAIVESAL x NAIVEGLU, p<0.001 and 
SHAMSAL x SHAMGLU, p<0.01]. Additionally, GLU in the DMH decreased TF latencies in NAIVE and 
SHAM when compared to ARTH [ANOVA2w, F(2,56)=4,915, p=0,0108; Bonferroni, NAIVEGLU x ARTHGLU, 
p<0.001 and SHAMGLU x ARTHGLU, p<0.05] (Fig. 4A). Note that in ARTH animals no difference was 
observed between SAL and GLU administration to the DMH (Fig. 4A).  
Identical results were obtained in the PF test, DMH activation by GLU microinjection significantly 
decreased PF latencies in NAIVE and SHAM animals but not in ARTH animals. PF latencies of 
NAIVE and SHAM animals, after GLU microinjection in the DMH, were significantly decreased 
when compared to SAL in NAIVE and SHAM [ANOVA2w, F(1,59)=14.77, p=0.003; Bonferroni, NAIVESAL 
x NAIVEGLU, p<0.001 and SHAMSAL x SHAMGLU, p<0.05]. Additionally, GLU in the DMH decreased PF 
latencies in NAIVE and SHAM when compared to ARTH animals [ANOVA2w, F(2,59)=6.045, 
p=0,0041; Bonferroni, NAIVEGLU x ARTHGLU, p<0.01 and SHAMGLU x ARTHGLU, p<0.05] (Fig. 4B). Note 
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that again the PF latencies of the ARTH group were not altered by the activation of the DMH by 
GLU (Fig. 4B). 
On the other hand, to evaluate a possible tonic role of the DMH in pain modulation in 
monoarthritis, TF and PF latencies were assessed after LIDO microinjection in this nucleus in 
NAIVE, SHAM and ARTH animals. Overall, DMH inhibition by LIDO microinjection significantly 
increased TF and PF latencies in NAIVE and SHAM animals but not in ARTH animals. In the TF 
test, a decrease in pain-like behaviour after LIDO administration in the DMH was observed, in 
NAIVE and SHAM animals, after 10 [ANOVA2w, F(3,155)=10.27, p<0.0001; SAL10 x LIDO-NAIVE10, 
p<0.01 and SAL10 x LIDO-SHAM10, p<0.01] and 20 minutes [F(3,155)=10.27, p<0.0001; SAL20 x 
LIDO-NAIVE20, p<0.01 and SAL20 x LIDO-SHAM20, p<0.01] of injection (Fig. 5A) but not in ARTH 
animals. Additionally, at 10 minutes, the latencies of both NAIVE [F(2,155)=3.281, p=0.04; LIDO 
(NAIVE10 x ARTH10), p<0.05] and SHAM [F(2,155)=3.281, p=0.04; LIDO (SHAM10 x ARTH10), p<0.05] 
were significantly increased when compared to ARTH (Fig. 5A). Note that in ARTH animals no 
difference was observed between SAL and GLU administration to the DMH (Fig. 5A). 
Similar results were obtained in the PF test as withdrawal latencies of NAIVE and SHAM animals 
after LIDO injection in the DMH were significantly increased when compared to SAL in NAIVE and 
SHAM at 10 minutes [ANOVA2w, F(3,117)=8.984, p<0.0001; SAL10 x LIDO-NAIVE10, p<0.001 and SAL10 
x LIDO-SHAM10, p<0.001] and 20 minutes [ANOVA2w, F(3,117)=8.984, p<0.0001; SAL20 x LIDO-
NAIVE20, p<0.001 and SAL20 x LIDO-SHAM20, p<0.01]. Again, TF latencies were not altered in 
ARTH-treated animals (Fig. 5B). Withdrawal latencies of NAIVE [ANOVA2w, F(2,117)=3.245, p<0.043; 
LIDO (NAIVE10 x ARTH10), p<0.05] and SHAM [ANOVA2w, F(2,117)=3.245, p<0.043; LIDO (SHAM20 x 
ARTH20), p<0.05] animals were significantly higher than ARTH 20 minutes after LIDO 
administration (Fig. 5B). Note that once more the PF latencies of the ARTH group were not 
altered by the activation of the DMH by LIDO (Fig. 5B). 
3.3 Downstream nociceptive modulation from the DMH is partially mediated by the RVM  
To investigate a possible downstream relay of the pronociceptive phasic and tonic drive from the 
DMH, the effect of its pharmacological manipulation, activation by glutamate or inhibition through 
lidocaine microinjection, upon the activity of RVM cells was analysed during peripheral thermal 
(TS) and mechanical (MS) noxious stimulation. 
3.3.1. Spontaneous activity  
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A total of 102 cells of SHAM animals [69 ON-cells - 39 ON-cells to mechanical stimulation (MS) 
and 30 ON-cells to thermal stimulation (TS) - and 33 OFF-cells - 19 OFF-cells to MS and 14 OFF-
cells to TS] and 253 cells of ARTH animals [137 ON-cells - 71 ON-cells to MS and 66 ON-cells to 
TS - and 116 OFF-cells - 65 OFF-cells to MS and 51 OFF-cells to TS] were analyzed in the RVM. 
Since no difference was observed in spontaneous activity [ON-cells, ANOVA2W, F(1,86)=1.031, 
p=0.32 and OFF-cells, ANOVA2W, F(1,10)=0.035, p=0.85] between NAIVE and SHAM animals, 
the results presented within the electrophysiological section correspond to comparisons between 
ARTH and SHAM animals.  
Microinjection of SAL in the DMH had no effect upon the spontaneous discharge rate of the RVM 
cells in either SHAM [ON-cells, ANOVArm, F(2,47)=0.57, p=0.57 and OFF-cells, ANOVArm, F(2,14)=1.07, 
p=0.39] or ARTH [ON-cells, ANOVArm, F(2,95)=1.055, p=0.8  and OFF-cells, ANOVArm, F(2,95)=0.027, 
p=0.99] (Fig. 6). However, the spontaneous activity of RVM cells before intracerebral DMH drug 
administration was significantly decreased in ARTH (ON-cell, 0.30±1.22 spikes/s and OFF-cell, 
2.49±0.31 spikes/s) when compared to SHAM (ON-cell, 3.25±4.88 spikes/s and OFF-cell, 
8.17±7.44 spikes/s), for both ON-cells [ANOVA2w, F(1,126)=26.22, p<0.0001; SHAMPI x ARTHPI 
p<0.01, SHAMI x ARTHI p<0.01 and SHAMPTI x ARTHPTI p<0.05] (Fig. 6A) and OFF-cells [ANOVA2w, 
SHAM x ARTH, F(1,72)=42.63, p<0.001; Bonferroni, SHAMPI x ARTHPI p<0.01, SHAMI x ARTHI 
p<0.001 and SHAMPo-I x ARTHPo-I p<0.001] (Fig. 6B).  
In SHAM animals, DMH activation by GLU significantly increased ON-cell [ANOVArm, F(2,53)=4.15, 
p=0.02; Bonferroni, GluPI x GluPo-I, p<0.05] (Fig. 7A) and decreased OFF-cell [ANOVArm, F(2,7)=4.45, 
p=0.04; Bonferroni, GluPI x GluPo-I, p<0.05] (Fig. 7B) spontaneous activity. This effect is absent in 
the ARTH group where GLU administration did not alter the spontaneous activity of RVM ON- 
[ANOVArm, F(2,80)=1.25, p=0.29] and OFF-cells [ANOVArm, F(2,44)=1.21, p=0.31]. The inhibition of the 
DMH by LIDO, in SHAM animals, had no effect upon the spontaneous activity of both RVM ON-
cells [ANOVArm, F(5,41)=2.05, p=0.10] (Fig. 7C) and OFF-cells [ANOVArm, F(5,53)=0.66, p=0.65] (Fig. 
7D) while in ARTH animals, spontaneous ON-cell activity was decreased [ANOVArm, F(5,71)=3.10, 
p<0.03; Bonferroni, LidoPI x Lido10 p<0.05] (Fig. 7C) but no effect was observed in OFF-cells 
activity [ANOVArm, F(5,113)= 1.30, p=0.27] (Fig. 7D). 
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3.3.2 The pronociceptive action of the DMH is partially modulated by RVM cell activity but is lost 
in monoarthritis  
In SHAM animals, DMH activation by GLU significantly increased ON-cell heat-evoked [ANOVA2W, 
F(1,54)=31.56, p<0.0001; Bonferroni, GluPI x GluI, p<0.05] (Fig. 8A) and mechanical-evoked 
[ANOVA2W, F(1,74)=18.9, p=0.02; Bonferroni, GluPI x GluI, p<0.05] noxious activity (Fig. 8B) and also 
increased OFF-cell heat-evoked [ANOVA2W, F(1,42)=5.75, p=0.02; Bonferroni, GluPI x GluI, p<0.05] 
(Fig. 8C) and mechanical-evoked [ANOVA2W, F(1,52)=18.7, p<0.0001; Bonferroni, GluPI x GluI, 
p<0.05] noxious activity (Fig. 8D). This effect is absent in the ARTH group, where GLU 
administration did not alter the noxious-evoked activity of both RVM ON- and OFF-neurones. 
In accordance to a facilitatory role for the DMH, its inhibition by LIDO significantly decreased ON-
cell heat-evoked at 20 minutes [ANOVA2W, F(1,110)=2.84, p=0.03; Bonferroni, LIDOPI x LIDO20, 
p<0.05] (Fig. 9A) and mechanical-evoked activity at 10, 20 and 30 minutes [ANOVA2W, 
F(1,144)=11.06, p<0.0001; Bonferroni, LIDOPI x LIDO10, p<0.001; LIDOPI x LIDO20, p<0.001; LIDOPI x 
LIDO30, p<0.001] (Fig. 9B), while it increased OFF-cell heat-evoked at 10 and 20 minutes 
[ANOVAr2W, F(1,60)=14.95, p=0.003; Bonferroni, LIDOPI x LIDO10, p<0.01 and LIDOPI x LIDO20, p<0.05] 
(Fig. 9C) and mechanical-evoked activity at 10 and 20 minutes [ANOVA2W, F(1,60)=14.95, p=0.003; 
Bonferroni, LIDOPI x LIDO10, p<0.01 and LIDOPI x LIDO20, p<0.05] (Fig. 9D). This effect is absent in 
the ARTH group, where LIDO administration did not alter the noxious-evoked activity of both RVM 
ON- and OFF-cells.  
4. Discussion 
In this work we demonstrated that the DMH has a pronociceptive (phasic and tonic) role 
enhancing pain-like behaviours in rodents during peripheral noxious stimulation. DMH facilitation 
is partly mediated by the RVM pain-modulatory ON- and OFF-cells. Unlike other supraspinal areas 
that enhance nociception in chronic pain, the facilitatory effect of the DMH is absent in arthritic 
animals.  
4.1 The DMH in pain modulation 
In 2009, Martensen and colleagues proposed that the DMH was involved in stress-induced 
hyperalgesia (SIH) as its desinhibition by gamma aminobutyric acid (GABA) antagonists resulted 
in behavioural hyperalgesia, an effect mediated by the RVM. Our results from the 
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pharmacological manipulation of this area in NAIVE and SHAM animals confirm that the DMH 
has the ability to enhance nociception since glutamate stimulation of the DMH decreased 
withdrawal latencies in nociceptive tests, whereas lidocaine block of the nucleus results in the 
opposite effect. Additionally, the DMH descending influence has a tonic pronociceptive role, 
unlike the majority of the forebrain descending influences (Gebhart, 2004) that are inhibitory. 
Descending facilitation, although less known, has been previously been demonstrated for other 
nuclei, namely the RVM (Heinricher et al., 2009) and the dorsal reticular nucleus (DRt) (Lima and 
Almeida, 2002). Although only a few studies have focused on SIH it has been shown that the 
enhancement of pain perception is associated with the emotional-affective dimension of pain 
processing (Wang et al., 2008). Humans suffering from anxiety display decreased thresholds to 
both noxious and innocuous stimulation when compared to non-anxious subjects (van den Hout 
et al., 2001) and similar results were observed for rats (van Dijken et al., 1992). DMH afferent 
projections from the amydala (AMY) (Thompson and Swanson, 1998), further support this 
hypothesis as the AMY is a key player in emotionality (Neugebauer et al., 2003). Additionally, 
AMY modulation of pain was shown to be not only antinociceptive (Helmstetter et al., 1998) but 
also pronociceptive (Ansah et al., 2009). DMH-induced behavioural hyperalgesia after GLU in 
NAIVE and Sham animals was paralleled with an increase of ON- and a decrease of OFF-
spontaneous cell activity in the RVM. Additionally, although a clear net phasic pronociceptive 
change in ON-/OFF-noxious evoked activity was not achieved after GLU, a tonic pronociceptive 
drive was reported after blocking the DMH with LIDO. 
4.2 DMH and arthritis  
On the other hand, the absence of an effect upon noxious-evoked withdrawal thresholds after the 
induction of arthritis was quite intriguing. We would expect an increase in the descending 
pronociceptive drive originating in the DMH since this nucleus is involved in the stress response 
(DiMicco et al., 2002), an hyperalgesic state is present and arthritis has been shown to enhance 
the responsiveness of AMY neurones (Neugebauer and Li, 2003). The RVM and the DRt, as 
sources of possible descending facilitation, have also been shown to contribute to the 
maintenance of a hyperalgesic state in chronic pain (Sotgiu et al., 2008; Porreca et al., 2002). In 
clinical settings, the most common comorbities of chronic pain patients are depression and 
anxiety, both known to enhance pain perception (Edwards et al., 2006; Ohayon and Schatzberg, 
2003).  
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In a previous study we reported that the paraventricular nucleus of the hypothalamus (PVN) 
exerted a tonic inhibitory drive upon the RVM OFF-cells present only after the induction of arthritis 
(Pinto-Ribeiro et al., 2008). In this context, the DMH efferent facilitatory drive in “intact rats” may 
be essential in the building of a response only to an acute challenge (fight and flight) but would 
not be recruited in a chronic inflammatory context. It seems possible that this apparent arthritis-
induced insensibility might reflect the existence of a tonic inhibition of the DMH from other nuclei 
within the hypothalamus, most of which have antinociceptive roles. As the PVN shares strong 
projections with the DMH (Thompson et al., 1996; Thompson and Swanson, 1998), we 
hypothesized that the PVN inhibitory influence might also target the DMH.  
Since, pain is a stressor that activates the hypothalamus-pituitary-adrenal glands axis (HPA axis) 
of which the PVN is the main effector, a potential contribution of the DMH in arthritis could be 
involved in the response to physiological imbalances in order to re-establish homeostasis of the 
nociceptive system. In a previous study, the RVM pronociceptive drive was maintained during 
arthritis through a tonic enhancement of OFF-cells activity (Pinto-Ribeiro et al., 2008). On the 
contrary, in this present study the induction of arthritis was sufficient to significantly decrease the 
spontaneous and noxious-evoked discharge rates of RVM cells; this discrepancy between 
increased vs. decreased spontaneous activity of RVM cells might be a result of a shift from 
facilitation to inhibition observed in descending modulatory influences during the process of pain 
chronification (Terayama et al., 2000). Accordingly, it is important to note this specific set of 
experiments was performed at a later stage of the arthritis settlement (15-21 days vs. 7-15 days 
in the 2008 study), which could result in the inhibitory effect upon RVM cells. Finally, as pain 
pathways suffer considerable remodelling during pain chronification, it is possible that the 
absence of DMH facilitation could be also due to this inhibition of the RVM and to the inability of 
RVM neurones to respond due to the shift from facilitation to inhibition in descending modulatory 
influences. On the other hand, a possible role for the DMH in the development of spontaneous 
pain in ARTH animals was reported, as LIDO block of the DMH decreased ON-cell activity with no 
effect upon OFF-cells. Future studies should evaluate the potential role of the DH in the 
development of spontanenous pain in arthritic animals. 
4.3 Conclusions 
The DMH participates in pain facilitation in normal animals through descending connections with 
the RVM. In arthritic animals, the DMH effect is lost, at least in what concerns noxious-evoked 
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activity, although its involvement in spontaneous pain following arthritis remains to be elucidated. 
Taking into account the potential clinical relevance of the latter possibility, the role of the DMH in 
arthritis should be evaluated using test of on-going pain (Boyce-Rustay et al., 2010).  
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Table 1 – Tail-flick and paw-flick baseline latencies of the NAIVE, SHAM and ARTH groups. Note 
that the baseline latencies were identical amongst the left and the right paws and between 
groups. 
Tail-flick test    
 Mean Latency (sec) SD N 
CTRL 5,90 0,99 14 
SHAM 5,98 0,17 5 
ARTH 5,91 0,39 7 
    
Paw-flick test    
 Left Paw Right Paw  
 Mean 
Latency 
(sec) 
SD 
Mean 
Latency 
(sec) 
SD N 
t-test (left-
right) 
CTRL 6,21 0,84 6,44 1,16 15 t(0,636)=0,53 
SHAM 6,08 0,73 6,35 0,82 6 t(0,491)=0,64 
ARTH 6,65 1,61 6,87 1,48 9 t(2,107)=0,07 
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Figure 1. Examples of original recordings of the activity of RVM pain modulatory cells. A - 
Neurone that increases activity during noxious peripheral heat stimulation but that decreases it 
during mechanical noxious stimulation of the tail. B) The first neurone (a) does not respond to 
either modalities of peripheral noxious stimulation whereas the second neurones (b) increases its 
activity during both the heat and the mechanical noxious peripheral stimulation. In the graphs, 
P–P indicates the duration of the noxious tail pinch (mechanical stimulation). The vertical 
calibration bar for neuronal response represents 10 Hz in A and 20 Hz in B. (red arrows – 
indicate an increase in neuronal activity during noxious peripheral stimulation; green arrow – 
indicate a decrease in neuronal activity during noxious peripheral stimulation; gray arrows – 
indicate no change in neuronal activity during peripheral noxious stimulation) 
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 Figure 2 – Example of the drug administration site in the DMH of the rat brain and schematic 
representation of other injection sites. A – Injection site in the DMH (RC: -3.24 mm Bregma) (B: -
3.00 mm Bregma, C: -3.12 mm Bregma, D: -3.24 mm Bregma and E: -3.36 mm Bregma). 
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Figure 3 - Schematic representation of the experimental design. Rats used to evaluate the effect 
of the DMH upon descending pain modulation were accustomed to the room for 5 days after 
which animals were implanted with a cannula in the DMH and allowed to recover for a week. 
Animal belonging to the ARTH group were also injected with kaolin/carrageenan in the knee joint 
of the right hind paw while SHAM were injected with saline. After recovery, animals included in 
the behavioral study were trained in the behavioural apparatus for one week, while animals 
destined to the electrophysiological studies were immediately analyzed. Pharmacological tests 
were performed at the same points for both the behavioral and the electrophysiological studies. 
(PI – pre-injection; I - injection) 
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Figure 4 - Behavioural analysis of the effect of the intracerebral administration of GLU in the DMH 
in NAIVE(white bars), SHAM(gray bars) and ARTH(black bars) animals. The microinjection of SAL 
was used as a control injection (TF, n=14 and PF, n=20) for both SHAM (TF, n=5 and PF, n=6) 
and ARTH (TF, n=7 and PF, n=9) groups. Note that the phasic pronociceptive downstream action 
of the DMH is lost after the induction of ARTH as the decrease in withdrawal latency after GLU in 
the DMH observed in NAIVE and SHAM animals is absent in the ARTH group. (SAL – saline; GLU 
– glutamate; ARTH – arthritis/arthritic animals; TF – tail-flick; PW – paw-withdrawal) (Mean ± SD) 
*p<0.05, **p<0.01, ***p<0.001. 
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Figure 5 - Behavioural analysis of the effect of intracerebral administration of LIDO in the DMH in 
the tail-flick (A) and paw-flick (B) tests in NAIVE(lightgray bars), SHAM(darkgray bars) and 
ARTH(black bars) in comparison to SAL administration in NAIVE(white bars) animals. LIDO 
microinjection in the DMH of NAIVE and SHAM animals increased TF (A) and PF (B) latencies 10 
and 20 minutes after its administration when compared to SAL. In ARTH animals, the tonic 
descending drive from the DMH is lost as LIDO failed to alter both TF and PW latencies. (SAL – 
saline; LIDO – lidocaine; ARTH – arthritis/arthritic animals; TF – tail-flick; PW – paw-withdrawal; 
PI – pre-injection; 10min – ten minutes after injection; 20min – twenty minutes after injection). 
(Mean ± SD) *p<0.05, **p<0.01, ***p<0.001. 
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 Figure 6 – The administration of SAL in the DMH had no effect upon spontaneous activity of ON- 
(A) and OFF-cells (B) of the RVM in both the SHAM and the ARTH groups. However it is important 
to note that the spontaneous activity of RVM neurones in SHAM and ARTH animals is significantly 
different. (A) The spontaneous firing rate of pronociceptive ON-cells of the RVM was significantly 
decreased in ARTH animals when compared to the SHAM group; (B) similarly, the spontaneous 
activity of antinociceptive RVM OFF-cells was significantly decreased in the ARTH group when 
compared to SHAM.  (PI – pre-injection; I – injection; PTI – post-injection). (Mean ± SD) *p<0.05, 
**p<0.01, ***p<0.001 
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Figure 7 – Effect of the administration of GLU and LIDO in the DMH upon the spontaneous 
activity of RVM pain modulatory cells. Note that the administration of GLU in the DMH increased 
the spontaneous activity of RVM ON- (A) and decreased the spontaneous activity of OFF-cells (B) 
in SHAM animals, respectively, but had no effect in RVM neurones in ARTH animals. However 
when LIDO was microinjected in the DMH although it had no effect in the spontaneous activity of 
RVM cell in SHAM animals, it significantly increase ON-cell (but not of OFF-cell) spontaneous 
activity in ARTH animals.  (PI – pre-injection; I – injection; 5min – five minutes; 10min – ten 
minutes after injection; 20min – twenty minutes after injection; 30min – thirty minutes after 
injections). (Mean ± SD) *p<0.05 
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Figure 8 - Effect of the activation of the DMH by GLU upon the noxious-evoked activity of RVM ON- 
(A,C) and OFF-cells (B,D) in SHAM and ARTH animals. Note that GLU administration in the DMH 
of SHAM animals increased the response of RVM ON-cells during thermal (A) and mechanical (C) 
noxious stimulation, while this effect was absent in ARTH animals. The activity of RVM OFF-cells 
was decreased during thermal (B) and mechanical (D) noxious stimulation and this effect was 
again absent in ARTH animals, whose baseline response was already significantly decreased in 
comparison to SHAM. (PI – pre-injection; GLU – injection of GLU in the DMH). (Mean ± SD) 
*p<0.05, **p<0.01, ***p<0.001 
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Figure 9 - Effect of the DMH inhibition by LIDO upon the noxious evoked activity of RVM ON- (A,C) 
and OFF-cells (B,D) in SHAM and ARTH animals. Note that LIDO administration in the DMH 
decreased the response of RVM ON-cells during thermal (A) and mechanical (C) noxious 
stimulation, while this effect was absent in ARTH animals. The activity of RVM OFF-cells was 
increased during thermal (B) and mechanical (D) noxious stimulation and this effect was again 
absent in ARTH animals, whose baseline response was already significantly decreased in 
comparison to SHAM. (PI – pre injection; I – injection; 10min – ten minutes after injection; 
20min – twenty minutes after injection; 30min – thirty minutes after injections) (Mean ± SD) 
*p<0.05, **p<0.01, ***p<0.001 
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3. DISCUSSION 
 
In this work, through the use of anatomical, behavioural and electrophysiological approaches, we 
sought to discriminate some of the underlying aspects of pain modulation by stress. We showed 
that a strong paradigm of chronic unpredictable stress (CUS) produced sustained analgesia after 
three weeks of treatment. By pharmacologically mimicking CUS, through the administration of 
corticosteroid agonists, we were able to correlate the resulting analgesia to changes in 
nociceptive neurotransmitter content in the spinal cord, to which each corticosteroid receptor 
contributed differently. A broad analysis of the neuronal network of the paraventricular nucleus of 
the hypothalamus (PVN), the effector of the stress response due to its role in the activation of the 
hypothalamic-pituitary-adrenals axis (HPA), highlighted the existence of afferent and efferent 
connections of this nucleus with several areas involved in the supraspinal pain control system. 
Pharmacological activation and inhibition of the PVN demonstrated that this area has an 
antinociceptive role that is exerted directly upon cells in brainstem areas classically involved in 
nociceptive modulation, such as the rostral ventromedial medulla (RVM) and the caudal 
ventrolateral medulla (CVLM). However, another counterpart of the stress response, the DMH, 
which appears to be implicated in SIH, exerts opposite pronociceptive effects by impinging in the 
same brainstem areas (RVM). In a chronic (arthritis) pain context, both the PVN and DMH 
descending drives upon nociception are altered due to neuronal plasticity resulting from the pain 
chronification process. In summary, this work provides detailed data on the alterations of 
nociceptive processing occurring during prolonged stress, its neuronal basis and the changes 
associated in a chronic pain context. 
 
3.1. Animal models and experimental considerations 
3.1.1. The choice of a stress model 
The first objective of this work was to determine how nociception is modulated by chronic stress. 
When inducing chronic stress the choice of experimental protocol is the major challenge to 
achieve the desired goals, a sustained elevation of circulating corticosteroids while maintaining 
the sensitivity to stressors. In acute stress, a stressful event induces the activation of the HPA 
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axis and a surge in the release of corticosteroids (Conrad et al., 2009). Corticosteroid secretion is 
under a negative feedback mechanism mediated by the binding of cortisol to specific receptors in 
the adrenal glands, the pituitary, the hypothalamus, the AMY and the hippocampus (Bradbury et 
al., 1991; Conrad et al., 2009). On the other hand, chronic stress is characterized by a 
hyperactivity of the HPA axis and subsequent sustained increase in the release of corticosteroids 
throughout time. While the acute stress response is aimed at restoring homeostasis, chronic 
stress (Swaab et al., 2005), like chronic pain (Apkarian et al., 2009), has no added biological 
value and when allowed to fully develop is highly detrimental resulting in neuronal dysfunction 
(Sousa et al., 2008; Cerqueira et al., 2008). 
The most frequent sources of divergence between chronic stress-inducing protocols seem to be 
related to the duration, the order of application of the stressful event and the number of stressors 
involved. In terms of duration, acute experiments are usually designed to evaluate immediate 
cause-consequence events within a small time span (e.g. immobilization effect upon nociception). 
On the contrary, chronic stress paradigms have to be designed to mimic clinical settings in which 
the detrimental effects of stress develop mainly after two or three weeks of exposure to stressors 
(Herman, 2010). In rodents, the development of chronic stress is accompanied by the presence 
of biological markers that include: (i) in physical terms, a decreased weight gain and a decrease 
in grooming activities leading to a general deterioration in fur condition and the presence of bare 
skin patches; (ii) at the physiological level, an increase in glucose and lipid metabolism, 
suppressed neurogenesis and increased neuronal apoptosis (Bachis et al., 2008), thymus 
atrophy and immunological impairment (Sapolsky et al., 2000; Tannenbaum et al., 2002). In our 
studies we opted for longer exposure periods of three to four weeks as most studies employing 
shorter periods failed to achieve a chronic stress phenotype (Vyas et al., 2002).  
Additionally, the sustained activation of the HPA axis requires that the stressful event applied is 
strong enough to avoid habituation. Several studies have demonstrated that the repeated 
application of the same stressor or of different stressors in the same order results in 
desensitization and a gradual decrease of the state of stress (Gamaro et al., 1998; Rivat et al., 
2010). Through the use of unpredictable stimuli applied in a random order, animals develop a 
state of learned helplessness reinforcing the physiological stress response. The unpredictability 
factor is a key factor in CUS, as it suppresses the development of coping mechanisms in these 
animals (Chapter 2.1.1). Stress-induced actions have been attributed to glucocorticoid receptor 
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(GR) activation since in basal conditions the occupancy of these receptors is 10% when compared 
to 90% of mineralocorticoid receptors (MR). The exogenous administration of MR and/or GR 
agonists is often used to discriminate the contribution of these receptors to a physiological 
process. Importantly, this method has previously been proven to replicate the systemic effects of 
prolonged glucocorticoid secretion from the adrenal medulla, while animals display the typical 
biological markers of CUS (Sapolsky et al., 2000). Hence, in the second set of experiments, we 
opted to pharmacologically mimic CUS through the exogenous administration of corticosterone 
(MR and GR receptor agonist) and dexamethasone (specific GR receptor agonist) to understand 
their involvement in the CUS-induced analgesia (Chapter 2.1.2).   
In the last decades of clinical practice, corticoids have been extensively used in the treatment of 
inflammatory diseases, such as arthritis (Morand, 2007). Corticosteroid action within this context 
has been aimed mostly at the control of inflammation and the prevention of joint damage in order 
to avoid loss of function (Schett et al., 2008) and not specifically as a pain management 
procedure. On the other hand, the typical pain syndromes that result from chronic pain 
conditions, amongst which arthritis, constitute constant discrete physiological stressors (Vierck et 
al., 2010) that alter the normal HPA axis functioning and can contribute to the plastic changes in 
this system (Latremoliere and Woolf, 2009). Patients often report an increase in pain levels in the 
morning, which has been correlated to hypoactivity of the HPA axis and decreased levels of 
circulating cortisol (Cutolo et al., 2005). Therefore, the second objective of this work was to 
determine how CUS impacted in the supraspinal pain control system (Chapter 2.1.3). Finally, 
after determining the neuronal connections of the paraventricular nucleus of the hypothalamus 
(PVN) (Chapter 2.2.1), we evaluated how the activation/inactivation of this area altered pain-like 
behaviour and neuronal activity in supraspinal pain control areas in the normal condition and in a 
pathological context (arthritis) (Chapters 2.3.1 and 2.3.2). 
3.1.2. The choice of a pain-like model 
Once more, the choice of an animal model representative of a persistent inflammatory 
component that replicate most processes observed in the human disease was crucial. The need 
to screen potential pharmaceutical agents has lead to the development of many models of 
arthritis (Bendele 2001), although the number of models available highlights the fact that none 
completely reflects all the features of the disease (Kaklamanis, 1992). Another difficulty is that 
arthritic conditions constitute a huge family of diseases amongst which the most common are 
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fibromyalgia, RA, psoriatic- and osteo-arthritis and gout. Human arthritis is characterized by the 
inflammation of joints leading to infiltration of granulocytes and later of mononuclear cells, 
synovial hyperplasia, bone erosion and formation, fibrosis and ankylosis of the joint (Roth et al., 
2005). Some methods, like the injection of Complete Freund's adjuvant (CFA) in the rat‟s tail or 
paw, induce widespread effects that might result in polyarthritis (Decaris et al., 1999), 
inappropriate for the study of specific mechanisms. Other protocols use the injection of 
carrageenan that induces the local release of neurotransmitters (Hong et al., 2002), primary and 
secondary hyperalgesia as well as central sensitization (Urban and Gebhart, 1999), but its 
inflammatory process presents a small immune component (Guthrie et al., 1996).  
Alternatively, a method involving the unilateral microinjection of a mixture of carrageenan/kaolin 
in the knee joint (K/C arthritis) mimic human osteoarthritis while providing both a model of acute 
and chronic inflammation (Lawand et al., 2000). Animals display ipsilateral heat hyperalgesia 
and mechanical allodynia only three hours after agent administration, which spreads 
contralaterally and is fully developed after seven days, lasting for at least eight weeks (Lawand et 
al., 2000). Finally, this model complies with the criteria for drug screening as it allows predicting 
the efficacy of agents in humans, it is easily induced and replicated, and it displays a progressive 
development of a full spectrum of pathological features concomitant with the pathogenesis of the 
disease in humans (Lawand et al. 2000). Therefore, it seemed adequate to choose the 
kaolin/carrageenan monoarthritis model while studying the effect of PVN and dorsomedial 
hypothalamic nucleus (DMH) pharmacological manipulation upon the neuronal activity of areas 
implicated in supraspinal pain control (Chapters 2.3.1, 2.3.2 and 2.3.3). 
3.1.3. Technical limitations  
In the electrophysiological studies performed along this thesis two other limitations arose, the 
performance of acute neuronal recordings and the application of acute noxious stimuli to study a 
time-dependent process. The electrophysiological analysis followed the method developed for 
single cell extracellular recordings (Neugebauer and Li, 2003). This method presents, by itself, 
several limitations, the major of which is related to the fact that it is an acute recording technique 
applied at different time points in order to evaluate the effect of a dynamically adapting neuronal 
process. An alternative method would imply the chronic implantation of electrodes in supraspinal 
pain modulatory areas before the induction of arthritis and the continuous recording of cell 
activity throughout the experimental period in free moving animals (Silva et al., 2008). Taking 
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into account that the descending modulation of pain is classically attributed to the net result of 
the activation/inactivation ratio of brainstem pronociceptive ON-cells and antinociceptive OFF-
cells, instead of a single electrode recording it would be necessary to implant the electrodes and 
be able to record single-cells throughout the whole process of development of arthritis. Also 
limitative is the proximity needed between the electrode and the neurone in order to perform the 
recordings as any slight change in the coordinates on the electrode, as a consequence of free 
moving animal normal activity, could cause neuronal death and/or the loss of the cells being 
recorded. To overcome this difficulty, we opted to sample a large number of neurones at each 
time point, ensuring that the sampling was representative.  
Joints, except for the cartilage, are innervated by Aβ, Aδ and C-fibres, allowing pain to be elicited 
through the application of noxious thermal, chemical and especially mechanical stimuli to the 
joints in conscious healthy humans (Dye et al. 1998). Electrophysiological studies have 
demonstrated the existence of two different sets of neurones that transmit noxious information 
from the joints to the spinal cord (Neugebauer et al. 1993), (i) a first set that converge noxious 
information from both the skin and deep tissues – mostly projecting to spinal wide-range-dynamic 
(WDR) neurones - and another set originating exclusively in deep tissues – mostly projecting to 
spinal nociceptive-specific (NS) neurones (Schaible et al., 2009). In persistent inflammation, 
hyperalgesia and allodynia are the result of plastic changes within spinal pathways and 
descending pain modulatory systems that mediate joint pain. Hence, the use of phasic stimuli, 
like heat, cold and mechanical stimuli applied to the skin were chosen in order to activate the 
same spinal pathways responsible for transmitting the nociceptive information from the two sets 
of neurones innervating the joints, with colorectal distension being a visceral type of stimulation 
for further comparison. The drawback of this methodology is that we can detect alterations in 
evoked pain-like behaviours, but not on on-going (spontaneous) pain. 
3.1.4. Behavioural assessment of pain 
The biggest challenge of animal experiments involving pain perception is the lack of verbal 
communication. Hence, while the application of acute noxious stimuli results in the display of a 
series of standardized behavioural responses, its absence does not prove the animals are not 
feeling pain (LeBars et al., 2001). The acknowledgement of these differences lead to the 
adaptation of the IASP definition of pain to animals as “an aversive sensory experience caused by 
actual or potential injury that elicits progressive motor and vegetative reactions, results in learned 
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avoidance behaviour, and may modify species specific behaviour, including social behaviour” 
(Zimmerman, 1986). Consequently, nociceptive behaviour is mainly ascertained by observing 
physical reactions of animals (van de Weerd et al., 1994) to a stimulus known to cause pain to 
humans.  
Throughout our studies, three different tests using noxious heat stimulation were used in order to 
overcome the limitations presented by each one alone. In the first work of this thesis, the effect of 
CUS upon nociception was evaluated weekly by stimulating the tail of the rat with radiant heat – 
tail-flick test (TF) – and determining the threshold of tail withdrawal from the heat source 
(D'Amour and Smith, 1941) (Chapter 2.1.1). As the TF measures mainly a spinal reflex (Sinclair 
et al., 1988; Jensen and Yaksh, 1986; Mitchell and Hellon, 1977) and is prone to habituation 
(Carstens and Wilson, 1993), while evaluating the possible contribution of MR and GR receptors 
to the CUS-induced analgesia the hot-plate (HP) test was used simultaneously. The HP measures 
supraspinally integrated responses as animals placed in a pre-heated metallic plate (O'Callaghan 
and Holzman, 1975) display a series of behavioural responses - chaotic defensive movements 
(Knoll et al., 1955), which include paw licking and jumping. Indeed the behavioural analysis 
highlighted the existence of both a spinal and supraspinally antinociceptive-mediated effect of 
CUS (Chapter 2.1.2).  
In the following studies however, as we acquired a new apparatus, the HP was substituted by the 
paw-withdrawal test (PF) (Chapters 2.3.1 and 2.3.3). The PW test is identical in concept to the TF 
test, but presents some additional advantages: (i) the area of stimulation is the paw, which is not 
a thermoregulatory organ and hence less prone to bias, (ii) the animals move freely, thus without 
the additional stress of being restrained, (iii) this test was specifically developed in order to study 
hyperalgesia after inflammation (Hargreaves et al., 1988), and (iv) the extent of the area of 
stimulation it smaller than when the HP is used, decreasing the chance of an involvement of the 
evoke diffuse noxious inhibitory controls (DNIC) (Le Bars et al., 2001). Overall, the conjugation of 
these tests, in which the behavioural outputs are mediated by partially overlapping circuits, 
allowed a better tuning of the pain-like alterations triggered by CUS (per example, the correlation 
between pain-like behaviour differences and the neurochemistry of the dorsal horn after three or 
four weeks of corticosteroid treatment – Chapter 2.1.1).    
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3.2. Chronic stress and pain modulation 
Chronic pain and chronic stress are pathologies that share common features, mutually 
reinforcing their effects in numerous disorders. While a series of well characterized physiological 
and behavioural changes are at the base of the stress-induced analgesia present during the acute 
stress response (McEwen and Kalia, 2010), the effects of prolonged stress upon pain perception 
are not linear as bidirectional changes in nociception are observed (Satoh et al., 1992; Quintero 
et al., 2000). Our first aim was to demonstrate a clear correlation between the level of 
engagement of the HPA axis and pain-like behaviour (Chapter 2.1.1).  
Indeed, the young and old rats submitted to long-term application of a series of unpredictable 
physical stressors displayed sustained hypoalgesia (Pinto-Ribeiro et al., 2004). As previously 
mentioned, our data conflicts with studies where chronic stress enhanced pain (Imbe et al., 
2006). A possible justification for this apparent paradox is the existence of distinctive descending 
modulatory pathways that are differently activated in response to homotypic (repeated single 
stressor) vs. heterotypic (variable stressor) stressors. Hyperalgesia, or enhanced pain-like 
behaviour, was observed in animals that were repeatedly exposed to the same stressor (Nasu et 
al., 2010). This methodology leads to a gradual decrease of circulating ACTH and corticosterone 
levels, an evidence of the decline of HPA axis responsiveness (Harvey et al., 2006). Remarkably, 
strong analgesic responses, in these animals, could be evoked if a novel stressor was introduced 
(Marti and Armario, 1998).  
The stress response as an acute adaptive mechanism enables the individual to cope with 
challenges and to adjust to new situations. However, prolonged activation will desensitise this 
mechanism unless the intensity of the stimuli is able to overcome habituation. Taking this into 
consideration, the development of learned helplessness in our animals implies the involvement of 
an additional emotionally-dependent stressor. Thus it seems likely that, in the CUS model, the 
unpredictability of the stress factor evoked an additional psychological modulatory component 
(despair) to the equation (), positively reinforcing the stress response (sustained activation of the 
HPA axis) and contributing to prolonged analgesia. On the other hand, in clinical settings the 
opposite effect may be observed. Patients with chronic on-going pain (a source of repeated 
identical stressor) suffer HPA axis hyporeactivity and present increased anxiety and depression 
(Cutolo et al., 2005), whereas patients suffering from mood disorders often suffer from HPA axis 
dysfunction and persistent pain (Fishbain, 1997). The possibility of neuronal remodelling of the 
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areas directly involved in pain modulation could not be discarded as it has been demonstrated 
that chronic stress promotes important structural changes in several brain areas associated to 
memory and cognition (Dias-Ferreira et al., 2010; Romeo, 2010; Cerqueira et al., 2008). In line 
with this reasoning, two other experiments were designed to evaluate the presence of sustained 
chronic stress-mediated functional changes in prime areas of the descending pain modulatory 
circuitry, such as the rostral ventromedial medulla (RVM) (Chapter 2.1.3) and the dorsal horn of 
the spinal cord (Chapter 2.1.2).  
Our results show that, in the brainstem, sustained HPA axis activation altered the neuronal 
activity of the RVM while it also impaired nociceptive transmission in the superficial spinal dorsal 
horn. The RVM is considered an end point of supraspinal pain modulation (Heinricher et al., 
2009; Almeida et al., 2006; Pertovaara and Almeida, 2006), integrating inputs from the 
hypothalamus, the limbic system, cortex and brainstem areas such as the midbrain 
periaqueductal gray (PAG) (Hermann et al., 1997). Additionally, The RVM modulates spinal 
nociceptive transmission by direct descending projections from presumptive pain modulatory 
neurones, the pronociceptive ON-cells and antinociceptive OFF-cells (Fields et al., 1995; 
Neugebauer et al., 2009). Our results demonstrate a significant decrease in the number pain 
modulatory ON- and OFF-cells active in CUS animals pointing to a loss of functionality in the RVM 
(Chapter 2.1.3). Additionally, although the spontaneous activity of both ON- and OFF-cells was 
augmented, preventing us from ascertaining a possible descending net effect, the noxious-evoked 
activity of pronociceptive ON-cells was significantly inhibited while no changes were observed in 
antinociceptive OFF-cells. These data are in accordance with the behavioural analgesia observed, 
as a partial loss of RVM function associated with impaired pain facilitation would inhibit 
nociception (Chapter 2.1.3). Curiously, selective loss of cellular activity in the RVM has previously 
been described to occur during inflammation (Montagne-Clavel and Oliveras, 1994), a pathology 
strongly associated with HPA axis dysfunction. Additionally, it is possible that the RVM cells 
undergo dendritic atrophy in response to overwhelming stress-induced input, similar to what was 
already observed in hippocampal neurones (Cerqueira et al., 2008). Further stereological and 
morphological studies in this area would help to understand the impact of CUS at the cellular 
level in the supraspinal pain control system.  
In parallel to the chronic stress-mediated RVM impairment, our data also demonstrates a strong 
involvement of GR receptors upon spinal nociceptive transmission and pain-like behaviour, as the 
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analgesia observed in the third week for CORT-treated animals (where MR and GR are activated) 
was mimicked by DEX administration (specific GR activation) (Chapter 2.1.2). Concomitantly, in 
the DEX-treated group, in the third and fourth weeks of treatment, GR activation also resulted in a 
decrease in the expression of spinal nociceptive neurotransmitters (CGRP and SP) and an 
increase in the availability of GABAB2 receptors. The GR-mediated effect was not completely 
unexpected since not only GRs have a greater basal availability, when compared to MRs, but the 
analysis of GR/MR receptor distribution throughout the rat brain already showed a stronger 
expression of GRs in brainstem areas such as the PAG and the RVM (Kolber et al., 2008) while 
MR is strongly expressed in the limbic system (McEwen et al., 1968). In addition, in the spinal 
cord, the terminals of nociceptors that express SP and CGRP, which are involved the 
transmission of noxious input from the periphery to the spinal cord, also co-express GR (DeLeon 
et al., 1994). 
However, in the fourth week of pharmacological treatment (DEX and CORT), the dichotomy 
between the recovery in the nociceptive processing of the CORT-treated group and the prolonged 
analgesia in the group treated with DEX was quite intriguing (Chapter 2.1.2). CORT-treated 
animals, in which a simultaneous activation of both MR and GR receptors is maintained, 
displayed a full recovery in nociception, measured by the TF and HP tests. This was further 
supported by a recovery to basal expression levels of nociceptive transmitter (CGRP) in the spinal 
cord. On the other hand, exclusive GR activation (DEX treatment) maintained the increased 
withdrawal threshold in the TF and HP, which was accompanied by a decreased spinal 
expression of SP and CGRP. Two main factors appear to contribute to this discrepancy between 
CORT and DEX after four weeks of treatment: the co-activation of MR in addition to GR in the 
recovery of the CORT-group, and the stronger deregulation of pain modulatory circuitries in DEX-
treated animals (Chapter 2.1.2). In fact, it has been demonstrated that although much less 
available in basal conditions, MR activation is essential to the development of behavioural 
plasticity and recovery (Kolber et al., 2008). Furthermore, Berger and colleagues (2006) had 
already demonstrated that mice where the MR gene had been inactivated in adulthood, exhibited 
a normal anxiety-like behaviour, but lacked behavioral flexibility, which could contribute to our 
contrasting CORT vs. DEX behavioural results. In summary, this study attributes an essential role 
to the equilibrium between MR/GR activation in long-term adaptation of pain circuits to chronic 
stress, identical to what is observed for emotional behaviour (Rozeboom et al., 2007). This 
author showed that a chronic mild elevation in the activation of MRs in the forebrain decreased 
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anxiety-like behaviour in mice through the modulation of the expression of GRs and serotonin 
receptors in the hippocampus, although MR and GR appear to identically regulate the activity of 
the HPA axis, the ratio between MR/GR is significant to the mechanisms involved in emotional 
reactivity.  
Alternatively, if we hypothetically transpose the peripheral effects of GR activation upon CGRP 
expression in primary afferents (decreased expression) to a more central action, the divergence 
between adaptative/maladaptive changes could partly be a consequence of changes in 
supraspinal CGRP content. CGRP expression has been described in the hypothalamus (Dhillo et 
al., 2003), where it is able to activate the HPA axis (Kovacs et al., 1995) and it is also present in 
the limbic system (van Rossum et al., 1997), namely in the central nucleus of the AMY, where it 
has been proven to exert a facilitatory role (Han et al, 2010). Therefore, in DEX- but not CORT-
treated animals, the reduction of CGRP in the AMY would contribute to a decrease pain-like 
behaviour.  
3.3. Role of the PVN in descending nociceptive modulation in normal and arthritic animals 
The ability of corticosteroids to modulate pain-like behaviours is a clear evidence of the 
involvement of the HPA axis in mediating the effects of chronic stress upon nociception. 
However, a specific role of the paraventricular nucleus of the hypothalamus (PVN) upon 
nociception and in pathologies that affect HPA axis function remained to be demonstrated. 
Through the use of retrograde and anterograde anatomical tracers (Chapter 2.2.1) it was 
possible to highlight the major input and output areas of the PVN and to identify those that are 
known to participate in pain control. The PVN shares intense bidireccional projections with many 
other hypothalamic nuclei, such as the dorsomedial and the arcuate nuclei, and the caudal 
hypothalamus besides strong inputs from the limbic system, notably the amygdala, which is in 
accordance with previous specific anatomical studies. Within the midbrain and the brainstem, 
numerous pain modulatory areas project to the PVN, such as the periaqueductal gray matter 
(PAG) (Farkas et al., 1998), the nucleus tractus solitarius (NTS) (Sawchenco and Swanson, 
1982), the rostral ventrolateral medulla (RVLM) (Card et al., 2006), the dorsal reticular nucleus 
(DRt) (Leite-Almeida et al., 2006) and locus coeruleus (LC) (Reyes et al., 2005). On the other 
hand, the PVN projects massively to the PAG followed by the NTS, and, more modestly, to the 
RVM and the CVLM (Chapter 2.2.1). Although most of these targets have already been revealed 
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by previous studies (Herman et al., 1997; Pyner and Coote, 2000; Almeida et al., 2006; Geerling 
et al., 2010), the present work shows the overall map of PVN projections. 
Taking into account the above anatomical data and that CUS decreased the spontaneous and 
evoked responses of RVM pronociceptive ON-cells (Chapter 2.1.3), then it is possible that the 
PVN may play a role in this process. Therefore, through pharmacological manipulation, the 
nociceptive regulatory effect of the PVN upon the spinal dorsal horn and on the response 
properties of RVM cells was electrophysiologically assessed in normal animals. Additionally, a 
second set of animals with monoarthritis (ARTH) was also used in order to evaluate potential 
changes in the descending pain-modulatory drive from the PVN (Chapter 2.3.1), as this pathology 
is known to alter the neurochemistry of this nucleus (Shanks et al., 1998) and chronic stress also 
changes the PVN neurochemistry (Flak et al., 2009). Our results show that the descending drive 
from the PVN is exerted upon RVM pain modulatory cells and spinal neurones. A phasic and tonic 
antinociceptive drive upon pain-like behavioural responses mediated by serotonergic and 
noradrenergic (but not opioidergic) descending projections from the PVN is observed in controls 
animals, but not in the arthritic group. Accordingly, the PVN-induced antinociceptive drive relayed 
by RVM cells in naive animals is also reduced in monoarthritis.  
The fact that modulation of spinal transmission by the PVN was mediated by serotonergic and 
noradrenergic pathways substantiates a role for the RVM and the LC in mediating this effect, as 
these nuclei are the source of spinal serotonin (Fields and Basbaum, 1999) and noradrenaline 
(Basbaum and Fields, 1999; Westlund et al., 1982), respectively. Moreover, Aimone and 
colleagues (1987) demonstrated that the analgesia produced by electrical stimulation of either 
the PAG or the RVM is mediated by serotonergic and/or noradrenergic - but not by opioid - 
receptors in the spinal cord (like the descending drive from the PVN). The loss of the descending 
serotonergic and noradrenergic drive from the PVN after the induction of arthritis points to a 
possible remodelling of the pain circuitry. Aira and colleagues (2010) reported, in chronic pain, 
the occurrence of spinal serotonergic receptor subtype-specific changes that were at the origin of 
enhanced spinal hyperexcitability, and may counteract the descending antinociceptive drive from 
the PVN. Additionally, Wei and colleagues (2010) demonstrated that, during the development of 
persistent pain, RVM descending serotonergic spinal projections contribute to pain facilitation. On 
the other hand, the tonic noradrenergic regulation of nociception has a protective role in disease, 
functioning as an antihyperalgesic mechanism (Mansikka et al., 2004) in response to peripheral 
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carrageenan inflammation (Tsuruoka and Willis, 1996). The decrease in descending 
noradrenergic PVN drive is probably related to plastic changes in spinal neurones and not to a 
decrease in noradrenaline expression as it has been demonstrated that, in supraspinal areas, its 
concentration doubled after arthritis (Harbuz et al., 1994).  
In the RVM, the spontaneous activity of both ON- and OFF-cells is increased in arthritis (Chapter 
2.3.1). Additionally, RVM NEUTRAL-cells have been described as serotonergic (Wei et al., 2010) 
and are possibly recruited in chronic pain conditions (Miki et al., 2002). Hence, the increase in 
RVM ON- and OFF-cell activity after the settlement of arthritis might reflect the recruitment of 
former “silent” pain modulatory neurones due to changes in the neurochemistry of the RVM. On 
the other hand, the effect of the PVN upon RVM nociceptive cells differs between normal and 
arthritic conditions, although always contributing to an overall antinociceptive role. These 
dissimilar activation patterns, before and after the induction of arthritis, are not random, as the 
PVN inhibits RVM ON-cells in control animals and facilitates OFF-cells in arthritic animals 
(Chapter 2.3.1). If we consider that the magnitude of the response of ON-cells to noxious input 
will dictate the intensity of the evoked-behavioural response (Jinks et al., 2007), then a major 
control of the PVN upon RVM cell activation is more important in “normal” conditions. Contrarily, 
taking into account that RVM OFF-cells are able to activate more OFF-cells and to inhibit 
surrounding ON-cells, then the enhancement of the activity of these cells by the PVN in arthritis 
may reveal a tentative counterbalance of the ascending nociceptive drive resulting from ARTH. 
The PVN projects also to the CVLM (Chapter 2.2.1) (Geerling et al., 2010), an area strongly 
implicated in descending pain modulation (Tavares and Lima, 2002), and thus may mediate also 
the descending modulatory action from the PVN. Additionally, we demonstrated for the first time 
the presence of CVLM pronociceptive (+) cells and antinociceptive (-) cells (Chapter 2.3.2), as 
already documented in other supraspinal pain control areas, as the PAG (Heinricher et al., 1987) 
and the RVM (Heinricher et al., 2009). In arthritic animals, nociceptive activity of the CVLM 
appears to partly mediate the antinociceptive drive from the PVN, but through a different 
mechanism of that triggered by the PVN upon the RVM (Chapter 2.3.1). Contrary to the PVN-RVM 
circuitry, the activation of the PVN significantly decreased presumptive CVLM ON-cell evoked-
response during all modalities of peripheral noxious stimulation. Since the effect of the PVN upon 
both the RVM and the CVLM in arthritic animals points to an increased antinociceptive 
modulation, it is possible that a fine tuning of the descending modulatory action from the PVN is 
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dependent on the balance of the antinociception mediated by both nuclei. Future studies should 
evaluate the interaction of these PVN-medullary pathways in coping with the development of 
chronic (arthritic) pain.  
3.4. Role of the DMH in descending nociceptive modulation in normal and arthritic animals 
Stress is known for long to produce analgesia (SIA) (Butler and Finn, 2009), but acute and 
chronic stress also produce hyperalgesia (SIH) (Imbe et al., 2006). It is already established that 
the DMH gives rise to autonomic, endocrine and behavioural changes associated with stress, 
such as increased circulating levels of ACTH, increased heart rate and blood pressure and 
hyperventilation. Additionally, inactivation of the DMH interferes with autonomic and 
neuroendocrine responses, validating the physiological relevance of the DMH in stress response. 
However, while the PVN has been associated with SIA (Filaterov et al., 1996), the DMH has been 
attributed a role in SIH, achieved through a strong activation of ON-cells and suppression of OFF-
cells following DMH desinhibition (Martensen et al., 2009).  
By direct manipulation of the DMH, we demonstrated that in normal pain-free conditions this 
nucleus has a clear pronociceptive role that is mediated, at least in part, by both an increase of 
RVM ON- and a decrease of RVM OFF-cells (Chapter 2.3.3). Again, and like previously discussed 
for the PVN-RVM and PVN-CVLM circuits (see above), the variation in the balance of the activity of 
RVM nociceptive cells is used to give an anatomical mechanism and support to the alterations 
observed in pain behaviour. This rationale, in addition to the simple logic of analyzing the 
variation in the activity of ON- and OFF-cells, is supported by elegant studies performed by 
Heinricher and colleagues. In fact, they showed that neurotensin applied to the RVM was 
hyperalgesic at low doses and analgesic at higher doses and that these pain behaviours were 
associated to a selective activation of ON-cells and a recruitment of OFF-cells, respectively 
(Neubert et al., 2004). Additionally, the secondary thermal hyperalgesia resulting from topical 
application of mustard oil to the skin was associated with an increase in the activity of ON-cells as 
well as a decrease in the activity of OFF-cells (Kincaid et al., 2005). Taking all these data into 
account, we can include the hypothalamic DMH in the up-to-now restricted group of areas of the 
neuroaxis with a clear descending pronociceptive effect upon nociception, as shown previously 
for the DRt (Almeida et al., 1996; 1999; reviewed by Lima and Almeida, 2002; Zhang et al., 
2005; Almeida et al., 2006; Sotgiu et al., 2008). Nonetheless, the parameters that led to a 
stress-related hyperalgesic, rather than analgesic, response are not yet defined. It is possible that 
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this outcome is triggered by forebrain pathways that integrate the motivational-affective 
dimensions of pain (Thompson and Swanson, 1998). Unexpectedly, the descending 
pronociceptive role of the DMH is lost in arthritic animals (Chapter 2.3.3), which was confirmed 
by the absence of a DMH descending drive upon the RVM nociceptive cells in the same 
conditions. This indicates that the DMH may play a role in acute stress-induced hyperalgesia and 
in the facilitation of withdrawal responses to stimuli threatening the integrity of the organism. 
However, and contrary to the PVN, the DMH has apparently no role in the increased noxious-
evoked nociceptive drive that occurs in chronic (arthritic) pain. Nonetheless, future studies should 
evaluate a potential role for the DMH in the spontaneous pain that is associated with the 
development of arthritis. 
Chronic nociceptive pain, as a result of arthritis, alters the PVN modulated endogenous pain 
control system, both at the spinal and supaspinal levels. As the PVN is the mediator of the 
physiologic response to stress, the deregulation of its descending drive upon the brainstem 
constitutes a substrate for the association between chronic stress and chronic pain states. This 
hypothesis is further supported by the neuroplasticity of the pain modulatory RVM cells observed 
after the administration of corticosteroids.  
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Chapter 4 
Conclusions and Future Perspectives 
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 During the course of our studies we were able to identify some of the underlying mechanisms 
that contribute to analgesia in animals under chronic unpredictable stress, while evaluating at the 
same time the influence of the nuclei responsible for mediating the stress response upon the 
neuronal activity of areas of the pain control system. More specifically we demonstrated that: 
 
1. The analgesic effect of chronic unpredictable stress (CUS) is the result of profound 
plastic physiological and neurochemical changes both in the spinal cord and in 
supraspinal areas modulating nociception. 
 
2. The CUS-evoked plastic changes appear to be mediated mainly by the activation of 
GR receptors, but the equilibrium between the activation of both MR and GR 
corticosteroid receptors appears to be essential for the animals to maintain the 
ability to adapt to the experimental challenges.  
 
3. The direct effect of CUS upon the activity of RVM pain modulatory cells was 
restricted to neurones receiving solely nociceptive inputs, as the activity of RVM 
convergent neurones that also processed innocuous stimulation were not altered. In 
these cells, CUS resulted in a decrease of both the spontaneous and noxious-evoked 
activity of RVM pronociceptive ON-cells, which is in accordance with the behavioural 
antinociception observed. 
 
4. Through the use of anatomical tract-tracing techniques, the PVN connections with 
the brain showed that it is part of an extensive network comprising many supraspinal 
pain modulatory areas. These included regions involved not only in the processing of 
the different dimensions of the pain experience, but also in descending pain 
modulation. 
 
5. The PVN, the effector of the stress response, decreases tonic and phasically spinal 
nociceptive transmission through serotonergic and noradrenergic (but opioidergic) 
pathways, while modulating also the activity of pain modulatory neurones in the RVM 
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and CVLM. The loss of serotonergic and noradrenergic descending drive, as well as 
the change in the ability of the PVN to modulate RVM and CVLM cell response in 
arthritic animals, indicates that the PVN-mediated antinociceptive systems suffer 
profound remodelling in pathological conditions. 
 
6. Arthritis induces substantial changes in the basal and evoked activity of pain 
modulatory neurones in both the RVM and CVLM. Interestingly, although an overall 
activation of basal neuronal activity in both nuclei is observed, subtle changes in the 
noxious-evoked responses of these cells in each nucleus will occur depending on 
stimulus modality applied. This indicates the possibility of a specific contribution of 
each area towards the enhancement of a specific component of chronic pain.  
 
7. SIH shares common descending modulatory pathways with SIA, through the 
modulatory effect of the DMH upon the activity of pain modulatory cells in the RVM. 
Surprisingly, the circuitry centered in the DMH and mediating noxious-evoked 
hyperalgesia does not participate in the development of arthritis. 
 
Further studies soughing to address the interaction between these two systems, chronic pain and 
chronic stress should focus on:  
1. Assessing the specific contribution of PVN outputs to nociceptive processing in a 
prolonged stress scenario, as it was demonstrated that the persistent HPA activation by 
arthritis altered not only the activity of pain modulatory areas, but also impaired PVN-
mediated antinociception. 
 
2. Determining the time-dependent biochemical and physiological changes occuring in 
prime areas within the neuronal network meditating pain chronification in arthritis. An 
initial behavioural assessment of cognitive performance would help to identify possible 
limbic and cortical counterparts involved in inflammatory pain. Additionally, and since the 
enhancement or inhibition of a specific area during persistent pain states is a dynamic 
mechanism, the prolonged recording of the neuronal activity in these areas in association 
to pain modulatory centres would help to uncover critical time points in the pain 
chronification process. 
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 3.  Investigating possible structural changes associated with the development of chronic 
inflammatory pain. The stereological analysis of the structure of the PVN and areas 
involved in pain descending modulation would highlight changes occurring in the number 
of neurones and glial cells as well as in the total volume of these areas. In parallel, the 
morphological study of the dendritic trees would further contribute to shed some light 
upon the dynamics of inflammatory pain at the cellular level. 
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